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Genetic mutations provide the raw material for evolution, they are responsible for her-
itable disease and drive the development of cancer. It has been previously shown that
the binding of chromatin and regulatory proteins to DNA can interfere with replication,
surveillance and repair processes but the proposed mechanisms presume the loading of
sequence-specific binding factors over nucleotide mismatches and other lesions. This
seems paradoxical for binders that recognise their docking sites by motif with defined
sequence. In this work I propose the biased mask model where the binding of some tran-
scription factors can tolerate mismatch substitutions or other lesions strand specifically
at some sites, acting as a selective filter of new mutations. I provide electrophoretic
mobility shift assay support for the biased mask, and illustrate how it is shaping the
mutation patterns of both cancers and the human germline. Being replication associ-
ated, the mutational burden of this biased mask predicts that the protein binding sites
occupied during germline replication are hotspots for functionally important mutations,
which will be exacerbated by increased paternal age. Exploring this, in collaboration
with other group we have isolated and applied chromatin accessibility assay, ATAC-
seq, to primary human and mouse spermatogonial cells, which account for up to 80%
of human and 30% of mouse germline DNA replication. I have used this data to de-
velop a custom ATAC-seq processing pipeline and map protein binding landscape of
the germline, and also of a number of somatic tissues for which ATAC-seq data was
available. By combining this map with human and mouse population variation data I
confirm sequence specific binding sites in germline as hotspots of deleterious mutations,





Mutations are changes in the identity of individual building blocks of DNA, which
is a molecule that carries instructions for the correct structure and function of a cell.
Mutations occurring in cells that lead to the formation of sperm in males and oocytes in
females (germline cells) can cause diseases that will be passed on to the next generation.
The occurrence of mutations in other cells of the body can lead to various diseases,
including cancer. Preservation of special sites on the DNA where proteins can attach
(protein binding sites) is important for the correct function of the cell. In this work
we isolated highly dividing germline cells where we anticipate that the majority of
heritable mutations are occurring. I have identified locations of protein binding sites
in those cells, as well as in a number of other tissue types. Here I show that binding
sites that are active in the germline exhibit a high frequency of mutations. I provide
evidence that those mutations are deleterious and are likely to cause hereditary disease.
I provide examples of such mutations in cancers and demonstrate that those mutations
are likely caused by the physical interaction of protein and DNA. I propose a model
that explains how proteins are able to cause harmful mutations at the sites on the DNA
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The central dogma of genetics postulates that the flow of information in a
cell is a step-wise conversion of instructions from the level of deoxyribonucleic acids
(DNA) to ribonucleic acids (RNA) and then to proteins (Crick, 1958). The storage
and inheritance of information in the cell is a prerogative of the DNA in the form of a
quaternary code. Individual units that the DNA consists of are four types of bases –
A (adenine), T (thymine), C (cytosine) and G (guanine). Those bases come together
to form long stretches of instructions encoding the components and organisation of a
living organism. This is our genome.
Genomes are normally faithfully replicated and inherited - the reason progeny
tend to resemble parents. However, changes to the order or identity of DNA bases do
occur and are termed mutations. While mutations provide a new material for selection
to act upon and drive evolution, they are more often deleterious than advantageous
and can result in disease (Kimura, 1968, 1991). Mutations come in different shapes
and sizes, including base changes (substitutions); the insertion or deletion of a single
or small number of bases (indels), to larger scale re-ordering with sequences ’flipped
around’ (inversions); or relocated to a different part of the genome altogether (translo-
cations). Normal endogenous processes within a healthy cell can lead to the generation
of new mutations but the rate of mutation can be dramatically increased when DNA
is damaged by exogenous agents, such as tobacco smoke or ultraviolet radiation (Chat-
terjee and Walker, 2017). There are processes within the cells that act to counteract
this and repair the damage.
The distribution of mutations across the genome is far from uniform (Makova
and Hardison, 2015), and uncovering the mutational patterns and processes that shape
them is important for understanding how diversity arises, how various types of genetic
diseases occur (e.g. cancer) (Alexandrov, 2018) or in what ways the process of ageing
is likely to affect the organism’s fitness (Garinis et al., 2008).
Our genome is akin to a globe, with continents and oceans, countries, seas and
deserts. Mutations can be meteors falling down from the sky and depending on the type
of area they impact, the consequences will differ. Mutations occurring within the coding
regions of genes, termed exons, can affect the functionality of the resulting protein,
while the ones occurring outside coding sequences might have an effect on regulation
of expression of a nearby gene, or possibly no biological consequence at all (falling into
the ocean far away from anything). Some areas get hit much more frequently than
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others. The frequency with which a certain position or an area gets mutated is termed
the mutation rate. The human germline mutation rate has previously been estimated
to be ≈ 1 − 1.5 x10−8 mutations per site per generation: a child is expected to have
between 70 and 80 new mutations that were not inherited by their parents (Michaelson
et al., 2012; Kong et al., 2012; Francioli et al., 2015), however if we were to travel
along the genome, we would find that there is a great regional variability (Makova and
Hardison, 2015). To understand fluctuations in the mutation rate we must consider
a manifold of states that can be ascribed to every region of the genome, spatial and
temporal organisation of different cellular processes and the context of the underlying
sequence, as well as the physical nature and properties of bases.
In the introduction to this work I will cover the general overview of DNA
and genome structure, how genetic information is read and expressed, and how it is
organised within a cell (Section 1.1). The vast part of the genome is thought to be non-
coding (International Human Genome Sequencing Consortium, 2001) and a portion of
it plays a role in regulation of gene expression (Dunham et al., 2012), acting as docking
sites for the proteins that bind to specific sequences and manage the expression of
genes. Hence I will describe why non-coding sequence preservation can be important
and how the sequence-specific binding of certain proteins regulates gene expression and
thereby a phenotypic outcome (Section 1.2). I will describe how cells ensure that high
fidelity copy of the genome gets passed on to the daughter cells (Section 1.3), and
discuss the variability in the mutation rate across the genome associated with aspects
of replication, but also with other features that underlie the difference in the mutation
rates (Section 1.4). I shall then go on to introduce the role of mutations in a particular
group of cells termed ‘germline cells’, the only cell population in multicellular organisms
that is able to propagate its genomic information through to the next generation. I
will also describe the importance of the mutations that occur in cells of the body
termed ‘somatic cells’ that never make it to the progeny, but are hugely important
for fitness and survival of the organism itself. I will give an overview of how multiple
repair mechanisms work to try and counteract those mutational processes, how their
activity fluctuates across the genome and hence contributes to the variability of the
genome-wide mutational landscape (Section 1.5).
Genetics poses many questions. How does all the variability we see around us
come about? What are the role of specific or stochastic processes in shaping variability?
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And how can we utilize knowledge of those processes to improve the quality of human
life? The work described here touches on all aspects of this, looking at whether certain
changes in the composition of our genome are likely to have any functional impact
(in relation to the regulation of the gene expression by the proteins such as transcrip-
tion factors), at how those changes come about (what are the mechanistic causes of
those changes), and provides some information that would help to identify where those
changes generally are more likely to happen.
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1.1 Genome structure
1.1.1 Basic blocks of life
One hallmark of a living organism, together with prerequisites of consisting of one or
multiple cells, responding to environmental stimuli and capacity to convert energy, is
an ability to reproduce, creating another life form that is similar, and in some cases,
identical to the original entity (Koshland Jr., 2002). This is achieved by utilization
of a molecule termed DNA, which is commonly referred to as a ’blueprint’ of the cell,
because it contains information that is necessary to ’build’ a cell/organism, maintain
it, and respond to external stimuli. Information encoded within the DNA can be
copied, which allows supply of identical, or nearly-identical, DNA molecules to each of
individual entities of a divided cell.
DNA consists of two strands of polymers that are made up of four types
of monomer units termed ’nucleotides’ - adenines (A), thymines (T), guanines (G),
and cytosines (C) (Figure 1.1) in a manner that has been proposed and described by
Watson and Crick (1953) more than 60 years ago. Each of the nucleotides consists of a
5-carbon sugar, a nitrogenous base, and one phosphate group, and can be classified as
ether purine, where nucleotide base contains two carbon-nitrogen rings, or pyrimidine,
containing one. Strands that make up the DNA duplex have opposite directionality.
Those two polymeric strands are connected to each other by hydrogen bonds in a
specific manner, where a pyrimidine-containing nucleotide on one strand only pairs up
with a complimentary purine on the other strand. Thymine and cytosine will normally
pair up only with adenine and guanine, respectively. The total set of those nucleotides,
or base pairs, present in a cell is termed a genome and the human genome contains
approximately 3 billion of those base pairs, and most cells contain two copies of the
genome.
1.1.2 Higher order structures
The complete genome is not distributed randomly across the cell, nor is it contained
within a single molecule. In humans, it is unevenly divided between 23 intricately
compacted units, termed chromosomes. The number of chromosomes varies between
6



















































Figure 1.1: DNA consists of two strands of polymers that are made up of four types of monomer
nucleotide units - adenines (yellow), thymines (blue), guanines (purple), and cytosines (red).
Each of the nucleotides consists of a 5-carbon sugar, a nitrogenous base, and one phosphate
group. Nucleotides are connected to each other in a linear strand by covalent phosphodiester
bonds that form between the phosphate group of one nucleotide and the hydroxyl group of another.
The end containing the hydroxyl group is termed 3’, and the end containing phosphate group
is termed 5’. Those two strands are connected to each by hydrogen bonds in a specific manner,
where thymine normally only pairs with adenine, and cytosine pairs with guanine.
species, e.g. mice have 20. Each cell of the human organism contain two copies of
each chromosome, in which case the genome is said to be diploid. Exceptions to this
are egg and sperm cells, where only one copy of each chromosome is present, in which
case it is said to be in a haploid state. While 22 of the chromosome pairs, which are
called autosomes, are more or less similar to each other, the individual chromosomes
of the 23rd pair (allosomes) can differ, and are involved in determination of sex. There
are two types of allosomes - X and Y. Individuals that possesses two copies of the X
chromosome are defined genetically as a female, while individuals that have one of both
the X and Y chromosomes are defined genetically as a male.
Chromosomes are compacted into ordered structures with a help of nucleo-
somes, that in turn consist of histones (reviewed in Cutter and Hayes (2015)) (Figure
1.2). Each nucleosome contains 8 histone proteins, which are positively charged. Due
to the fact that DNA is negatively charged, it interacts with the histones well. Ap-
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proximately 147 base pairs (bp) of DNA wrapped around a nucleosome, together with
a special type of linker histone (H1/H5) that binds at ≈ 20− 80 bp region between nu-
cleosomes, forms a chromatosome. Those structures then fold up to form 30 nm fibres,
which in turn form higher order structures that are tightly coiled to form a chromatid
(Li and Reinberg, 2011). Collectively, the DNA-protein complex is termed chromatin.
In humans, sister chromatids are held together at the region called centromere. Ends
of the chromosomes are called telomeres, which are DNA-protein complexes that act to
prevent fusion between chromosomes, and their degradation (O’Sullivan and Karlseder,
2010).







Figure 1.2: Higher order chromatin structure. Approximately 147 base pairs of DNA wrap
around eight core histone proteins, which make-up a nucleosome unit, and these form 11 nm
fibres. Nucleosomes are compacted to form 30 nm chromatin fibres which then form loops
averaging ≈ 300 nm in length and are further compressed and coiled to form a chromosome.
1.1.3 The coding and non-coding genome
DNA encodes instructions for the synthesis of proteins out of amino acids. A segment of
DNA that codes for a particular type of protein is called a protein-coding gene. For pro-
duction of that protein one of the DNA strands containing the gene (template strand)
is ’read’ by an RNA polymerase II enzyme to produce a messenger RNA molecule
(pre-mRNA) (Brenner et al., 1961), which is complementary to that DNA strand using
8
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similar base pairing rules to double-stranded DNA, in a process called transcription.
Genetic positions towards the 5’ end of the template strand are referred to as being
upstream, while the ones towards the 3’ end - downstream. Transcription can only
proceed from 3’ to 5’ on the template strand, with RNA growing in 5’ −→ 3’ direction
(nucleotides are always added to the 3’ end). The chemical difference between DNA
and RNA is that the latter contains a ribose sugar backbone, instead of deoxyribose,
and it is single-stranded. In addition to that, thymine is replaced by its analogue uracil,
which does not contain a methyl group.
Pre-mRNA contains within itself two types of sequences - exons and introns
(Chow et al., 1977; Berk and Sharp, 1977). Exons are part of the transcript that contain
information about the structure of a protein, while introns are intervening sequences
in between exons that do not code for protein products. Introns are excised from pre-
mRNA in a process termed splicing. In the process of splicing, not only introns, but
also exons can be excised, which leads to a single gene being able to produce several
alternative transcripts, and therefore multiple protein products. An mRNA molecule
is then processed by a ribosome (Palade, 1955), which constructs a protein from the
polymerisation of amino acids in an order dictated by the RNA nucleotide sequence,
in a process termed translation. Each nucleotide triplet sequence falling into non-
overlapping windows, termed codons, defines that a specific amino acid be added to
the growing peptide (Nirenberg et al., 1966). Considering that there are 4 nucleotide
types and 64 possible triplet sequences, they could potentially code for that many
amino acids. However, there is a degree of redundancy, and multiple codons represent
the same amino acid, thereby limiting the number of possible options to 20. This
redundancy mainly comes from the third position within the codon, and is commonly
referred to as third position wobble, as in most cases change in the nucleotide identity
at that position does not alter the incorporated amino acid. Some of the codons act as
a mechanism that instructs translation to cease. Conversely, a special type of codon,
called a ’start codon’, that codes for the amino acid methionine, signals the position
from which a ribosome should initiate translation.
Only a small proportion of the human genome is thought to be coding (less
than 2%) (International Human Genome Sequencing Consortium, 2001). The rest does
not code for any currently known proteins and consists of various different elements
(Dunham et al., 2012), and a large portion of the genome is transcribed and generates
9
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Figure 1.3: Transcription and translation. One of the two strands of DNA, which contains
a gene going in the 3’−→5’ direction - a template strand - is copied by RNA polymerase to
produce a messenger RNA (mRNA) molecule that is single-stranded and contains uracils in
place of thymines. mRNA is then processed by a ribosome that assembles amino acids into a
peptide to form a protein according to the information encoded on mRNA in chunks of three
nucleotides termed codons.
different forms of RNA molecules (Forrest et al., 2014). This includes ribosomal RNAs
(rRNAs), which play an important part in the ribosome structure, transfer RNAs
(tRNAs) that serve as a link between mRNA and amino acids, as well as several others
such as long non-coding RNAs (lncRNAs) and small nuclear RNAs (snRNAs). Those
regulate many processes, including gene expression, with many functions still unknown
(reviewed in Cech and Steitz (2014)). Transposable elements - sequences that have
an ability to move to different locations in the genome; pseudogenes - genes that have
lost their functionality; and satellite DNA - arrays of tandemly repeating sequences
also contribute towards a vast part of human non-coding genome. One of the most
important functions of the non-coding genome is regulation. With a limited number
of protein-coding genes and their similarity between species, it has been proposed that
the differences between organisms stems in a large part from the variation in regulation
(King and Wilson, 1975; Wittkopp and Kalay, 2012), therefore regulatory sequence
elements within the non-coding genome are recognized to carry an important role.
10
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1.1.4 Chromosomal domains, compartments and their interactions
Not all of the chromatin is compacted in the same way and to the same degree. It can
be broadly divided into euchromatin and heterochromatin. Euchromatin is less com-
pacted permitting DNA accessibility for frequently transcribed genes and as a result,
most of the genes tend to be located in euchromatic regions. Heterochromatin is a more
tightly compacted and tends to be located towards the periphery of the nucleus. Con-
stitutive heterochromatin tends to assemble at repetitive elements, while facultative
heterochromatin can harbour developmentally regulated genes, compaction of which
can vary depending on the stimuli (Wang et al., 2016).
Chromosomes are thought to reside within distinct locations throughout the
nucleus, chromosome territories (CT) (Cremer et al., 2001). Individual chromosome
segments have also been suggested to be organised into topologically associated domains
(TADs), though to be conserved across different cells (Dixon et al., 2012). TADs are
regions of the genome that tend to interact with each other more than with the other
regions. It is not clear whether larger scale TADs are similar to smaller-scale structures
present within them, such as sub-TADs and individual chromatin loops, leading to
the idea that variable organization on smaller level structures might be associated
with cell-specific gene expression (Dixon et al. (2016)). Binding sites of the main
architectural protein of chromosomes - CTCF - have been found to be enriched at TAD
boundaries, consistent with its role as an insulator, which together with cohesin protein
complex brings close distant genomic regions to form loops, and is a key player in TAD
organisation (Dixon et al., 2016). Loss of cohesin complex has been shown to eliminate
formation of loops and TAD domains, but only modestly affects expression of active
genes (Rao et al., 2017; Schwarzer et al., 2017).
Recent studies have revealed that distinct genomic megabase-sized compart-
ments (which are roughly equivalent to closed and open chromatin) form without
CTCF/cohesin involvement (Rao et al., 2017; Schwarzer et al., 2017; Seitan et al.,
2013). Those compartments are characterised by particular chromatin marks and have
been speculated to arise due to formation of a ’compartment globule’ mediated by either
bridging of proximal nucleosomes by proteins (polymer-polymer phase separation), or
stabilization by proteins that exhibit multivalent interactions among each other (liquid-
liquid phase-separation) (Erdel and Rippe, 2018). Association of compartments with
11
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particular chromatin marks is a possible underlying reason for recruitment of various
elements, such as DNA repair systems whose targeting is known to be linked to histone
modifications (House et al., 2014), to certain sub-compartment regions.
Therefore, these two modes of 3D architecture (loops/TADs and compart-
ments) are thought to comprise two distinct layers of chromatin organisation, which
can be acting in opposing manner. For example, a TAD might be bringing together
two loci that would normally reside in separate sub-compartments (Rao et al., 2017;
Schwarzer et al., 2017).
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1.2 Transcription factors and regulation of gene
expression
1.2.1 Regulatory elements in the genome
There are several types of trans- and cis- regulatory elements, previously suggested to
constitute up to 80% of the human genome (Dunham et al., 2012). Trans-regulators
mainly consist of proteins and various non-protein coding RNAs (reviewed in Cech and
Steitz (2014)), while cis-acting elements contain, among others, promoters, enhancers,
insulators and silencers. Those elements can often be characterised by the presence
of specific chromatin marks - modifications on the histones that are in an immediate
proximity to those elements, what is often referred to as a histone code (Strahl and Allis,
2000). More than 500 different histone modification have been characterised (Zhao
and Garcia, 2015). Different histone marks might be present on a particular type of
elements depending on whether they are in active or inactive states, or compartments.
Those elements, when active, are located within the accessible part of the genome
because various proteins, termed transcription factors (TFs), require access to the
DNA sequence to bind. Recent attempts at characterisation of the regulatory elements
in the non-coding genome have resulted in large-scale generation and aggregation of
multiple types of data in project such as ENCODE (Dunham et al., 2012) and Roadmap
Epigenomics (Roadmap Epigenomics Consortium et al., 2015).
1.2.2 Transcription factors
TFs are proteins that regulate transcription so that it occurs in the right cells at the
right time. While different TFs can be simplistically classified as either activators or
repressors, depending on whether they promote or block transcription, some TFs have
been found to be both, with their function being dependent on context (Schmitges
et al., 2016). They interact with DNA in a sequence-specific manner through their
DNA-binding domain (DBD). Modes of action among different TFs can vary - while
some act by recruitment of co-factors, or even RNA polymerase itself, binding of some
is actually aimed at occlusion of specific sequences to prevent other TFs or nucleosomes
from binding.
13
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While TFs are generally thought of as binding to the nucleosome depleted
DNA, where binding motifs tend to be more exposed, there is a specific class of TFs,
termed pioneer factors (Takahashi and Yamanaka, 2006), which are able to bind nucle-
osomal DNA and promote chromatin opening. Ability of those proteins to bind might
be due to the position of their binding motif, that is displayed on the nucleosome sur-
face (Soufi et al., 2015). This process permits subsequent binding of other TFs, and
demonstrate their dynamic interplay for controlling gene expression.
Evolution of TF activity can be driven by alterations in protein-protein inter-
actions and sequence specificity, and levels of TF expression (Schmitges et al., 2016).
Proteins that contain a C2H2 zinc finger DBDs are the largest family of TFs in ver-
tebrates (Hughes, 2011). In a recent review by Lambert et al. (2018), authors have
undertaken a survey of human TFs, and have re-analysed and extended the previously
compiled lists of 355 (Fulton et al., 2009) and 1,391 (Vaquerizas et al., 2009) human
TFs to 1,639 known or likely transcription factors, most of which are C2H2 zinc finger
proteins.
1.2.3 Promoters
Promoters are a class of regulatory element that are normally within ≈ 500bp upstream
of TSS and are regions where a transcription initiation complex forms. Promoters of
expressed genes generally show open conformation and are bound by multiple TFs that
recruit RNA polymerase II and other components necessary for transcription to the
core promoter (approximately 50bp upstream and downstream of the TSS) (Haberle
and Stark, 2018). Sites of transcription initiation can be defined by various techniques,
such as cap analysis of gene expression (CAGE), which works by capture of the 5’ end
cap of mRNAs (Shiraki et al., 2003).
Because active promoters harbour a dynamic range of TFs and transcription
machinery, they are considered to be nucleosome-depleted. Though rather than being
completely devoid of them, they might instead harbour more ’dynamic’ nucleosomes,
that contain specific histone variants (Jin et al., 2009; Young et al., 2017). For dif-
ferential regulation of gene expression, some promoters exhibit open conformation, to
allow gene transcription, while others remain closed to suppress it. This is frequently
accompanied by a change in the histone modifications such as trimethylation of histone
H3 Lys4 (H3K4me3) and acetylation of H3 Lys27 (H3K27ac), which are active marks,
14
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or trimethylation of H3 Lys27 (H3K27me3), an inactive mark (reviewed in Elkon and
Agami (2017)). Interestingly, promoters at 5’ ends of genes encoding for key devel-
opmental TFs have been found to be kept in a ’poised’ state in embryonic stem cells,
marked with both active and repressive chromatin marks (Bernstein et al., 2006). A
subset of housekeeping promoters can be consistently found open/active in multiple cell
types, and those are likely to accompany genes that are essential for basic cell mainte-
nance and function. Promoters that are only found to be active in a specific tissue are
termed tissue-specific promoters and are more likely to control expression of genes with
a specialized role. Promoter regions tend to be enriched in CpG dinucleotides relative
to the rest of the genome, and overlap with CpG islands (Gardiner-Garden and From-
mer, 1987; Deaton and Bird, 2011). This tends to be more pronounced at housekeeping
promoters, presumably because of their hypomethylated status in the germline (Sax-
onov et al., 2006), as methylated CpGs frequently undergo C −→T change (Youssoufian
et al., 1986), which is predominantly a mammalian feature.
1.2.4 Enhancers
The role of promoters in the regulation of transcription is complemented by activity
of more distal elements termed enhancers. Enhancers are regions that are not nec-
essarily located in linear proximity to the TSS, or co-oriented with the direction of
transcription (Bulger and Groudine, 2011). Instead they are thought to interact with
promoters through the three-dimensional organisation of chromatin, regulated through
TADs (Subsection 1.1.4). Enhancers may also be bound by TFs and co-factors, and in-
teractions with promoters can have an effect on the transcription of promoter-proximal
genes (Figure 1.4).
In recent years the notion of super enhancers has emerged, which defines large
genomic regions several kilobases in length, which bind multiple TFs at increased den-
sity and are responsible for driving cell type-specific gene expression (reviewed in Pott
and Lieb (2015)). Initially defined as master regulators of pluripotent embryonic stem
cells (ESCs), and characterised by a large number of binding sites for pluripotency-
associated TFs (such as KLF4, OCT4, SOX2, NANOG, and ESRRB), and Media-
tor complex, super-enhancers have also been found in other cell types (Whyte et al.,
2013). Enhancer elements are commonly considered to exhibit acetylation of histones,
lower ratio of tri- versus mono- methylation on the histone H3 lysine 4 (H3K4me3
15










Figure 1.4: Regulation of gene expression. The core promoter constitutes a region approximately
50bp upstream and downstream of the transcription start site (TSS), where RNA polymerase
and TFs bind. TFs regulate gene expression and can recruit other co-factors. Enhancers are
regions that can be bound by TFs, which can be located far from the TSS on linear DNA, but are
brought into proximity to a promoter through the three-dimensional arrangement of chromatin.
Enhancer-promoter interaction can further regulate gene expression.
and H3K4me1, respectively), and presence of particular histone variants, such as H3.3
and H2A.Z (Calo and Wysocka, 2013). Transcription, often bidirectional and resulting
in production of short and unstable transcripts, has been found to occur at enhancers
(Kim et al., 2010). While the presence of bidirectional transcription has previously been
proposed to mark enhancer activity, it has also been shown to be a general property
of accessible regions, rather than a mark of functionality, and not specific to enhancer
elements (Young et al., 2017).
1.2.5 Identification of protein-binding sites
There have been multiple techniques and methods developed for identification of tran-
scription factor binding sites (TFBSs) and sequence motifs associated with those. Chro-
matin immunoprecipitation followed by sequencing (ChIP-seq) is one of the most widely
used techniques for TF binding site identification (Johnson et al., 2007) and involves
16
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cross-linking a protein to DNA using formaldehyde following precipitation with an an-
tibody that is specific in recognising the target TF. It does have a caveat in the form of
detection of indirect binding due to protein-protein interactions, and does not measure
equilibrium binding due to the cross-linking step. ChIP-seq results constitute rather
wide ’peaks’ that define sites where TFs are bound, but lack single nucleotide-resolution
of protein-DNA interactions. ChIP-exo is a variation of ChIP-seq which with addition
of the exonuclease digestion step gives a much more precise measure of protein binding
(Rhee and Pugh, 2011), but to date has been implemented in relatively small number
of studies. Regions defined by ChIP-seq can then be scanned to look for recurrent
sequences, or motifs, that TFs preferentially bind to.
More general techniques, aimed at identification of the open chromatin in-
clude DNase I hypersensitive sites sequencing (DNase-seq) (Song and Crawford, 2010),
formaldehyde-assisted isolation of regulatory elements (FAIRE-seq) (Simon et al., 2012),
and more recently developed assay for transposase-accessible chromatin using sequenc-
ing (ATAC-seq) (Buenrostro et al., 2013). Those techniques take advantage of the sensi-
tivity of nucleosome-bound DNA to formaldehyde cross-linking (in case of FAIRE-seq),
and enzyme accessibility of the open chromatin (DNase-seq and ATAC-seq), whereas
DNA that is bound by nucleosomes or other proteins is protected from digestion. These
techniques can also be used for the identification of the transcription-factor binding
sites.
The ability of proteins to protect interacting DNA from digestion is a general
idea employed in methods for identification of TFBSs, and their detection is commonly
called ’footprinting’. Multiple methods and software have been developed for identifi-
cation of binding sites from DNase-seq data (comparative analysis of such software has
been done by Gusmao et al. (2016)), and less so for ATAC-seq, mainly due to former
being available for longer. While theoretically DNase-seq methods for footprinting can
be applied to ATAC-seq data as well, properties of two types of data can differ, primar-
ily due to the different sequence biases associated with the enzymes used for digestion.
Difficulty in evaluating the performance of any of the methods is the lack of a ultimate
’gold standard’: ChIP-seq results are generally useful in this respect, but the variability
in site occupation dynamics between cells, and the limited number of TFs for which
ChIP-seq has been performed, can be prohibitive.
17
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1.3 DNA Replication
As mentioned in the beginning, one of the hallmarks of live organism is its ability to
procreate. In order to achieve this, genetic information in form of DNA has to be copied
in the process termed replication, followed by a cell division. Replication takes place at
the S phase (synthesis) of the interphase that precedes mitosis, the division into two
daughter cells (Flemming, 1879). During S phase, all of the chromosomes are duplicated
to form two identical copies. This is followed by prophase, when chromosomes condense,
metaphase, when chromosomes align along the cell equator, anaphase, when sister
chromatids separate and are pulled apart, and telophase, after which point one cell
becomes two individual daughter cells upon undergoing cytokinesis.
1.3.1 Replicative asymmetry
The process of replication occurs in a semi-conservative manner (Meselson and Stahl,
1958), which means that each of the two DNA strands serve as a template, are paired
with newly synthesised strands of DNA and separated into daughter cells. Replication
initiates in an organised manner at sites within the genome, termed the origins of
replication, which fire at specific times during S phase of the cell cycle (Jacob et al.,
1963; Burgers and Kunkel, 2017). Initiation of this process leads to separation of two
strands with the help of specific protein complexes (Moyer et al., 2006). As replication
origins are not located at the ends of the chromosomes, this causes the formation of the
replication bubbles with two replication forks proceeding in opposite directions (Figure
1.5). As new nucleotides can only be added to the 3’ end of the growing strand,
replication is also said to be asymmetric. While synthesis of one of the new strands can
proceed continuously, essentially following the replication fork, the other strand has to
be synthesised in a discontinuous manner, in stretches of short Okazaki fragments, a
couple of hundred base pairs at a time (Okazaki et al., 1968). The former is termed as
the leading strand, while the latter is known as the lagging strand.
Class of enzymes termed DNA polymerases are responsible for synthesis of new
DNA (reviewed in Johansson and Dixon (2013)). There are several DNA polymerases
that are primarily responsible for replication in eukaryotes - Polα, Polδ, and Polε.
Possessing a primase activity - the ability to create a RNA primer, Polα is responsible
18
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for initiation of both leading and lagging strands at the origins of replication, and
also for every Okazaki fragment on the lagging strand thereafter (Perera et al., 2013).
Initial stretches synthesised by Polα are then extended by Polε on the leading strand
and Polδ on the lagging strand (Stith et al., 2008). Some evidence suggests that Polδ
might also be involved in initial steps of leading strand replication (Daigaku et al., 2015;
Garbacz et al., 2018). On lagging strand, Polα-synthesised DNA is normally replaced
by Polδ which is synthesising preceding Okazaki fragment. It has been shown that a
substantial proportion of Polα-synthesised DNA (≈ 1.5%) is retained in the mature
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Figure 1.5: Replication initiates bidirectionally from multiple origins across the genome. Nu-
cleotides can only be added to the 3’ end of the growing strand, therefore one of the strands
(leading) can be synthesised continuously, while the other one (lagging) has to be synthesised
in stretches of discontinuous Okazaki fragments. Nucleosomes have to be disassembled in front
of the replication fork and reassembled on the newly synthesised duplex. Transcription factors
similarly have to be removed as the fork progresses.
19
20 1.3. DNA REPLICATION
1.3.2 Replication and chromatin
As mentioned in Section 1.1, DNA is compacted by being wrapped around nucleo-
somes, and in nucleosome-depleted regions it is bound by other proteins such as TFs
(Section 1.2). All of those present obstacles to the progression of the replication fork
if they remain bound to DNA during replication. Therefore they must dissociate and
then re-associate on the newly synthesised duplexes. Due to the doubling of the DNA,
twice as many histones are needed to preserve the same chromatin compaction as was
present on the original duplex and a mixture of old and newly synthesised histones are
laid down behind the replication fork (Lai and Pugh, 2017). Histone marks present on
the old histones are copied over to the new ones, thereby preserving the histone code
(Petryk et al., 2018). In yeast, Okazaki fragment termini are enriched at the nucleo-
some dyad positions and at some of the protein-binding sites, suggesting that Okazaki
fragment processing is connected to nucleosome assembly and TF binding (Smith and
Whitehouse, 2012). The presence of only one copy of the TF per two newly-synthesised
genomes has lead to speculation that the distinct patterns of gene expression in daughter
cells can be the result (Whitehouse and Smith, 2013). Reassembled nucleosomes have
been shown to lack precise positioning immediately following replication, and ascer-
tain a more stable location after undergoing maturation (Ramachandran and Henikoff,
2016). The same study reported deposition of histones at normally nucleosome-depleted
regions, such as promoters and enhancers, shortly after replication, and necessity of the
TFs to compete with histones to access their binding site. Interestingly, TFs at the
tissue-specific enhancers were less efficient at competing, while broadly active ones had
TFs that were quicker to associate with DNA.
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1.4 Mutational heterogeneity
1.4.1 Mutation types
Mutations are changes in the identity, order, or number of nucleotides within the DNA
sequence. Mutations can be classified into several different categories based upon the
type of change, or the effect that the mutation produces. The simplest type of mutation
is a single nucleotide substitution, where nucleotide identity is changed at a genomic
position. While the initial change likely occurred on only one of the complementary
strands, after a single round of replication this change can lead to altered nucleotide
identities on both of the strands in one of the daughter cells, with potentially no change
in the second daughter cell. Single nucleotide changes can result from a variety of
DNA lesions. Loss of the nucleotide’s nitrogenous base leads to formation of an abasic
site, which are more likely to affect purines, rather than pyrimidines, with adenine
preferentially incorporated opposite the lesion (Randall et al., 1987). Incorporation of
the non-complementary base opposite the template during replication, or a spontaneous
change in the nucleotide identity on one of the strands, leads to formation of a mismatch.
Some bases can be modified by endogenous or exogenous factors, such as oxidative
stress, UV radiation and tobacco smoke (Chatterjee and Walker, 2017).
Other types of mutations include insertions and deletions, collectively termed
indels; duplications, inversions, translocations, and others. When occurring within
genes, mutations can be classified on the type of effect that they have on the resulting
protein product. Missense mutations lead to the formation of a codon that encodes
for a different amino acid. Nonsense mutations result in the occurrence of a STOP
codon, that signals for termination of translation and formation of a truncated protein
product. Silent mutations have no effect on the product, due to some of the different
codons encoding for the same amino acid. Frameshift mutations, as a consequence
of indels, result in shifting of the reading frame in a way that subsequent codons are
changed. Analysis in this work is largely focused on single nucleotide substitutions,
and term mutation will be further referred to in this context.
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1.4.2 Mutations, selection, and evolution
Mutations provide the raw material for selection and evolution. Differences in genome
sequences between living organisms, species, and individuals of the same species have
all originated as mutations at some point. Mutations that result in phenotypic traits
that are advantageous to the organism are more likely to persist within the population
and rise to a higher frequency, while deleterious mutations that hinder the ability of
the carrier organism to reproduce are less likely to be propagated. Single nucleotide
changes that have risen to a particular frequency within the population are termed
single nucleotide polymorphisms (SNPs). Alternative nucleotides that can be found to
be present at a single location in the genome are termed alleles. Allelles that were
present in the common ancestor are ancestral alleles, while a nucleotide with an alter-
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A TA TGGG
Figure 1.6: Alleles observed at polymorphic
sites (3 and 5; grey shading) can be separated
into either derived (green) or ancestral (pur-
ple) based on the reconstructed ancestral se-
quences (orange and pink shading).
The process of an allele, and therefore associated traits, becoming more or
less frequent within a population in response to environmental perturbation is termed
selection. Negative, or purifying selection, is a process by which a certain detrimental
allele is removed from a population, while positive, or diversifying selection refers to
an allele rising in frequency due to it conferring a selective advantage. Mutations that
have no effect on the fitness of an organism or its ability to procreate are said to be
evolving neutrally and can be subjected to genetic drift, a stochastic process of changes
in allele frequency due to random sampling inherent in a finite population (Kimura,
1968, 1991).
Genomic elements such as exons are frequently found to be highly conserved
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as a result of purifying selection - precise sequences within those are so important for
the formation of the final functional product, that deviation would be deleterious, while
introns are not subjected to purifying selection to the same extent, therefore exhibit
more variability. Hence, conservation is sometimes used to define functionality - if a
sequence is conserved it is thought to be important, and therefore functional (Lindblad-
Toh et al., 2011). At the same time, sequences that exhibit large degrees of variation
are also sometimes likely to be functional. After all, without diversifying selection
there would be no evolution and no variation of phenotypes. Therefore, significant
deviations from the pattern expected for neutral evolution are indicative of selection
and thus organism level function.
1.4.3 Determinants of regional mutation rates
Estimation of the neutral rate of mutations is important, as it provides a reference point
relative to which sites could be compared and defined as either conserved or evolving
at increased rates. This is complicated by the fact that the mutation rates are not
uniform, but vary at different scales across the genome, leading to a notion of regional
mutation rates (Wolfe et al., 1989; Makova and Hardison, 2015). Regional mutation
rates can be affected by the frequency of the lesion occurrences, and by the frequency
of their repair. There are multiple features and genomic states that correlate with both
of these (Figure 1.7).
One of the most striking examples is dependency of the mutation rate on
sequence, and more specifically on the presence of CpG dinucleotides. CpGs have 10-18
times more C−→T mutations than any other dinucleotides in the genome (Campbell
and Eichler, 2013). Cytosines in the CpG context are frequently methylated, and
methylated cytosines have a high propensity to undergo deamination due to its unstable
nature, resulting in formation of thymine in their stead (Youssoufian et al., 1986).
While some genomic regions are often enriched in CpGs (CpG islands), they exhibit
lower levels of mutability than the rest of the genome. This is potentially due to reduced
methylation in those regions, higher selectional pressures, or lower levels of deamination
due to stronger binding between strands (Ségurel et al., 2014; Acuna-Hidalgo et al.,
2016).
Clusters of mutations can occur as a result of the activity of ”apolipoprotein
B mRNA editing enzyme, catalytic polypeptide-like” (APOBEC) enzymes. It has
23
24 1.4. MUTATIONAL HETEROGENEITY
Promoters
Gene

















Figure 1.7: Some of the determinants of regional mutation rates. Factors that are thought to
promote increased numbers of mutations ↑ are in red, while those that suppress mutations ↓ are
in green.
been proposed to result from APOBEC enzymes attacking single-stranded DNA, as
such can occur during transcription, upon formation of double-stranded breaks, and at
dysfunctional replication forks (Chan and Gordenin, 2016). Mutations are also more
likely to arise at the regions where double-stranded breaks occur at high frequency,
such as recombination hotspots (regions 1-2kb in size), with nucleotide composition at
those sites likely to be shaped through biased transmission of alleles by gene conversions
(Tiemann-Boege et al., 2017).
Replication across the genome occurs in a temporarily non-uniform manner.
There are certain replication origins that fire at early stages of the S phase, while
others fire later. It has been previously shown that late-replicating regions tend to
exhibit higher rates of single nucleotide substitutions due to the lower level of mismatch
repair (Supek and Lehner, 2015), depletion of free nucleotides (Watt et al., 2015), and
accumulation of single-stranded DNA (Stamatoyannopoulos et al., 2009).
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The process of transcription can influence the propensity of the genomic region
to mutate. While a lot of transcriptional activity occurs at generally conserved regions
of the genome, such as protein-coding genes, the process itself leads to transcription-
associated mutagenesis (TAM) (Jinks-Robertson and Bhagwat, 2014). Exposure of
susceptible single-stranded DNA is associated with increased damage. A study by
Lodato et al. (2015) found that numbers of single-nucleotide variants were increased
within the transcribed gene regions of neurons. The process of transcription can also be
mutagenic due to the occurrence of structures termed R-loops - as formation of hybrids
derived from nascent RNA and a template strand of DNA leave the non-template
strand in the single-stranded conformation. At the same time, transcription tends to
be associated with transcription-coupled repair (TCR), thereby partly counterbalancing
the mutagenic effects of TAM (Hanawalt and Spivak, 2008). In addition to the TAM
and TCR that goes on in the genic regions, exons and introns have been shown to
exhibit differences in mutation rate due to their differential targeting by mismatch
repair machinery (Frigola et al., 2017).
Nucleosome occupancy has been shown to be correlated with an increase in
genetic variation, with more substitutions observed at nucleosome dyads (Semple and
Taylor, 2009; Tolstorukov et al., 2011; Reijns et al., 2015), and this relies upon intact
DNA repair machinery (Yazdi et al., 2015). Interestingly, rates of C−→T mutations
have been found to be reduced in the core regions of nucleosomes (Prendergast and
Semple, 2011; Sasaki et al., 2009). This is possibly due to the fact that packaged
DNA undergoes less local conformational fluctuations within double-stranded DNA,
which leads to transient single-stranded DNA exposure, commonly referred to as ’DNA
breathing’ (Fei and Ha, 2013). Lower levels of this would make cytosines less likely
to undergo deamination (Chen et al., 2012b). This has also been proposed to be due
to selection acting to maintain optimal GC composition at the nucleosomal sites and
linker regions (Prendergast and Semple, 2011).
At larger scale, open chromatin regions (defined by DNase-seq) have been
associated with reduced densities of mutations in cancer, attributed to higher accessi-
bility of DNA repair machinery in those regions (Polak et al., 2015, 2014). On smaller
scales, Perera et al. (2016) has shown that there is an increased number of mutations at
the midpoint of accessible regions, and more specifically at promoters, associated with
transcriptional activity and reduced repair by nucleotide excision repair in UV- and
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tobacco smoke- induced cancers. Promoters have previously been observed to exhibit
increased variation and high rates of evolutionary turnover, in particular housekeeping
and testis-specific ones (Young et al., 2015; Taylor et al., 2006).
Mutation rates have been shown to vary even at relatively small scales such as
single protein binding sites. Following analysis of sequence divergence between species
around particular sequence-specific protein-binding sites, Reijns et al. (2015) demon-
strated that there is an unusual increase in numbers of single nucleotide substitutions
immediately surrounding highly conserved human TF binding motifs (Figure 1.8). This
was proposed to be a reflection of the increased mutational pressure that is acting all
across the region physically occupied by the protein. While the motif itself is being
preserved through action of purifying selection, stretches of sequence just immediate to
it are not, and are thus mutated at a higher rate then the flanking regions that are not
occupied by the protein. This has lead to the proposition of the lagging strand hypoth-
esis, where enrichment of mutations at protein binding sites is attributed to retained
Polα-synthesised tracks post-replication, due to being trapped by the fast binding pro-
teins that hinder track removal (Figure 1.9). However, this increase in numbers of
between-species single nucleotide substitutions surrounding highly conserved protein
binding motifs has not been directly shown to be a consequence of increased mutation
rate, rather than evidence of, for example, diversifying selection favouring variation
at the protein binding site edges. Thus, separation of individual contributions of mu-
tation rate and selection would be necessary to demonstrate difference between these
possibilities.
Perturbation of DNA replication has similarly been suggested as the reason
for an increased numbers of mutations in colon cancers across CTCF binding sites
(Katainen et al., 2015). Also, Sabarinathan et al. (2015) demonstrated an increased
number of melanoma mutations at TF binding sites, but found that a decrease in
nucleotide excision repair was responsible. However, cancer cells can be subject and
driven by processes distinct from those taking place in the germline. For example,
melanomas are known to arise from high levels of UV damage that is by enlarge re-
paired by nucleotide excision repair, while mutational burden of germline cells is not
driven primarily by UV and role of nucleotide excision repair at protein binding sites
in germline might not be as important. Thus, separate investigation of the mutational
burden of the protein binding sites in germline is necessary. Also, models that rely on
26
CHAPTER 1. INTRODUCTION 27
the interference of proteins with normal cellular maintenance processes do not explain
how DNA-interacting proteins that are known to be sequence-specific binders, such as
TFs, would be able to bind to their mutated target sequences to do so, a discrepancy
that needs to be reconciled.
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Figure 1.8: Increase in between-species diver-
gence around NFYA, REST and CTCF TF mo-
tifs. There is an increase in sequence divergence
immediately proximal to the motifs. The so-
called ’shoulders’ of increased substitutions are
proposed to result from an increased mutation
rate in the protein-occupied region. Darker red
lines corresponds to the top quartiles of ChIP-
exo signal strength at the motif region, taken as
proxy for binding strength and occupancy. Pos-
itive correlation between the level of divergence
and ChIP-exo signal is consistent with protein
binding being causal of increased mutation rate.
Grey lines represent the trinucleotide expecta-




















Figure 1.9: Lagging strand hypothesis. Retention of the error-prone Polα-synthesised Okazaki
primers by TFs bound shortly post-replication is proposed to increased mutation rate at those
protein-binding sites. Figure adapted from Reijns et al. (2015).
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1.4.4 Germline mutations
The germline is the only population of cells in which new mutations have a chance
of being passed on to the organism’s progeny. Therefore any differences in genome
sequence between individuals must have arisen at some point as mutations in a cell
of the germ lineage. The germline mutation rate has previously been estimated at
≈ 1 − 1.5 x10−8 mutations per site per generation: ≈ 70 − 80 new mutations that
occurred in parental germ cells are inherited by a child (Michaelson et al., 2012; Kong
et al., 2012; Francioli et al., 2015). Importantly, germline mutations form the basis
for heritable disease, therefore estimating the impact of these mutations is important.
Models of mutation retention in germline cells are relatively unknown.
The occurrence of germline mutations can be inferred from polymorphisms
present within the population, and between species. On average, single human genome
is estimated to have ≈ 40, 000−200, 000 variants with allele frequency of less than 0.5%,
which constitutes 1-4% of all variants, with the rest being more common (Gibbs et al.,
2015). The most direct way of identifying germline mutations is to look at the de novo
variants that occur in offspring relative to genetic variants observed in the parents,
which is typically done by comparing genomes of the family trios (Roach et al., 2011).
Presence of a variant in the proband at a frequency close to 0.5 (as the genome is
diploid), but not in either of the parents means that the mutation must have occurred
in a germ lineage cell of one of the parents. This assumption does not always hold
true when taking into account post-zygotic mosaicism (Campbell et al., 2015). In this
instance, mutations that occur at an early stage of the post-zygotic cell divisions are
likely to be present at high frequency in the tissue of one type, with about 7% of de
novo mutations found in blood being mosaic (Acuna-Hidalgo et al., 2015).
There are differences in mutation types and rates between male and female
germlines. This is primarily due to the inherent differences in germ cell formation and
progression between the two genders. Female germline cells undergo fewer divisions
and are formed before birth (Drost and Lee, 1995). This makes them less suscepti-
ble to mutations that are replication-associated in nature, but more likely to undergo
formation of lesions due to cells having to maintain themselves while in meiotic arrest
(Herbert et al., 2015). There is an association between the maternal age and chromoso-
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mal abnormalities in the offspring that is thought to result from an inability to properly
segregate the sister chromatids, leading to aneuploidies (Sherman et al., 1994).
The paternal germline, on the other hand, undergoes multiple rounds of cell
division, and therefore multiple round of genome replication over the lifetime of a
male (Drost and Lee, 1995). This has lead to the notion of a male mutational bias
- a preposition that the majority of the mutations in offspring are paternal in origin.
What more, the numbers of de novo mutations in offspring have been found to increase
with the age of the father at conception (Kong et al., 2012; Francioli et al., 2015).
Age-related increase in both male and female germline mutations is also likely to stem
from lower levels of repair - general failure to repair non-replicative damage between cell
divisions and the lower efficiency of repair mechanisms (Guo et al., 2015). Additionally,
mutations in offspring of younger fathers tend to localize in late-replicating regions,
while more de novo mutations in the genic regions has been observed in older fathers
(Francioli et al., 2015). Some mutations can confer a selective advantage to the germ
cell, such as clonal expansion of sperm progenitors, and at the same time be causing
disease in the offspring. These ’selfish’ mutations in genes such as PTPN11, HRAS,
FGRF2, FGFR3, and others, have been implicated in various, often developmental,
disorders (Acuna-Hidalgo et al., 2016).
1.4.5 Somatic and cancer mutations
Mutations that occur in the cells of the soma are not going to be passed on to the
progeny and will cease to exist with the death of an organism. Mutations occur in
each somatic cell during the lifetime of a person. While most of those have virtually
no effect, others may confer a selective advantage leading to expansion of that cell
population, resulting in somatic mosaicism. Somatic mosaicism can occur during early
development, and is a known cause of developmental disorders, but also has been
recognised to a phenotype of ageing (De, 2011). Somatic mutations that confer a
selective advantage to the cell through increased proliferative ability and the loss of
programs characteristic of normal cellular function can lead to cancer (Hanahan and
Weinberg, 2011).
Mutations in cancer can be defined as either drivers or passengers. Driver
mutations are though to be a causative for cancer initiation, or contributing to its
progression. They could be mutations that result in hyper-activation of oncogenes,
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leading to an increase in cell growth, proliferation and metabolism. In conjunction with
inactivating mutations in tumour-suppressor genes, such as those that are responsible
for initiation of apoptosis (programmed cell death) that renders its products inactive,
cancer cells typically undergo uncontrollable proliferation. Identification of driver genes
within tumours is not always straightforward due to the presence of large numbers of
passenger mutations. Those mutations do not confer any selective advantage to the
cancer cells, but are rather ’hitch-hikers’, and are able to rise to the same frequency in
the tumour as driver mutations because they happened to co-occur in the same cell.
Most known driver mutations are located in the protein-coding part of the
genome, in genes such as TP53, PIK3CA, KRAS, BRAF and others, which is not
surprising considering that most of studies have been conducted using whole-exome
sequencing (Campbell, 2016). One of the well-known examples of the non-coding cancer
driver is a mutation in the promoter of the TERT gene, which creates a binding site
for a TF ETS and leads to gene’s over-expression (Vinagre et al., 2013).
Most cancers carry 1,000-20,000 single nucleotide substitutions, however num-
bers can vary greatly depending on the type (Campbell, 2016). While some cancers
occur through the activity of external mutagens, the variation in cell divisions of affected
tissues has been shown to explain variation in cancer risk (Tomasetti and Vogelstein,
2015).
Somatic mutations can be the result of germline predisposition. An example
of this would be a germline mutation in genes associated with maintaining genome
integrity, such as those coding for the components of the mismatch repair machinery
(MLH1, MLH2, MLH6, PMS2, and PMS1 ) (Peltomäki, 2001). Heterozygous germline
mutations in those genes can lead to accumulation of the DNA replication errors and
cause Lynch syndrome, which is characterised by occurrence of early onset colorectal,
endometrial, ovarian and other cancers (Cohen and Leininger, 2014).
As different cancers are driven and dominated by distinct mutational pro-
cesses, they exhibit different mutational signatures - consistent patterns of changes
occurring on the local sequence background, and with variable distribution across the
genome. More than 20 different mutational signatures have been initially classified by
Alexandrov et al. (2013) and this number is growing constantly. Some are attributed
to specific mutational processes, such as APOBEC mutagenesis or exposure to UV,
while others reflect the ’clock-like’ mutational process that operate in normal human
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cells (Alexandrov et al., 2015), and others are of unknown aetiology.
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1.5 Repair processes
As mentioned previously, heterogeneity of mutation rates across the genome results
from both the differences in the rate of lesion formation, and in the efficiency and
accuracy of lesion repair. Unlike other cellular components, DNA exists as necessary
entity whose encoded information cannot be regenerated if lost, and therefore must be
maintained and repaired upon formation of damage. There are multiple mechanisms
in the cell that act to try and preserve the integrity of the genome including mismatch
repair (MMR), nucleotide excision repair (NER), base excision repair (BER), as well
as single and double stranded break repair (SSBR and DSBR, respectively) (reviewed
in Ciccia and Elledge (2010)).
1.5.1 Replication-coupled repair
Despite its remarkable fidelity, the process of replication is inherently mutagenic. The
necessity to faithfully replicate 3 billion base pairs in a relatively short period of time
calls for strict quality-control. DNA polymerases are responsible for replicating the
genome, and the various families of this enzyme vary in their fidelity. On average,
for every ≈ 104 − 105 bases that they incorporate during replication, one mismatch is
produced (Kunkel, 2009). Polδ and Polε, which are the main replication polymerases in
eukaryotes, make fewer mistakes than Polα, as they posses 3’−→5’ exonuclease activity,
an ability to cleave and remove a wrongly incorporated nucleotide, triggered by the
abnormal geometry of base in the active site and slowing of polymerisation (reviewed
in Ganai and Johansson (2016)).
When normal replicative polymerases are unable to deal with a lesion, a special
type of translesion polymerase might be recruited to the site of the damage (reviewed in
Vaisman and Woodgate (2017)). Those polymerases are quite often good at bypassing
damage to allow replication to proceed, but do not possess high levels of fidelity. Inter-
estingly, the error-prone nature of some polymerases can be utilized by cells to drive
adaptive capability as in bacteria (Janion, 2008), and in processes such as somatic hy-
permutation and diversification of the immunoglobulin variable regions in humans for
ability to recognise and rapidly respond to infection (Faili and Gue, 2009).
Most mistakes that go unnoticed by replicative polymerases can be repaired
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by MMR (reviewed in Kunkel and Erie (2015)). MMR is broadly involved in repair
of short indels and single base-base mismatches. In MMR-deficient yeast, high rates
of CG−→TA mismatches are observed to be generated at a highest rate, probably
through higher occurrence of G:T mismatches that are most efficiently corrected by
MMR (Lujan et al., 2014). In addition to that, lower level of MMR activity are apparent
on the lagging strand versus leading strand, which corresponds to the increased number
of mismatches generated on the former (Lujan et al., 2014; Andrianova et al., 2017).
MMR is thought to be temporarily coupled with DNA replication, suggesting that some
types of replication errors, such as the ones generated during particular DNA repair
and recombination processes, would not be readily available to MMR to fix (Kunkel
and Erie, 2015). This temporal coupling of MMR to the replication fork, accessibility
of DNA to the repair machinery, or opportunity for repair might be responsible for
lower levels of MMR observed in late-replicating regions (Supek and Lehner, 2015).
Interestingly, exons have been shown exhibit higher levels of MMR, surveillance and
activity than introns, due to the recruitment of MMR components to H3K36me3 histone
mark enrichment within exons (Frigola et al., 2017).
1.5.2 Nucleotide-excision repair
Nucleotide excision repair (NER) works by recognising and removing DNA-helix-distorting
lesions. NER has the ability to remove a large number of different types of lesions, such
as UV-induced lesions, bulky chemical adducts, inter-strand crosslinks, and damage in-
duced by reactive oxygen species. NER repairs those by excising a ≈30bp fragment on
a single strand around the lesions followed by re-synthesis of the stretch. Germline in-
activating mutation in the components of NER lead to an extreme phenotypes that are
highly sensitive to UV damage and elevated risk of various tumours, resulting in a con-
dition termed Xeroderma Pigmentosum (Cleaver, 1968; Lehmann et al., 2011). NER
can be classified into the transcription-coupled NER (TC-NER) and global genomic
NER (GG-NER). GG-NER can recognize a wide variety of different lesions, owing to
its ability to detect the distortion of the DNA helix, while TC-NER is recruited to
the sites of stalled RNA polymerase II (reviewed in Marteijn et al. (2014)). Histone
modifications, in particular acetylation and ubiquitylation, that are suggested to pro-
mote histone displacement, are thought be play a role in allowing access of NER to
lesions (Wang et al., 2006; Lans et al., 2012). Recently, GG-NER complexes have been
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found to be located at the nucleosome-free regions at gene promoters that can be found
at the boundaries of the higher order nucleosome-nucleosome interacting domains in
undamaged cells, and is initiated from there upon damage (Eijk et al., 2018).
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1.6 Aims and research outline
1.6.1 Specific motivations and importance
Large proportion of studies, particularly those concerned with human disease aetiol-
ogy, are still mainly confined to a frame of protein-coding part of the genome. In
recent years, in particular due to advances in whole-genome sequencing capability and
availability, the importance of the role played by the non-coding fraction is becoming
more evident. The ability to sift out mutations and variants that are causal for the
specific phenotype is in a large part hampered by the lack of means to pinpoint the
genomic regions where functionally consequential mutations are more likely to occur,
and this is confined by our estimations of selection and mutation pressures. There are
differences in regional mutation rates, and this variability is attributed to a growing
number of genomic features, such as protein-binding sites. However, the mutational
cost of TF-DNA interactions and its interplay with genome maintenance is not fully
understood.
The focus of the work described herein concerns the investigation of the mu-
tational burden at protein-binding sites. Increased numbers of mutations at protein-
binding sites has been supported by several recent studies, and is attributed to the
TF-DNA interactions interfering with DNA replication and repair. More specifically,
Reijns et al. (2015) has previously proposed that occlusion of the lesion-containing
stretch of error-prone polymerase-synthesised DNA by bound TFs interferes with nor-
mal cellular maintenance processes, leading to retention of mutations in the mature
genome. If true, his would then suggest that (1.) mutation rate are elevated within as
well as adjacent to the binding sites, and that (2.) only sites that are bound by pro-
teins within the cells where mutations are occurring are expected to exhibit elevated
mutation rates.
The main focus of the work here are mutations that occur in the cells of the
germline, and therefore have a chance of being passed on to the next generations and
cause hereditary disease, and estimation of the impact that those mutations have. This
is of particular importance in light of the evidence for replication-related nature of those
mutations and potential association with the increasing numbers of de novo mutations
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in offspring with advancing paternal age. Identification of the protein-binding landscape
of the most highly-dividing germline cells can provide a map of the mutational hotspots
where disease-causal variants are likely to be found. As no inference is made here about
the function of proteins that interact with analysed binding sites, the range of binders
investigated in this work includes, but is not limited to, transcription factors. Thus,
identified binding sites might be occupied by sub-nucleosomal-sized proteins that do
not regulate transcription, but could nevertheless be important for proper cell function,
such as those playing a role in organisation of chromatin structure (for example, CTCF).
A mechanistic basis for the paradoxical occlusion of the mutagenic lesions by
the sequence-specific binding proteins is unexplained and intriguing. Here I aim to
address this and propose a model that could resolve this. The resulting observations
of protein-DNA interaction in connection with mutagenesis will provide an insight into
the mechanistic basis of the occurrence of mutations at regulatory sites.
1.6.2 Main research questions
The research project described in this thesis aims to answer the following questions,
also illustrated in Figure 1.10:
1) Are protein binding sites subjected to increased mutational burden adjacent to
and within the sites? If so, are the mutations occurring at binding sites in the
germline deleterious and do they have the potential to lead to heritable disease?
2) Can sequence-specific DNA-binding proteins be responsible for inducing increased
numbers of single-nucleotide changes within their binding motifs and if so, how
can this be reconciled with the sequence specificity of their binding?
1.6.3 Thesis structure
Throughout this thesis I aim to address the first question through identification of the
protein-binding sites in the human and mouse germlines and, for comparison, in somatic
cells by generation and analysis of ATAC-seq data (Chapter 2), followed by estimation
of the selection and mutation pressures acting up on those sites using between-species
sequence divergence and alleles in human and mouse populations (Chapter 3). The
second question is addressed through analysis of cancer mutation rates at sequence-
specific protein binding sites of several TFs (Chapter 4), and experimental testing of
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Figure 1.10: In the current work I aim to address the following questions: (1) Is the increased
variation next to TF motifs shaped by the combined actions of increased mutation rate and
purifying selection? If so, is the mutation rate elevated within, as well as adjacent to the
protein-binding sites, making them mutational hotspots and leading to hereditary disease if they
occur in the germline? (2) Is protein binding causal for retention of mutations at their binding
sites and how can this be reconciled with sequence-specificity of TF binding?
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2.1 Introduction
2.1.1 Male germline is more mutagenic than female due to large
number of cell divisions
For most cells of the living entity, the set of mutations that it acquires during its life-
time will disappear with the death of the organism and have no effect on any progeny.
The exception to this are germline cells (sequence of cells which develop into eggs and
sperm), which provide the genetic basis for the next generation. Mutations acquired
during the life of germ lineage cell that will go on and form a zygote will be present
in every cell of the subsequent generation. Therefore all variation is shaped by muta-
tions that have occurred at some point along germ cell lineage, and termed germline
variation.
It is known that germline variation, in the form of de novo mutations in
offspring, is correlated with parental age (Ségurel et al., 2014). While some of the
individual contributions of both male and female germline are known, the overall burden
associated with each is not clear. Generally, the male germline is widely regarded as
a major contributor to mutation load, estimated to add 1.5-2 mutations per year of
the father’s life prior to conception, compared to 0.25-0.37 mutations per year of the
mother’s age (Kong et al., 2012; Francioli et al., 2015; Michaelson et al., 2012; Jónsson
et al., 2017; Goldmann et al., 2018), with most mutations found in the paternally
inherited haplotype (Gao et al., 2018). Differences in estimated mutation rates between
males and females are in accordance with differing numbers of zygote-to-zygote divisions
that male and female germlines undergo (Figure 2.1). The view of replication process
as primary contributor to human mutations stems from this observations of increased
variation with rising numbers of germline cell divisions (Ségurel et al., 2014).
The male germline undergoes continuous replication cycles aimed at produc-
tion of large number of sperm cells and self-maintenance of stem cell populations (Drost
and Lee, 1995). In males, spermatogenesis initiates at the onset of puberty (≈13-14
years after birth), at which point each cell has been estimated to have already under-
gone 33-34 divisions (Drost and Lee, 1995; Ségurel et al., 2014). Thereafter, a set of
stem-like spermatogonial cells (SSCs) divide every 16 days, both in order to maintain
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Figure 2.1: Overview of human female and male germlines. Numbers on arrows indicate the
estimated numbers of divisions each cell type undergoes before transformation into the next stage
cell. Female germline divisions are shown in yellow and male germ cell ones in pink. On the
bottom are estimations of the numbers of divisions each spermatogonial cell would have had to
have undergone at indicated age of a male. (Figure adapted from Prof Martin Taylor; principal
source Drost and Lee (1995))
a their pool, and to produce cells committed to differentiation, which then undergo
further 3 divisions before formation of sperm. Therefore, in humans, about 80% of all
germline replications occur in the spermatogonial cells, while in mice this number is
around 30% due to a shorter generation time (see Box 2.1 for calculations).
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Box 2.1: Calculation of spermatogonial cell divisions
General formula for the calculation of the number of spermatogonia stem cell
(SSC) divisions (Div) in male:
DivSSC =




















Assuming the average age of father at conception is 30 (Jónsson et al., 2017),
puberty occurs at 14 years, spermatogenesis takes 74 days, and SSC divide every
16 days thereafter (Drost and Lee, 1995), then:
DivSSC =
(30− 14− (74÷ 365))× 365
16
= 360.375 (f:2.1.4)




× 100 = 84.7% (f:2.1.6)
While in mice:
DivSSC =
274days − 6days − 43days
8.6
= 26 (f:2.1.7)




× 100 = 35.1% (f:2.1.9)
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Conversely, in females the eggs undergo all rounds of DNA replication prior to
birth following relatively small number of divisions (approximately 31 in human) (Drost
and Lee, 1995). The integrity of the bivalent chromosomes (homologous chromosomes
that are physically held together) within an oocyte has to be preserved for many years
in humans, and while there is no replication taking place, mutations can arise as a
result of such features as structural chromosome fragility due to cohesin depletion
(Herbert et al., 2015). Therefore, maternal age effects tend to be associated with risks
of aneuploidies and found to be correlated with the numbers of clustered mutations
at particular locations linked to processes involving the formation of double-stranded
breaks (Goldmann et al., 2018; Jónsson et al., 2017). Recently it has also been argued
that the maternal age contributes more substantially to the parental age effect than
thought previously, as until the 4-cell stage the zygote relies on the repair and replication
machinery of maternal oocytes, which may undergo degradation and lose fidelity in
older mothers (Gao et al., 2018). This could also imply that lesions acquired in the
paternal germline due to the larger number of divisions would be less likely repaired in
older females.
2.1.2 Most germline mutations at protein-binding sites are expected
to occur at spermatogonia-active sites
We hypothesise that the increase in germline variation proximal to TF binding motifs
observed by Reijns et al. (2015) (Figure 1.8) represents increased mutation rate at the
genomic regions that are physically occupied by bound proteins. If the increase in the
mutation rate is indeed protein binding dependent, we would expect to see this eleva-
tion in germline variation at protein binding sites that are bound by proteins (”active”
binding sites) in germline cells, where those mutations are occurring, in contrast to
those that are not occupied by proteins in the germline, such as somatic-specific pro-
tein binding sites (Figure 2.2). This is testable, assuming we know where proteins in
germline and soma bind. Increased variation at germline-active, but not at the somatic-
specific binding sites would support our hypothesis. Increase at both categories of sites
would indicate that the elevated variation is not dependent on the protein binding,
but instead is just a general feature of the binding sites. No elevation at either of the
categories would mean that the protein binding sites do not exhibit increased mutation
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Figure 2.2: Expected differences in
germline mutation rate, selection
and between-species divergence in
germline, housekeeping and somatic
binding sites, if binding of proteins
does induce increased mutation rate.
rate as such.
This mutational phenomenon has been proposed to be related to replication
(Reijns et al., 2015). Even though the replication machinery has evolved to have an
impressive level of fidelity (Kunkel and Erie, 2015), some mutations escape surveillance
and repair. As mentioned in Subsection 1.5.1, most mismatches that would lead to
the formation of mutations are normally repaired by mismatch repair machinery and
exonuclease activity of the replicative polymerases. Obstruction of those processes
would be expected to raise mutational load substantially. Proteins could conceivably
present such an obstruction if they bound DNA shortly after synthesis of the daughter
strand. This has lead to proposition of the lagging strand hypothesis, where binding
proteins hinder the process of error-prone Polα-synthesised Okazaki primer replacement
(Figure 1.9) (Reijns et al., 2015). One would then expect the majority of mutations to
occur at binding sites active in germline cells that are most highly replicating, which
are spermatogonial cells.
2.1.3 Spermatogonial cells sub-populations and challenges in their
isolation
In humans, spermatogonia are classified into several categories of A-type stem-like
(Apale - active, euchromatic, Adark - reserve, heterochromatic) and differentiating B-
type cells (Di Persio et al., 2017). In mice there are several additional populations of
Apaired and Aaligned spermatogonia, which form clusters of interconnected cells (Wa-
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heeb and Hofmann, 2011). While in humans during the pre-pubertal period A-type
spermatogonia comprise 80-90% of germ cells, after onset of puberty they comprise
a small percentage of the total germ cell population (Wu et al., 2009). In part due
to this, there is currently limited amount of data available that would allow compre-
hensive identification of the protein-binding sites in spermatogonial cells. Hence, here
we have set out to describe the protein-binding landscape for both mouse and human
that represents the primary tissue in which the majority of germline DNA replication
occurs.
There is wide interest in spermatogonial cell isolation due to the high value of
those cell populations in fertility preservation of males undergoing chemotherapy and
fertility treatment of patients with azoospermia (lack of sperm in the semen) (Forbes
et al., 2018). Isolation of pure spermatogonial cell populations is challenging due to a
number of reasons. First, as already mentioned, spermatogonial cells, and particularly
stem-like sub-populations (SSCs), which are of the main interest here, represent a
relatively small percentage of cells in testis post-puberty . The sub-populations of
stem-like and differentiating cells also become difficult to morphologically differentiate
after the onset of puberty (Wu et al., 2009). Due to the challenges in obtaining large
quantities of tissue and cell isolation, human spermatogonial cell specific markers have
not been robustly established. More is known about the spermatogonial cell populations
in rodents, as tissue is more readily available (Kopylow and Spiess, 2017). While the
general germ cell progression is somewhat similar between humans and rodents, they
exhibit differences in marker expression (He et al., 2010). Additionally, some of the
recent attempts at comprehensive compilation of published markers and cross-study
intersection analysis found that most marker expression is not uniform between the
morphologically identical spermatogonial cell types and even the few markers that
are common to all types do not always show uniform expression within the subtypes
(Kopylow and Spiess, 2017).
2.1.4 Questions addressed in the current Chapter
The main aim of the work described in this Chapter is to (1.) isolate populations of
the highly replicative germ cells from specimens of mouse and human adult testicular
tissues, and to (2.) define sets of binding sites that are active specifically in germline or
somatic cells, or in both. With main focus in obtaining spermatogonial cell populations
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free of somatic cell contamination, we ideally would want to obtain the sub-population
of most highly dividing stem-like spermatogonial cells (SSCs). However, partially differ-
entiated cells are also replicative cells of the germline lineage which are likely to exhibit
commonality of binding landscape, so are likewise relevant for this analysis. As SSCs
constitute a rare population within adult testes with no clear-cut marker expression,




2.2.1 Spermatogonial cell marker selection
For isolation of the live cell populations we used fluorescent-activated cell sorting
(FACS), as this method should not majorly perturb chromatin composition and gene
expression (Richardson et al., 2015) and allows for a fine-scale resolution gating of the
sorted populations based on the marker signal, but also size and shape of the cells (Valli
et al., 2014). FACS requires fluorescently-labelled antibodies against at least one of cell
type specific marker, which has to meet several criteria. First, the epitope (part of the
marker molecule to which the antibody attaches itself) recognised by the antibody has
to be a surface marker (located outside the cell membrane), as that is the only way
to label cells without the need for permeabilization. Secondly, spermatogonial cells
reside within the seminiferous tubules and are surrounded by somatic cells, such as
Sertoli and Leidig cells, that play roles in supporting spermatogenesis. Therefore, any
marker used must not only be expressed in the germ cells, but also not be expressed
in any of the somatic cell populations present within the testes. Thirdly, the antibody
against the epitope of a marker has to be commercially available, and ideally have been
validated for cell isolation before. Wu et al. (2009) previously compared expression
of multiple candidate markers within the cells of human pre-pubertal spermatogonial
cells with their expression levels in somatic cells of the testes, and reported some of the
surface markers to show enrichment in the former, mostly in accordance with a recent
comprehensive review of the published spermatogonial cell markers by Kopylow and
Spiess (2017). Among those there were markers that have been reported to be more
biased towards the expression in differentiating cells (KIT) (Di Persio et al., 2017),
or show contradictory results across multiple studies (some reviewed in Kopylow and
Spiess (2017)), with likely expression in somatic cells within the testes (THY1, ITGA6,
GPR125, GFRalpha1R) (He et al., 2010; Altman et al., 2014). Of the remaining mark-
ers, we have chosen to use FGFR3 (fibroblast growth factor receptor 3), which has
been reported as a protein not expressed in gonocytes or somatic cells within testes
(Ewen et al., 2013). Kossack et al. (2013) also confirmed FGFR3 to be the only specific
cell surface biomarker in agreement with the earlier Von Kopylow et al. (2010) study.
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Wu et al. (2009) has reported 85-fold increase in FGFR3 expression in human sper-
matogonia versus somatic cells within testes. Figure 2.3 shows an example of FGFR3
staining from the Human Protein Atlas (https://www.proteinatlas.org/). The commer-
cially available antibody used here (FAB766P, clone 136334, R&D systems) recognises
the IIIc isoform that is expressed in testis (Ewen et al., 2013). FGFR3 encodes a
cell surface protein that spans the cell membrane and is speculated to be involved in
spermatogonial survival signalling (Ewen et al., 2013). At the time of our initial use of
FGFR3 as a marker for the spermatogonial cells there had not been any other stud-
ies that successfully implemented it for FACS. Since then FGFR3 has been used in
another study reporting successful isolation of spermatogonial cells via magnetic cell
isolation (Von Kopylow et al., 2016), where isolated cells were shown to express FGFR3
mRNA. In addition, they described absence of somatic cell transcripts, such as WT1,
ACTSA2 and INSL3, and co-expression of the pluripotency-associated protein UTF1,
an established human spermatogonial intracellular marker (Valli et al., 2014).
Figure 2.3: FGFR3 staining (brown)
in seminiferous ducts of adult testis
sections from Human Protein Atlas
(Thul et al., 2017) (image available




Specimens of human testicular tissues were collected from patients undergoing orchiec-
tomies at the Western General Hospital, Edinburgh. Tissue was obtained after informed
consent through the Lothian NRS BioResource, and study was approved by NHS Loth-
ian (Lothian R&D Project Number 2015/0370TB). After extraction, testis was cut
open by the surgeon and one or more fragments (typically ≈ 0.5cm3) of the inner tis-
sue were excised and put into ice-cold phosphate-buffered saline (PBS) and kept on
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ice. It would be most desirable to obtain phenotypically and genetically ‘normal’ tis-
sue from healthy individuals; however obtaining such samples would present difficulties
in finding suitable donors and obtaining ethical approval. The majority of patients
from which the tissue was obtained were undergoing orchiectomies due to presence of
a suspected testicular tumour, and in rarer cases due to undiagnosed testicular pain,
or gender reassignment surgery. In cases of testicular tumours, tissues used here were
taken away from the site of the tumour and appeared to be exhibit grossly normal struc-
ture. Tissue was then rapidly transported downstream analysis, with total processing
completed within ≈ 5-7 hours of explant.
Human analyses were complemented by those in mice. In collaboration with
the research group of Dr Ian Adams (IGMM, HGU MRC, Edinburgh), we were able to
obtain pure mouse spermatogonial cell populations from mice hemizygous for a germ
cell-specific Cre driver Ddx4-Cre (Tg(Ddx4-cre)1Dcas) (Gallardo et al., 2007), and
heterozygous for a yellow fluorescent protein (YFP) reporter conditionally expressed
from the ROSA26 locus (Gt(ROSA)26Sortm1(EY FP )Cos) (Srinivas et al., 2001). At 6
days post partum these mice express YFP specifically in spermatogonia.
2.2.3 Cell isolation and FACS
Tissue desegregation was performed by Dr Marie MacLennan or Dr Fiona Semple
(trained in biohazard safety containment level 2 procedures for primary human tissues).
First, tissue was subjected to mechanical desegregation using a scalpel. Cells were
then pelleted by spinning in the centrifuge for 3 minutes at 3000 RPM. Enzymatic
degradation was carried out by re-suspending tissue in 5 ml of 0.25% trypsin (in PBS),
followed by 10 minute incubation at 37 ◦C. 5 ml of 20% fetal bovine serum (10% final
concentration) was then added to stop digestion. After mixing by inversion, tissue was
spun for 3 minutes at 3000 RPM. PBS was then discarded and tissue re-suspended in
5 ml of PBS with 10% FBS. Cells were then filtered through 35 µm strainer (Becton
Dickinson) using a pastette. Cells were the spun for 3 minutes at 3000 RPM and
supernatant discarded. Cells were then re-suspended in total of 1 ml of PBS+10%FBS.
20 µl of the cell suspension was used as a negative control for FACS analysis, rest was
used for the antibody labelling. 10 µl of the PE-conjugated FGFR3 antibody was added
to ≈1 ml of the cell suspension and incubated at room temperature for 20 minutes with
rotation. Antibody was then washed away by spinning cells at 3000 RPM, discarding
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supernatant and re-suspending in 1 ml of PBS+10%FBS. This was repeated twice.
Finally, cells were re-suspended in 200ul PBS+10%FBS for FACS analysis.
FACS was performed by Dr Elizabeth Fryer on Aria II cell sorter (BD bio-
sciences). Mouse cells were sorted based on YFP fluorescence. Most PE-positive (hu-
man) cells gated as ‘live’ were then sorted into three separate populations and labelled
as ‘small’, ‘large’, and ‘large with high side-scatter’ based on their relative position
along Forward Scatter (FSC) vs Side Scatter (SSC) axis.
2.2.4 ATAC-seq
To define the chromatin landscape of spermatogonial cells we utilized Assay for Transposase-
Accessible Chromatin using Sequencing (ATAC-seq) (Buenrostro et al., 2013). ATAC-
seq has benefits over other methods, such as the DNase-seq, because it requires fewer
cells as an input. The cell numbers isolated from the limited amounts of the hu-
man testicular tissue that we were obtaining were expected to be relatively small
(<50,000), as spermatogonial cell population represents a minor proportion of cells
in adult testes. Another advantage of ATAC-seq is that it requires fewer steps and is
less time-consuming than competing accessibility and footprinting methods. Previously
published protocol for ATAC-seq was followed (Buenrostro et al., 2013). ATAC-seq was
carried out by Dr Yatendra Kumar. In short, during the ATAC-seq procedure a hy-
peractive Tn5 transposase, preloaded with DNA adaptors, is added to the cell lysate.
This modified Tn5 enzyme works by interacting with DNA at the sites of accessible
chromatin, creating a double-stranded break separated by 9 base pairs before ligat-
ing Illumina sequencing adaptors (with one free end). The proximal activity of two
transposases results in the formation of genomic DNA fragments flanked by Illumina
sequencing adaptors. Highly compacted DNA or regions protected by bound nucle-
osomes/other proteins are protected from digestion. Since Tn5 binds to DNA as a
dimer, it has been reported to require at least 38bp of accessible DNA due to steric
hindrance (Adey et al., 2010). After PCR amplification, fragments were subjected to
the paired-end sequencing (with a typical read length of 75bp and ≈100-230 million
fragments per library). The details of the sequencing platforms (sequencing carried out
by Edinburgh Genomics) used can be found in Tables 2.1 and 2.2. Samples sent in
the same batch were multiplexed and each sample was run on two lanes to allow for
correction of lane-specific bias.
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2.2.5 Computational analysis of ATAC-seq data
The .fastq.gz files containing raw read sequences for our primary data were down-
loaded from the Edinburgh Genomics delivery server and md5sums were checked. The
human somatic tissue ATAC-seq reads were obtained from the ENCODE project repos-
itory (https://www.encodeproject.org). Data from the Guo et al. (2017) were ob-
tained from the NCBI GEO repository (accession GSE92280). Pre-aligned reads in .bam
format were obtained for mouse lung, bone marrow and large intestine ATAC-seq from
Cusanovich et al. (2018). Raw .fastq reads from other mouse somatic tissue ATAC-
seq were obtained for cerebellum (Feng et al., 2017) (NCBI GEO accession GSE76984),
B cells (Minnich et al., 2016) (NCBI GEO accession GSE71698), and mammary gland
(Dravis et al., 2018) (NCBI GEO accession GSE116386). See Table 2.3 for descriptions
of all the human spermatogonial datasets, Table 2.4 for other publicly available human
ATAC-seq datasets, and Table 2.5 for mouse datasets that were processed.
Reads were then trimmed to remove any retained adaptor sequences at both
3’ and 5’ ends using the command cutadapt -n3 --format=fastq --overlap=3
-g GAGATGTGTATAAGAGACAG -g CAGATGTGTATAAGAGACAG -a CTGTCTCTTATACACATCTG
-a CTGTCTCTTATACACATCTC (Martin, 2011). Trimmed reads were aligned to the ref-
erence genome (GRCh38/hg38 for human; NCBI37/mm9 for mouse) with Bowtie2
(Langmead and Salzberg, 2012) in paired-end mode and default settings, with the ex-
ception of limiting the insert size to 4Kb. The resulting .sam files were then compressed
to .bam format using the samtools view (Li et al., 2009) command with –q 30 flag,
which only kept the reads with map-quality score >30. Then samtools flagstat (Li
et al., 2009) was used to get information about numbers of reads. Reads were sorted
by name using samtools sort (Li et al., 2009). The resulting file was fed to the
bamToBed (Quinlan and Hall, 2010) command in –bedpe mode to convert the .bam file
to the paired-end .bed file. The starting coordinate of the 5’ read and end coordinate
of the 3’ read were then extracted to get a .bed file with the coordinates of the insert
fragment (subsequently termed fragments). Upon encountering fragments with exactly
matching start and end coordinates, only one was retained, as those were likely to be
PCR duplicates produced during amplification, rather than truly distinct fragments
coming from separate chromosomes. Any fragments with reads that aligned to the
mitochondrial genome were filtered out and excluded from further analysis. Fragments
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overlapping with the regions previously blacklisted as mitochondrial homologs were
discarded as well. Reads from the same sample, but sequenced on separate lanes were
initially processed individually to ensure that they correlate well with each other, and
then were merged together for further analysis.
2.2.6 Peakcalling
All filtered fragment files were converted to .bampe format for peakcalling using bedpeToBam
(Quinlan and Hall, 2010). Peaks were called using MACS2 (Zhang et al., 2008) with the
following arguments: callpeak -f BAMPE -g hs --keep-dup all -B --SPMR --nomodel.
Separate sets of peaks were called either from all the fragments for each individual bi-
ological replicate (data coming from technical replicates has been combined after con-
firming high degree of correlation), further termed peaks All Fragment (AF) peaks;
or from only short fragments of sub-nucleosomal length (<100bp), with some of the
datasets combined together based on the same tissue type and, in the case of human
spermatogonial cells, similar cell morphology (see Tables 2.3 and 2.4 for details on
which replicates were combined), further termed peaks Short Fragment (SF) peaks.
For visualization, .bedGraph format files of the fragment pileups output by MACS2
(genome-wide normalized coverage of fragments) were converted to the binary .bigWig
format and uploaded to the UCSC Genome Browser mirror installed on a local secure
machine. Separate files with the non-normalized fragment coverages were created us-
ing the bedtools genomecov -bg (Quinlan and Hall, 2010) command for downstream
analysis where required.
2.2.7 Peak classification
AF peaks were classified as either ’tissue-specific’ or ’common’ based on the number
of tissues and replicates each peak has been called in. A schematic demonstrating this
classification is shown in Figure 2.4. Peaks defined as ‘present’ in all of the datasets
were classified as ’common’. In order for the region to be classified as ’tissue specific’,
the AF peak had to be found ‘present’ in at least one of the datasets belonging to the
tissue type and ‘not present’ in all of the other datasets belonging to different tissue
types. For each of the individual datasets, the SF peaks that intersected with each of
the AF-peak defined category of regions were used to get the exact coordinate and the
peak scores. MACS2-derived peak scores represent fold enrichment for the peak summit
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against a random Poisson distribution with local (5Kb and 10Kb) lambda (Zhang et al.,
2008). These scores were then used to match each of the peaks in the ’tissue-specific’
category to a corresponding peak in the ’common’ category, thereby creating two files
with peak coordinates with matched distributions of peak scores, that being done for
each of the datasets. A separate (‘ultimate’) set of ’common’ peaks was constructed
by defining the genomic coordinates covered by SF peaks from all the tissue datasets
analysed (see Figure 2.4 bottom left panel).
54
























under somatic-specific AF peaks
under germline-specific AF peaks









Figure 2.4: Peak classification. From the top: AF peaks were called from individual replicates
(circles) for each of the cell types. Overlapping peaks were merged (using bedtools merge)
and considered as one. Any somatic tissue or germline cell type (squares and pentagons, re-
spectively) with > 1 biological replicate (n) required the peak to be present in at least n − 1
replicates to be considered as ‘present’. AF peaks that were ’present’ only in somatic or only
in germline tissue/cell types were classed as either ’somatic-specific’ or ’germline-specific’, re-
spectively. SF peaks were called from the set of fragment where replicates for each tissue/cell
type were combined together. SF peaks that overlapped with a particular category of the AF
peaks were defined as SF peaks belonging to that category. An ”ultimate” set of common peaks




2.2.8 An alternative method for protein-binding site identification
The exact location of the Tn5 insertion site can be a useful measure when looking
for single-nucleotide precision level span of DNA-protein interaction. As mentioned
before, open chromatin regions that are easily accessible to Tn5 enzyme would exhibit
a high frequency of adaptor insertion, while sites protected by TFs bound to DNA are
likely to be depleted from the Tn5 enzyme activity. Those short insertion-depleted
regions within broader regions of frequent insertion would form sites similar to what
are commonly termed ‘footprints’ when looking at DNase-seq data. Footprints are not
always strongly pronounced and, depending on the depth of the fragment coverage,
are not easily identifiable. From visual inspection of patterns of the Tn5 insertion
frequency, it came to our attention that insertion sites tend to cluster at one or both
edges of the potential protein-binding sites (as defined by measures such as ChIP-seq
and presence of the TF-specific motif; see Figure 2.5 for examples).
200 bases hg19
Transcription Factor ChIP-seq (161 factors) from ENCODE with Factorbook Motifs
Tn5 cut sites shifted to the middle of transposition event (+5/-4)




chr13: 80,916,800 80,916,900 80,917,000 80,917,100 80,917,200 80,917,300 80,917,400 80,917,500
Figure 2.5: UCSC browser snapshot showing an example of Tn5 insertion frequency (blue bars)
around a potential binding site defined by ChIP-seq signal (grey) and presence of binding motif
(green).
I have therefore employed this observation to develop a Fragment Length
Occurrence Propensity method (FLOP) to identify edges of the bound proteins and de-
fine the location of protein relative to those edges. Initially peaks of increased frequency
of Tn5 insertion are defined. Tn5 insertion sites are defined as coordinates of the 5’ and
3’ ends of the insert fragments. The Tn5 enzyme inserts two adaptors at the same trans-
position event, one on the Crick and one on the Watson strand, and those insertions sites
are known to be separated by 9 base pairs (Adey et al., 2010; Buenrostro et al., 2013). It
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is currently a common practice when analysing ATAC-seq data to shift the coordinates
of the adapter insertion sites at the 5’ end of the fragment and 3’ end of the fragment
by +4 and -5 bp, respectively (Buenrostro et al., 2013). The resulting coordinate would
then represent the middle of transposition event. Those 9 base pairs between the inser-
tion sites must be physically occupied by the Tn5 enzyme, and therefore represents an
unoccupied region on DNA, 9 base pairs in length. Therefore, when calling peaks of the
insertion sites, each mid-transposition event coordinate was shifted in the 5’ direction
by 4 bp and then extended by 9 bp towards 3’ (macs2 callpeak -f BED --keep-dup
all --nomodel --shift 4 --extsize 9 --call-summits). Assignment of edges of
bound proteins is described in Box 2.2. Results validating this novel approach are
presented in Subsection 2.3.7.
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Box 2.2: Description of the FLOP method
Peak summits were assigned to represent edges of interacting proteins, and compared
the ratios of short (<100bp, sub-nucleosomal length) and long (>100bp) fragments on
either side of the peak summit to define the edge as being located either to the left or to
the right of the DNA bound protein. Due to the increased insertion frequency around
the interacting protein, a higher number of the fragments spanning it would be expected
to be short. Lower number of short fragments would be present immediately outside the
edge with the presence of anything as large as a nucleosome next to the protein. The
total coverage of long and short fragments within the 15 bp windows immediately to the
right and to the left of the peak summit were determined and the ratio of short vs long





















If the absolute ratio was higher in the right window, then the peak was classified as the
left side of the protein and vice versa, as in formula:
SF: Short fragment (<100bp) coverage LW: Left window (15 bp)





FLOPrat > 1 : right edge peak
FLOPrat < 1 : left edge peak
FLOPrat = 1 : ambiguous peak
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2.3 Results
2.3.1 Data description and quality assessment
Details of each individual human specimen that has been collected and processed can
be found in Table 2.1, along with the numbers of cells of every morphology type that
were FAC-sorted from individual samples and details of the sequencing platforms that
were used. Details of mouse sorted cells are in Table 2.2.
Table 2.1: Tissues collected and numbers of cells FAC-sorted into populations based on distinct
morphological appearance: small (yellow), large (purple), and large cells with high side scatter
(SSC) (blue). Colour correspond to the cell populations on Figure 2.6. Some populations
contained cells of multiple morphological types (H2.2 and H8.3)
Table 2.2: Numbers of mouse-derived cells FAC-sorted based on YFP-fluorescence and sequenc-
ing platforms used for each sample.
Across human samples, on average, the ‘small’ cell populations had the largest
number of sorted cells, followed by the ‘large’ category. Figure 2.6 shows an example
of the FACS plots with the gates used for the sorting of separate cell populations.
59
60 2.3. RESULTS
23,000 - 69,000 cells were used for the subsequent ATAC-seq processing. Tables 2.3
and 2.4 show the details of the each of the processed ATAC-seq samples. Generally,
our primary data showed little mitochondrial contamination (5-21%), which is known
to be a problem with ATAC-seq analysis in some tissues (Montefiori et al, 2017). Mito-
chondrial sequences are normally discarded as unrelated to the scope of the experiment
(Tsompana and Buck, 2014) and a high percentage of these would reduce the numbers
of usable nuclear genomic reads. The proportion of PCR duplicates was estimated
to be 10-24%. The number of resulting fragments for each of the individual samples
varied between 100 and 150 million (just below 100 million for mouse data), which is a
sufficient depth to be able to perform peakcalling for identification of potential binding
sites. Figures 2.7 and 2.8 show the fragment length distribution for each human and
mouse samples. All of the samples analysed show pattern of mono-, di- and tri- nu-
cleosomal fragment length enrichment, indicating that the chromatin structure of cells
was intact when the assay was performed.
In some samples (H1.1, H1.2, H2.1, H2.2, H5.3, H8.2, H7.2, H7.4, H8.3), visual
inspection of the fragment pileups revealed lack of the localized enrichment of fragments
that would be sufficient to form distinct peaks. Figure 2.9 shows a genome-wide-
normalized fragment coverage around the promoter regions of some highly expressed
housekeeping genes from Eisenberg and Levanon (2013). While some of the datasets
show a clear enrichment of fragments over the promoter regions, others do not.
If the ‘noisiness’ reflects distressed chromatin state of cells, one would intu-
itively expect to see a difference in the fragment length distributions between those
that exhibit it and those that do not. However, there did not seem to be any definitive
difference. To quantitatively measure this ‘noisiness’, I have calculated the percent-
age of fragments that overlapped with the ’housekeeping’ DNase-seq footprints defined
by Reijns et al. (2015). Those measures for each of the samples can be seen in Ta-
bles 2.3 and 2.4. While not an absolute measure, the comparison of signal at these
housekeeping-like binding sites as defined from many cell types to background signals
provides a useful relative comparator of signal to noise between datasets. I postu-
late that such ‘noisy’ data could represent cells being subjected to high level of stress
during the desegregation and, in particular, FACS procedures, possibly also indicat-
ing loss of nuclear integrity during preparation. Additionally, during the ATAC-seq
processing of the samples H1 and H2, the amount of Tn5 enzyme was not titrated to
60






















Figure 2.6: FACS plots showing the gates used for the sorting of different cell populations. (a)
Gating of the cell populations based on the forward (FSC) and side (SSC) scatter (measures of
cell size and granularity, respectively). Three cell populations were defined based on those mea-
sures - P2 (blue), P1 (red and purple), and P8 (yellow and green). Subpopulation of those have
then been sorted based on the level of fluorescence (RFP - red fluorescence; GFP - green fluo-
rescence), and ”Small” (b), ”Large” (c) and ”SCC” (d) subpopulations forming bright clusters
were isolated.
the numbers of cells. This could potentially have caused over-digestion of the DNA in
those samples, even at the regions of DNA that were highly compacted or protected by
bound proteins/nucleosomes. Percentages of the fragment-derived bases falling within
the DNase-seq footprints was higher for almost all other human samples (Tables 2.3
and 2.4). For all the downstream analysis I have excluded the datasets that did not
show formation of distinct peaks by the visual inspection on the fragment coverage and
showed <3% overlap with the DNase-seq footprints. An example of the data can be
seen on the Genome Browser snapshot in Figure 2.10.
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Figure 2.7: Distribution of the fragment length for each of the human datasets. Histogram on
the top represents the average percentage of fragments of each length among all the datasets. The
dips at 48-49bp, 73-74bp and 123-124bp followed by peaks in the top histogram (also observable in
the heatmap) result from the inability of the cutadapt software to trim the adaptor sequences at
ends of reads that are <3bp when actual fragments are 1-3bp shorter than read length. For better
color discrimination in the heatmap, numbers of fragments have been log2-transformed. There is
a substantial variability in the maximal lengths of the fragments, but most of the datasets show
an observable enrichment in the mono-, di- and tri- nucleosomal length fragments (indicated by
*).
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Figure 2.8: Distribution of the fragment length for each of the mouse datasets. Histogram on
the top represents the average percentage of fragments of each length among all the datasets.
The dip at 123-124bp followed by peaks in the top histogram (also observable in the heatmap)
result from the inability of the cutadapt software to trim the adaptor sequences at ends of
reads that are <3bp when actual fragments are 1-3bp shorter than read length. For better color
discrimination in the heatmap, numbers of fragments have been log2-transformed. There is a
substantial variability in the maximal lengths of the fragments, but most of the datasets show




Table 2.3: Summary statistics of primary spermatogonial cell ATAC-seq datasets that were
analyzed. Sample: the name of individual sequenced samples (same samples run on different
lanes are not combined here); Reads: raw numbers of reads ; Quality < 30 : percentage of
reads with map-quality < 30 ; Mapped : percentage of reads mapped (without quality filter)
; chrM : percentage of reads aligned to the mitochondrial genome ; Duplicates : percentage
of fragments that were discarded as PCR duplicates ; Fragments : total number of fragments
(de-duplicated); DHSF overlap : percentage of fragment bases overlapping with housekeeping
DNase-seq footprints ; Combined : samples with the same combined dataset name were merged
for SF-peak identification
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Table 2.4: Summary statistics of ATAC-seq datasets from other studies that were analyzed.
Sample: the name of individual sequenced samples (same samples run on different lanes are
not combined here); Reads: raw numbers of reads ; Quality < 30 : percentage of reads with
map-quality < 30 ; Mapped : percentage of reads mapped (without quality filter) ; chrM : per-
centage of reads aligned to the mitochondrial genome ; Duplicates : percentage of fragments
that were discarded as PCR duplicates ; Fragments : total number of fragments (de-duplicated);
DHSF overlap : percentage of fragment bases overlapping with housekeeping DNase-seq foot-




Table 2.5: Summary statistics of mouse ATAC-seq datasets that were analyzed. Sample: the
name of individual sequenced samples (same samples run on different lanes are not combined
here); Reads: raw numbers of reads ; Quality < 30 : percentage of reads with map-quality
< 30 ; Mapped : percentage of reads mapped (without quality filter; reads from lung, large
intestine and bone marrow were obtained pre-mapped, and therefore have value of 100%) ;
chrM : percentage of reads aligned to the mitochondrial genome ; Duplicates : percentage
of fragments that were discarded as PCR duplicates ; Fragments : total number of fragments
(de-duplicated); Combined : samples with the same combined dataset name were merged for
SF-peak identification
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Distance to transcript start site (bp)
Figure 2.9: Normalized ATAC-seq fragment coverage of all of the human datasets across a
number of highly expressed housekeeping gene transcription start sites (-1000:+1000bp from
the TSS). Datasets that have been used for subsequent analysis (Spermatogonia H10.2, H5.1,
H5.2, H5.4, H5.5, H7.3; data from all patient from adrenal gland, breast epithelium, leg muscle,
pancreas, sigmoid colon, thyroid gland, spermatogonia (Guo et al)) are in pink, while the ones
that have been excluded from analysis (Spermatogonia H1.1, H1.2, H2.1, H2.2, H5.3, H7.2,
H7.4, H8.3) are in purple. Kept datasets show a more prominent open state of the promoters
that are expected to be accessible in all of these cell types, indicating a better quality of data.




Figure 2.10: An example Genome Browser track snapshot showing the coverage of all fragment
lengths (dark) and short fragment coverage (light) for two of high quality spermatogonia datasets
(green), a spermatogonia dataset with ’noisy’ fragment distribution (purple), and colon dataset
(orange). Clear formation of peaks is observable at the promoter regions of several genes (blue,
top), except for the purple dataset, corresponding to the patterns of H3K27Ac (histone mark
associated with active transcription) and DNase-seq Clusters (black). H3K27Ac marks are
enriched in the gaps between SF peaks, where nucleosomes would be expected to reside.
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2.3.2 Enrichment of sub-nucleosomal length fragments mark
regulatory regions, while Tn5 insertion sites can mark some
individual protein-binding sites
Plotted coverage of fragments around RefSeq (O’Leary et al., 2016) and CAGE-defined
transcription start sites (TSSs) from Young et al. (2015) can be seen in the Figures
2.11a and 2.11b, along with the fragment coverage over previously-defined DNase-seq
footprints (Figure 2.11d). ATAC-seq fragment coverage shows expected patterns of
enrichment around TSSs and DNase-seq footprints. These TSS locations are either an
aggregate of all defined transcription start sites (as in RefSeq), or are expressed specif-
ically in testes (as in CAGE). Both datasets, however, contain regions that represent
housekeeping regulatory sites and patterns of accessibility at those is a good check for
the quality of data and its ability to identify the housekeeping and, hopefully, cell-type
specific regulatory regions.
To assess the suitability of the ATAC-seq data for identification of the indi-
vidual protein-binding sites, I looked at the distribution of the Tn5 insertion sites in
the colon tissue around the motifs of TFs found under ChIP-seq peaks in the matching
cell type (Figure 2.12). Colon was chosen because both ATAC-seq from the tissue and
ChIP-seq data (Yan et al., 2013) from a tissue-derived cell line could be obtained for
multiple different TFs. I also looked at the distribution of the insertion sites around
the protein-binding sites defined by DNase-seq footprinting (Figure 2.13). While there
is heterogeneity in the patterns of Tn5 insertion frequencies around motifs of different
TFs, many sites show peaks on both sides of the motif. For some TFs, the insertion
frequency does not form obvious footprints with strong depletion at and around the
motif, but instead exhibit formation of ragged ’insertion signatures’ within the motif,
similar to what has previously been observed for DNase-seq data (Neph et al., 2012;
He et al., 2014; Sung et al., 2014; Baek et al., 2017).
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(a) TSSs defined by RefSeq
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Figure 2.11: Coverages of short (<100bp) and long (>100bp) fragments over TSSs (a, b, and
c) and DNase-seq footprints (d). Promoters have been oriented so that the transcription would
initiate at x=0 and proceed towards the right. Each individual dataset is represented by a thin
line, while the mean of all the datasets is represented by a bold line. There is greater enrichment
of the sub-nucleosomal length fragments at the promoter regions with depletion at the site where
the +1 nucleosome would be expected to be located (a,b). Enrichment of spermatogonia-derived
ATAC-seq fragments is absent at the muscle-restricted promoters (c), as expected. Similarly,
there is an enrichment of the sub-nucleosomal length fragments over the DNase-seq footprints
(d). This shows that sub-nucleosomal length fragments are indeed enriched at regions where
proteins are expected to bind and are depleted at closed non-accessible regions and at sites
occupied by nucleosomes.
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Distance from motif left edge (bp)
Figure 2.12: Enrichment (relative to the flank) in the frequency of Tn5 insertions from one
of the colon ATAC-seq samples. Individual plots are centred on aggregate of motif mid-points,
and a TF would be expected to bind in the middle. These motifs were found under ChIP-seq
peaks of corresponding TFs in LoVo cell line (colorectal adenocarcinoma-derived cell line). Tn5
insertion pattern shows identifiable peaks on both sides of some of the TF binding sites (such
as CREB1 and CTCF), while binding sites of others are more poorly captured (such as HNF1B
and SOX2).
At least in relation to DNase-seq footprints, the observed specific profiles of
the nuclease digestion over the binding sites of different TFs have previously been shown
to reflect the physical interaction of protein with DNA (Neph et al., 2012), or argued
to reflect nature of the DNA structure (He et al., 2014; Sung et al., 2014; Baek et al.,
2017), rather than protein binding property. The depth of the footprint has also been
reported to be dependent on the dynamic nature of protein binding, with TFs exhibit-
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Figure 2.13: Enrichment of the Tn5
insertion sites from all the ana-
lyzed datasets (enrichment over the
average calculated from -1000:-800
and +800:+1000 regions away from
DNase-seq footprint left edge) cen-
tered on the left edge of footprints.
Tn5 insertion sites show a distinct
peak of enrichment coinciding with
the edge of DNase-seq footprint. Av-
erage width of a footprint is ≈10bp.
ing short residency time not producing deep footprints (Sung et al., 2014). ATAC-seq
data is likely to be similar to DNase-seq data in this respect, although exhibiting a dis-
tinct enzyme-specific bias and therefore generating different footprint shapes (Calviello
et al., 2018). Therefore, not all of the TF binding sites would be identifiable by Tn5
insertion, especially for TFs with short residence time, and some erroneous assignments
are possible, particularly with the TFs that exhibit strong insertion signatures within
the motif.
2.3.3 Isolated cells show open spermatogonial cell promoters by
ATAC-seq
While the human cells that we have isolated are likely to be spermatogonial cells, as
they were all FGFR3-positive, those cells also represent distinct populations of size
and shape and potentially amount to various stages of the spermatogonial lineage.
To better understand the identity of these cellular sub-populations, I investigated the
promoter regions of some of the genes that are thought to be active or poised in our
cells of interest. Figure 2.14 shows ATAC-seq fragment coverage from spermatogonial
cell datasets over the promoter regions of some of the pluripotency-related genes that
have been shown to be expressed in spermatogonia, along with the germ cell-specific
markers. While accessible chromatin defined by ATAC-seq peaks is often correlated
with transcription initiation activity and gene expression (Wang et al., 2018), it is not
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Figure 2.14: Fragment coverage over the germ-cell (DAZL, DDX4 and FGFR3) and pluripo-
tency (ITGA6, KLF2, KLF4, MBD3, STAT3 and TCF3) gene promoters. Coloured lines
represent our primary data, while black lines are hSCCs from two patients from Guo et al.
(2017).
Surprisingly, the promoter region of the FGFR3 gene does not show a peak,
as would be expected, as that is the marker that was used to FAC-sort the cells in
question. Promoters of DAZL and DDX4 genes, which are germ-specific markers show
some degree of openness (in all datasets except for H10.2, in purple), while most of the
pluripotency markers that have been previously been observed to be expressed in both
73
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spermatogonial stem cells and those committing to differentiation (Guo et al., 2017)
show clear ATAC-seq peaks.
2.3.4 Analysis of peaks
The numbers of AF peaks called from each of the datasets can be seen in the Tables
2.6 (human), and 2.7 (mouse).
Table 2.6: Numbers of human AF (all fragment) peaks identified in all of the analyzed datasets
with counts and proportions of peaks that have been classified as ’common’ or ’tissue-type specific’
based on comparisons with replicates and other tissues.
Datasets H5.2 and H5.5; H5.1 and H5.4; H10.2 and H7.3 were combined for
the SF peak calling based on similar size and shape appearance of those cells in FACS.
All of the mouse spermatogonial datasets (m1, m5 and m7) were combined for SF peak
calling. Matching cell types tend to exhibit better correspondence between peak scores
in linear regression (Figures 2.15 and 2.16). Neither of the three human pancreas
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Table 2.7: Numbers of mouse AF (all fragment) peaks identified in all of the analyzed datasets
with counts and proportions of peaks that have been classified as ’common’ or ’tissue-type specific’
based on comparisons with replicates and other tissues.
datasets show much similarity to each other, probably owing to the low numbers of
peaks called in two out of three samples (Table 2.6). All of the H5 datasets correlate
best with each other (0.85 > R2 > 0.75), likely due to cells having come from the same
patient (even though some of those cells were of different morphologies).
Table 2.8: Numbers of human ”Short Fragment” (SF) peaks (short fragment peaks) identified
in each of the tissue types with counts and proportions of peaks that fall into ’common’ or




Figure 2.15: Matrix representing R2 scores from linear regression of the human AF peaks
called from each of the individual datasets (only technical replicates combined, not biological
replicates). Only scores for peaks that were detected in both compared datasets were used.
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Figure 2.16: Matrix representing R2 scores from linear regression of the mouse AF peaks
called from each of the individual datasets (only technical replicates combined, not biological
replicates). Only scores for peaks that were detected in both compared datasets were used.
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Table 2.9: Numbers of mouse SF (short fragment) peaks identified in each of the tissue types
with counts and proportions of peaks that fall into ’common’ or ’tissue-type specific’ category
based on intersections with AF peaks (all fragment peaks) of the corresponding category.
2.3.5 ’Common’ peaks are more proximal to transcription start sites
Numbers of SF and AF peaks defined as ’tissue-specific’ or ’common’ can be seen
in the Tables 2.6 and 2.8 (human); Tables 2.7 and 2.9 (mouse). While I used the
scores from MACS2 output to match the ’tissue-specific’ and ’common’ peaks, those
pairs might represent sites that are located in distinct genomic contexts, such as with
different proximities to other open regions or genes. Scores output by MACS2 callpeak
command represent the measure of fold enrichment of the fragment coverage in the
peak area relative to that observed in local region (5-10Kb). Thus, the score of the
peak that is located in a generally more open region (such as at promoters) could be
assigned a lower score than a peak of the same magnitude, but located in a region that
is generally less accessible. Figure 2.17a illustrates a difference in absolute fragment
coverage between the same number of ’tissue-specific’ and ’common’ sites in the same
dataset. ’Common’ peaks have what looks like a ‘dip’ next to the peaks that are being
compared (which probably marks the +1 nucleosome) in general more open regions with
additional clustering of adjacent signals. Total number of fragments at the summit is
also higher for ’common’ peaks. This suggests that more ’common’ peaks might be
located at promoter regions, while ’tissue-specific’ peaks are more distant, stand-alone
binding sites. Indeed, when measuring the distance from a peak to the nearest TSS, in
all the datasets examined, ’common’ peaks seem to be located markedly closer to TSSs
than the ’tissue-specific’ ones (Figure 2.17b). Figure 2.17c shows that 40%-70% of all
the ’common’ peaks defined in all the tissue types are overlapping transcription start
sites (RefSeq-defined), while less than 10% do so in the ’tissue-specific’ peak category.
This is an important observation to keep in mind when comparing those two
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Figure 2.17: Differences in distributions
and scores of the ’common’ and
’tissue-specific’ peaks. Each individual line
represent data from one SF peak dataset.
In 2.17a, for each ’common’ and
’tissue-specific’ pair the maximal point of
the plot is the maximal value in that pair,
hence the y-axis would differ between pair
sets.
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(a) Absolute coverage of fragments in sets of
’common’ and ’tissue-specific’ peaks that have


























































(b) Distance to the nearest Ref-seq
transcription start site. Note log-scale x-axis.






























(c) ’Common’ peaks are enriched around
Ref-seq transcription start sites in comparison
to the ’tissue-specific’ peaks.
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categories of sites, as we are looking at peaks of slightly different magnitude, and
therefore possibly varied binding frequency/strength, and also diverse types of sites
located in distinct genomic contexts.
2.3.6 ’Tissue-specific peaks’ are enriched over tissue-biased
promoters
To see if the distribution of ’common’ and ’tissue-specific’ peaks differs between cell
types, I looked at the enrichment of each of the peak categories over promoter regions
that have been classified as tissue-biased using CAGE data of 52 tissues from Young
et al. (2015). Figure 2.18 shows what proportion of peaks overlaps with the testis-biased
(2.18a), skeletal muscle-biased (2.18b) and pancreas-biased (2.18c) promoters. While
’common’ peaks from all of the datasets show enrichment over the tissue-biased pro-
moter regions, when looking at the ’tissue-specific’ peaks, they show greater enrichment
over the matched tissue type-biased promoter.
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(a) Testis-biased promoters and spermatogonia
peaks. Spermatogonia-specific peaks (bold orange
lines) are enriched at the testis-biased promoters
in contrast to other peaks specific to other tissues
(thin orange lines).
(b) Skeletal muscle-biased promoters and leg
muscle peaks. Leg muscle-specific peaks (bold or-
ange line) are enriched at the skeletal muscle-
biased promoters to a larger extent than peaks
specific to other tissues (thin orange lines).
(c) Pancreas-biased promoters and pan-
creas peaks. Pancreas-specific peaks
(bold orange lines ) are enriched at the
pancreas-biased promoters to a larger ex-
tent than peaks specific to other tissues
(thin orange lines).
Figure 2.18: Enrichment of common and tissue-type
specific peaks over the tissue-biased promoter regions.
Tissue-biased promoter regions have been defined by
the enrichment of the CAGE-tags in different tissues
(Young et al., 2015). Thin lines represent peak en-
richment for individual tissues, with the bold lines
showing enrichment of peaks from the tissue that
matches the tissue to which the promoter is biased.
Promoters have been oriented in a way so that the
gene would be located on the right side of the plot. En-
richment of the tissue-specific peaks at the promoter
regions biased to a matched tissue type indicates suc-




2.3.7 Novel method identifies edges of protein binding sites
Using the alternative method that I have developed and implemented to find the single-
nucleotide-precision edges of the bound proteins (see description of the FLOP method
in Subsection 2.2.8), I have identified 400,000-2,000,000 genomic positions in human
data that could be classified to represent either right or left boundary of an interacting
protein (see Table 2.10 for the total numbers for each of the datasets). For each of the
tissue types, I intersected the identified edges with the ’tissue-specific’ and ’common’
peaks described earlier in this Chapter (Table 2.8).
To assess whether the separation of the edges with the FLOP method is ef-
fective, I plotted the distribution of edges around a number of motifs of the sequence-
specific TFs found under ChIP-seq peaks in the matched cell type (Figure 2.19). Clas-
sification of the edges by FLOP method appears to work effectively, with most of the
edges falling at the expected side relative to the motif. Different TFs appear to show
distinct patterns of the edges around them. For example, the pattern around CTCF is
reminiscent of the protein bound in promoter-distal regions (Chen et al., 2012a), with
few other edges found in the vicinity; whereas CREB1 and ZNF143, which are known
to bind around promoter regions (Conkright et al., 2003; Bailey et al., 2015), show
a noisier patterns that are consistent with more TFs being bound in the immediate
proximity.
The advantage of this method is that more precise boundaries can be identi-
fied, but it is also more prone to identification of false-positive binding sites due to the
more sporadic nature of the insertion peak incidence, as reflected by a large numbers of
identified peaks. Low levels of ’smoothing’ effect derived from the extension of single-
nucleotide insertion positions by 9 bp act as a trade-off for the higher degree of precision
and effectively leads to more frequent formation of smaller peaks and higher degree of
sensitivity to the contribution of Tn5 enzyme preferential insertion bias. While some
papers have discussed the Tn5 preferential insertion bias phenomenon in ATAC-seq
data (Buenrostro et al., 2013; Madrigal, 2015) and there have been some studies that
tried to quantify and account for this bias when analysing the data (Wang et al., 2017;
Martins et al., 2018), to date there is no method or software that has been successful
at completely eliminating it. Looking at the patterns of Tn5 insertion around binding
sites of some of the sequence-specific DNA-interacting proteins, TFs would be expected
82
CHAPTER 2. IDENTIFICATION AND SEPARATION OF BINDING SITES 83
Table 2.10: Numbers of increased Tn5 insertion frequency peaks identified that represent protein
binding edges in each of the human tissue types with counts and proportions of those that have
been classified as ’common’ or ’tissue-type specific’ based on intersections with SF peaks (short
fragment peaks) of corresponding category (Table 2.8).
to be affected to a varied degree. In particular, a TF REST appears to have a bind-
ing motif that closely resembles the Tn5 preferential insertion sequence. Therefore,
binding sites for some of the TFs might not be effectively captured with this method
and a relatively high false positive rate in overall binding edge identification is antic-
ipated. However, by combining the FLOP method with intersection of binding edges




Figure 2.19: Distribution of the putative protein binding edges (identified by FLOP method
from sigmoid colon ATAC-seq data). Edges that were classified as marking right side of the
bound protein are in blue, while those marking left side are in red. Individual plots are centered
on the midpoint of aggregate TF binding motifs found under the ChIP-seq peaks (LoVo cells,
colon adenocarcinoma; from Yan et al. (2013)). Points represent an enrichment of the number
of edges at each of the position relative to the average of -1000:-800 and +800:+1000 regions
away from the motif mid-point, while the lines represent a rolling average of 20bp. FLOP
method edge separation is working well, as evidenced by an enrichment of right-classified edges
to the right of the putative binding sites, and left-classified edges to the left around most of the
TF motifs.
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2.4 Discussion
2.4.1 Novel chromatin accessibility primary data for spermatogonial
cells
In order to be able to compare the differential mutational pressures acting at the pro-
tein binding sites of the somatic and germline cells, it is necessary to have aggregate
information about the protein-binding landscape of multiple tissues. There is already
abundant information from different types of assays such as DNase-seq, ChIP-seq/exo
and its variations, and ATAC-seq available through large data collections such as EN-
CODE (Dunham et al., 2012) and Roadmap Epigenomics (Roadmap Epigenomics Con-
sortium et al., 2015) Consortia as well as other individual studies. While some of those
methods, such as ChIP-exo, are ideal for high-confidence and high-resolution binding
site identification, they also require a high number of cells as input material, along
with protein-specific antibodies, and performing those assays on large numbers of TFs
in multiple tissues is labour-intensive. One would also need sufficiently good knowledge
of the types of TFs that are likely to be bound in different cells. Therefore, there is a
rather limited range of proteins for which those assays have been performed, let alone
in multiple types of tissues or looking at tissue-specific TFs. For the type of analysis
proposed here we require an aggregate of a relatively large number of tissue-specific
binding sites. In this respect, assays such as DNase-seq and ATAC-seq are ideal, as
they can provide a ‘snapshot’ of the accessibility landscape of the whole cell in one
experiment, and the whole protein-binding landscape can be inferred from that.
We propose that large numbers of mutations occur at germline active protein-
binding sites as a result of TF interference with normal processes of replication and
repair. Therefore, we expect the highest numbers of mutations to accumulate at the
protein-binding sites that are active in the most replicative cells of the germline, which
are spermatogonial cells. In this work, we have generated novel, primary ATAC-seq
data obtained from the FAC-sorted spermatogonial cell populations from both mouse
and human testicular tissues. We used the FGFR3 surface marker to enrich for human
spermatogonial cells. At the time of our first cell separation experiments FGFR3 has
not been utilized for spermatogonial cell enrichment. Since then it has been confirmed
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to be suitable for this purpose by another study that used the FGFR3 antibody to
perform magnetic cell isolation on cell populations obtained from fragments of testis
tissue (Von Kopylow et al., 2016).
To confirm that we are working with the right cell type, I looked at the
promoters of genes that we expect to be expressed in human spermatogonial cells based
on RNA-seq evidence from Guo et al. (2017). In most of our FAC-sorted cells there was
some degree of openness at promoter regions of germ-specific genes DAZL and DDX4,
which is encouraging. Promoter regions for most of the pluripotency TFs that have
been confirmed to be expressed in both unipotent and differentiating spermatogonia
(Guo et al., 2017) show a high level of accessibility in most of the samples. Surprisingly,
the promoter region of FGFR3, which is the marker that was used for cell sorting does
not show evidence of being accessible in our datasets. While FGFR3 promoter does
show some evidence of openness in some of the other (somatic) datasets, the chromatin
state of the region seems to be rather poorly captured by ATAC-seq based on visual
inspection of the fragment pileups. It is fair to note that the open state of a promoter
region of a gene does not necessarily imply gene expression, and transcript abundance
(hence, protein abundance) is affected by other factors such as post-transcriptional
regulation.
I assert that the number of replicates of our primary data are of good quality
and sufficient depth to use for protein-binding site identification. There were also 8
samples whereby the quality did not appear to be suitable for analysis. Those datasets
were exhibiting a high level of ‘noisiness’, which could conceivably be a reflection of
the perturbed chromatin state of cells due to the stress of desegregation procedures
and FACS or, alternatively, as consequence of the over-digestion with the Tn5 enzyme.
While some of the datasets appeared to show a better result after an adjustment of
the Tn5 amounts to the numbers of cells, others were still exceedingly ‘noisy’. This
could be due to the fact that the alteration of the Tn5 amounts was approximate, or
to widespread rupture of the nuclear membrane in the sample and fragmentation of
genomic DNA with loss of native chromatin conformation. While the exact nature of
this phenomenon currently remains unclear, I provide some measures that could help
identify such datasets (in ways distinct from the visual inspection of the coverages), by
quantifying overlap of fragments with DNase-seq footprints. When narrowing analysis
to the good quality datasets, the fragment coverage distributions shows that our data
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is suitable for identification of promoter regions as well as protein binding sites.
Overall, these data provide a valuable resource for exploration of the sper-
matogonial cells outlined in this work, or any of the future studies that might be
undertaken to further investigate the chromatin landscape of spermatogonial cells in
both humans and mice.
2.4.2 Identification of separate categories of protein-binding sites
In this work, I have applied the same analysis to data from one type of assay (ATAC-seq)
performed on a number of different tissue types. I used some publicly available raw data
from ATAC-seq performed on various human and mouse somatic tissues from GTEX
and other studies; SSCs from Guo et al. (2017); and our in-house generated human
and mouse spermatogonial cell ATAC-seq. I developed a data-processing pipeline for
identification of protein-binding sites in each of the analysed type of tissue, and also
separate categories of sites that are either ’tissue-specific’ or ’common’ across all of
the tissues. I devised a method that identifies potential edges of the bound proteins at
near-nucleotide resolution and assigns which side the edge represents.
I applied the aforementioned analyses to spermatogonial cells, and human
tissues of pancreas, colon, thyroid and adrenal glands, breast epithelium and skeletal
muscle; along with mouse spermatogonial cells, B cells, cerebellum tissue, bone marrow,
lung, intestine and mammary glands. I identified a number of sites that I conclude to
be either specific to each of those tissues, or common to all. I find that ’common’ and
’tissue-specific’ sites exemplify slightly distinct categories of regions, with the former
potentially being more representative of sites located at promoters, while the latter
showing patterns more reminiscent of ‘stand-alone’ protein binding regions, e.g. en-
hancers. This might be a reflection of the fact that sites such as enhancers differ more
between tissues than promoters do (Villar et al., 2015). For further analysis of those
sites, I propose using pairs of sets of ’common’ and ’tissue-specific’ sites with matched
distributions of peak scores, which here I use as a proxy for the strength or frequency
of the protein binding.
One of the shortcomings relating to the use of ATAC-seq for nucleotide-
resolution protein-binding site identification is the phenomenon of the Tn5 preferential
insertion bias. Tn5 has previously been reported to have a preferential sequence that
is enriched around its insertion sites, a feature common to greater or lesser degrees
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to all DNA cleavage methods (Martins et al., 2018). Lately, there have been multiple
attempts to characterize and account for this bias (Wang et al., 2017; Martins et al.,
2018), however none of those are able to fully eliminate it. I was not successful at
removing the bias either by my own methods or by utilizing recently available software
(Martins et al., 2018). While Tn5 preferential insertion sequence being present at the
aggregated edges of identified binding sites might distort the pattern of mutation and
variation we are looking at, due to the uniform nature of the bias, it is unlikely to affect
the comparisons of the sites between different tissues.
There have been a number of methods developed previously for near nucleotide-
resolution protein-binding site identification from the chromatin accessibility data, such
as footprinting (reviewed in Gusmao et al. (2016)), mainly for DNase-seq data analy-
sis, less so ATAC-seq specific methods. Most of those methods still rely on pre-defined
motifs of the TFs that one would expect to find. Here, our primary goal is to identify
protein binding sites specific to the poorly-characterised population of spermatogonial
cells. Therefore we expect that there might be a number of TFs for which defined mo-
tifs are not available. The ’footprints’ detection method as such has also been shown to
be widely affected by the ragged digestion/insertion patterns within the binding motif,
speculated to result from the DNA shape (He et al., 2014; Sung et al., 2014) or protein
binding conformation (Neph et al., 2012), with estimated 80% of TFs being affected
by this (Baek et al., 2017). The advantage of the FLOP method described here is
that it does not rely on finding regions of insertion depletion, but rather an increase in
insertion frequency in accessible DNA proximal to bound TFs. It is also built on the
ATAC-seq data specific observation about the distributions of the fragments around
the binding sites. This has potential in identification of the binding edges and their
spatial classification, but could be improved on. One possible line of improvement
would be to integrate this method together with machine-learning approaches, such as
the Segway software designed for the identification of epigenetic states (Roberts et al.,
2016). One can envisage an implementation of Hidden Markov or dynamic Bayesian
network (as used in Segway) models with several observations, such as insertion fre-
quencies within the sample and control (e.g. ’naked’ DNA) on either strand, counts of
short and long fragments overlapping each genomic position, and DNA sequence. One
could define a number of chromatin states, such as ’closed’ (1), ’open accessible’ (2),
’open nucleosome-occupied’ (3), ’open left side of TF’ (4), ’TF occupied’ (5) , ’open
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right side of TF’ (6), and some state transition probabilities. Knowing that along the
DNA sequence states can change in 1→ 2→ 3→ 4→ 5→ 6→ 3→ 2→ 1 manner, but
not in 1→ 4→ 3 sequence, the model could be trained on a set of known binding sites
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3.1 Introduction
3.1.1 Patterns of mutation rate and selection are intermixed, and
not uniform across the genome
Differences in DNA sequences between species (e.g. human and mouse), or between
individuals of the same species, originate as mutations that have occurred in a cell of
germline lineage. The frequency with which mutations occur is defined as the mutation
rate. The mutation rate is not the only thing shaping the pattern of germline variation
that we observe. Some mutations that occur might be deleterious for the organism, or
even incompatible with life. Therefore, selection shapes the landscape of the genome
on top of the mutational pressures in observed nucleotide diversity data. In a simplis-
tic view, the absence of variation is often taken as evidence of purifying selection at
functionally important underlying locus, while high variability is often interpreted as
a lack of function. Increased sequence variability can also be evidence of diversifying
selection, where a change in sequence if favoured and its retention is driven by natural
selection and adaptation (Gittelman et al., 2015).
This, however, is complicated by the fact that mutation rates are not uniform,
but vary greatly across the genome on different scales (Wolfe et al., 1989; Makova and
Hardison, 2015). In order to be able to determine whether sequence is significantly
conserved to a higher or lesser degree than expected, one needs to have an estimate of
the nucleotide conservation in the absence of selection, under ”neutrality”. Due to the
variability in the mutation rates across the genome, the estimation of conservation under
neutrality would differ accordingly. Non-uniformity of mutation rates gives rise to the
notion of regional mutation rates. A variety of different factors have been implicated as
having an effect on the regional mutation rate. Those factors can affect different types
of mutations in various ways - for example there can be an inverse reverse relationship
between the rates of single nucleotide variants (SNVs) and indels (Semple and Taylor,
2009). In this work, I look exclusively on SNVs.
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3.1.2 Regional mutations rates vary at different scales
Each genomic region is affected by multiple categories of features that determine its
mutation rate. Replication timing is one of the large-scale correlates of the variability
in mutation rates, with more mutations occurring in late-replicating regions, which is
proposed to be due to depletion of free nucleotides (Watt et al., 2015), accumulation
of single-stranded DNA (Stamatoyannopoulos et al., 2009) and lower level of mismatch
repair (Supek and Lehner, 2015).
Sequence composition can affect the rate at which mutations occur. CpGs ex-
hibit an elevated mutation rate (with a distinct high frequency of C−→T change) due
to the high incidence of methylated cytosine deamination (Youssoufian et al., 1986;
Hodgkinson and Eyre-Walker, 2011). In turn, most regulatory regions, such as pro-
moters, in the human genome tend to be GC-rich (Gardiner-Garden and Frommer,
1987) and unmethylated (Thurman et al., 2012), leading to lower mutation rates than
sequences of similar composition but located outside of regulatory regions.
There is a complex association between the mutation rates and transcription.
On one hand, transcribed regions tend to spend more time in an open state and be
more accessible to mutagens, in addition to a non-template strand spending some time
in a sensitive single-stranded conformation (Jinks-Robertson and Bhagwat, 2014). On
the other hand, that is counterbalanced by the presence of transcription-coupled repair
(Hanawalt and Spivak, 2008). Exons are generally more conserved than introns, but
they are also have been shown to exhibit lower mutation rates due to the preferential
targeting of mismatch repair (Frigola et al., 2017). This could also be counted as a
dependence of mutation rates on histone marks, as H3K36me3, that is enriched in exons
of actively transcribed genes, is hypothesised to be responsible for recruitment of MMR
(Frigola et al., 2017). DNA accessibility shows a positive correlation with the incidence
of SNVs. At a low resolution (several kilobases), promoter regions, important for
binding transcription machinery and other TFs, have been found to exhibit increased
mutation rates (Young et al., 2015; Taylor et al., 2008, 2006), while there is more
heterogeneity at higher resolution around individual protein binding sites. The way that
certain bits of DNA are packaged can influence the likelihood of them being mutated -
there is a higher level of substitutions observed at nucleosomal dyads when compared
to linker sequences (Sasaki et al., 2009; Semple and Taylor, 2009; Tolstorukov et al.,
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2011).
3.1.3 Increased germline variation around protein binding sites can
be shaped by variable mutation rate or selection
Increased germline variation is observed surrounding some sequence-specific TF binding
sites, that rises above the estimated level of neutrality (Figure 1.8). There are several
conceivable explanations for how this pattern has occurred, represented in Figure 3.1.
The ’diversifying selection’ model explains the observed pattern purely as a reflection
of selection, with diversifying selection favouring variation near TF binding motifs (Fig-
ure 3.1, left). The ’reduced constraint ’ model similarly explains the observed pattern
of single nucleotide substitutions between species as shaped by selection (Figure 3.1,
right). This model assumes that the increased numbers of substitutions in fact matches
the level of neutrality (dashed green line), and that the proximal sites are under some
selective constraint due to a higher probability of other binding motifs occurring in
the vicinity (Boyle et al., 2011). The ’increased mutation rate’ model describes the
observed shape of substitutions as a composite imprint of patterns laid down by both
purifying selection that is acting to preserve a functionally important protein-binding
motif, and mutation rate, that is increased all across the binding site spanning the















Figure 3.1: Possible explanations for the observed pattern on increased divergence near TF-
binding motifs (burgundy lines on the top). Green ”selection” curves at the bottom show the
influence of selection pressure on nucleotide diversity, with dotted lines denoting level of neu-
trality. For detailed explanation of all models see Section 3.1
As with most statistical analyses, the shape of these substitution rate profiles
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is more accurately measured with more data. Many sequence changes are observed
between species, for example between human and mouse there are typically 0.57 nu-
cleotide substitutions per site in four-fold degenerate positions of protein coding genes
(Forrest et al., 2014), where as there 0.002 substitutions per site in the same four-fold
degenerate sites between any two distantly related humans (Gibbs et al., 2015). In a
simple rate-comparison analysis one would need alignments of 285 human sequences to
equal the statistical power of one human to mouse pairwise alignment. However, not
all sequences do align between human and mouse, and biology has diverged such that
many protein binding sites in human are not present at orthologous positions in mouse
(Schmidt et al., 2010), problems that are exacerbated by comparisons over greater evo-
lutionary distance. It is also the case that selection pressures and mutational processes
may have shifted over large evolutionary times. For these reasons, the calculation of
substitution rate profiles on within species variation is a useful complement to between-
species analysis. There is another major advantage to utilising within species variation
to investigate patterns in substitution rate profiles. That is the leveraging of ancestral
state and allele frequency information to deconvolve the contributions of mutation from
selection - the central theme of this chapter.
3.1.4 Selection can be inferred through derived allele frequency
distribution
It is possible to infer the selective pressures through analysis of the frequency distri-
bution of the derived alleles in a population (Fay et al., 2001). Derived alleles initiate
as mutations, which result in differences between ancestral sequence and the one that
is present in derived state (Figure 1.6). The frequency of the derived allele would then
depend only on subsequent evolutionary pressures acting on the site. Alleles that have
a deleterious effect on organism fitness result in lower frequency within a population.
In contrast, alleles that confer an advantage to the organisms fitness would increase in
frequency up to the point where they become fixed. Alleles that have no effect on the
fitness of an organism would only by subject to the stochastic sampling of genetic drift
and neutral evolution. In the case of neutral evolution, most derived alleles are ex-
pected to be rare, assuming a relatively large population size (under neutral evolution,
the probability of an allele to become fixed is inversely proportional to the population
size) (Kimura, 1968, 1991). In case of purifying selection acting upon the category of
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Figure 3.2: Schematic of derived al-
lele distributions under different selec-
tional pressures. Purple line shows
expected derived allele frequency dis-
tribution under diversifying selection,
while green one under purifying.
sites being studied, the frequency distribution of those derived alleles would be expected
to be shifted to the left even rarer (Figure 3.2). Conversely, diversifying selection would
favour variation and drive alleles to shift to the right, moving into the common category
leading them towards fixation. By performing a derived allele frequency (DAF) test -
comparing the ratios of the rare/common alleles at regions of interest (e.g. protein-
binding sites) with the ratio of rare/common alleles in regions that are thought to be
neutrally evolving, it is possible to infer the predominant selection pressure acting on
categories of sites selected for analysis. Such analyses are usually performed relative
to a reference category of sites that is expected a priori to be under no or minimal
selection pressure.
3.1.5 De novo mutations are a most direct way of measuring
mutation rate
The most direct and practical way of measuring mutational pressures is to look at the
accumulation of de novo mutations (Veltman and Brunner, 2012). De novo mutations
are variants (alleles) that are present in all of the cells in the offspring, but were not
inherited by either of the parents, i.e. they must have arisen during the lifetime of the
parental germ cell (in some cases those mutations might represent low-level parental
mosaicism, or have occurred in the zygote during the first few cell divisions) (Acuna-
Hidalgo et al., 2015). Detection of de novo mutations is possible though sequencing
of the family trios, where both parents and one, or occasionally more, proband are se-
quenced and their genomes compared (Kong et al., 2012). Sequencing of large numbers
of families is costly, so the datasets with de novo variants are not very large (when
comparing the numbers of variants with numbers we get from the comparisons of se-
quences within populations), with around 70 de novo mutations per proband detected
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from trio sequencing (Jónsson et al., 2017).
3.1.6 Questions addressed in the current Chapter
In the current Chapter I test the hypothesis that DNA-binding proteins, such as TFs,
are causing occurrence of mutations at their binding sites. To this end, I utilize protein-
binding sites that I have defined in Chapter 2 to (1.) test if mutation rate is elevated
within the binding sites. I aim to (2.) discriminate the selection versus mutation
models (Figure 3.1). I also aim to (3.) test the model of elevated germline mutation
by comparison to somatic-only binding sites defined in Chapter 2.
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3.2 Methods
3.2.1 Between-species conservation measures
Genomic Evolutionary Rate Profiling (GERP) provides a per-nucleotide measure of
constraint across the genome (Davydov et al., 2010). Neutrality is estimated genome-
wide from the number of substitutions observed at fourfold degenerate sites and normal-
ized to zero. By subtracting the number of substitutions at every position of the genome
from the number of those expected under neutrality, the resulting scores represent the
amount of ‘rejected substitutions’ (RS). In this manner, positive scores represent con-
straint (purifying selection), while negative scores represent an excess of substitutions
(positive selection). An underlying assumption of GERP is that the mutation rate does
not vary across the genome. As previously discussed in Section 3.1, that is an invalid
assumption, so with this in mind positive scores could imply purifying selection or re-
duced mutation rate and negative scores could be either positive selection or elevated
mutation rate.
I used GERP ++ software to create an RS score for every position of the
multiple species alignment of the human genome (hg38 ) to the genomes of 30 other
mammalian species (27 primate) from UCSC (http://hgdownload.soe.ucsc.edu/
goldenPath/hg38/multiz30way/). Pairwise alignments were generated using lastz
and then linked into chains using a dynamic programming algorithm (Kent et al.,
2003). The best-in-genome pairwise alignments were progressively aligned using multiz
(Blanchette et al., 2004) to produce multiple alignments. Multiple species alignment
files for each of the human chromosomes, along with the file that describes the evolu-
tionary tree of the species for which the alignments were present have been supplied
to the gerpcol component of the GERP++ software. Mouse RS scores (for mm9
assembly) were downloaded form UCSC (http://hgdownload.cse.ucsc.edu/gbdb/
mm9/bbi/All_mm9_RS.bw)
The advantage of using GERP over other available methods, such as Phast-
Cons (Siepel et al., 2005), is its ability to detect the above neutral substitution rates,
and to logically deal with alignment gaps, which reduces the assignment of erroneous
scores. Detection of above neutral substitution rates is of particular value, as it allows
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for detection of elevated mutation rate and positive selection.
3.2.2 Within-species human variation measures
To estimate the evolutionary forces acting upon the region of interest, I used the fre-
quency of the derived alleles in the population. While there have been multiple large-
scale studies looking at within-species variation, such as 1K Genomes (Durbin et al.,
2010), many of those studies only include variant calls from exome or targeted sequenc-
ing. In this work, I am interested in identifying the variation that occurs at protein-
binding sites that are mostly located within the non-coding portion of the genome,
therefore requiring variants obtained from the whole-genome sequencing.
To measure variation within the human population I used data from the
whole-genome sequencing of the isolated Icelandic population from the deCODE cohort
(Jónsson et al., 2017). This data contains information about the alleles found within
the Icelandic population and their frequency. To resolve the state of the allele (ances-
tral or derived), I used human ancestral reconstructed sequence based on the 12-way
mammalian EPO alignments (version 86) from Ensembl. Variants where the ancestral
state could not be resolved, or where the change did not represent a single-nucleotide
substitution, were discarded. Variants were then split into rare (<1.5%) and common
(>5%), based on the frequency of the derived allele. The 1.5% and 5%-thresholds were
defined by Young et al. (2015) based on maximizing the odds ratio while minimizing
the confidence interval for the comparison of (1.) the second codon position that are
assumed to be constrained and (2.) fourfold-degenerate sites (which are often used as
proxy for neutral evolution) in protein-coding sequence.
3.2.3 Within-species mouse variation measures
While human within-species and within-population variation has been relatively widely
investigated, there is much less information available for the mouse within-species or
within-strain variation. Here I used data from a study where 10 wild house mice
individuals from North-West India have been whole-genome sequenced to a mean depth
of ≈ 30-fold (Halligan et al., 2013). Since there were few individuals sequenced in this
study, I have discriminated between rare and common alleles by assigning any variants
seen once as heterozygous as rare and rest as common.
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3.2.4 Human de novo mutations
One of the largest collections of data with the human de novo mutations is the MSSNG
cohort (C Yuen et al., 2017). MSSNG contains variants inferred from whole-genome
sequencing of family trios, where at least one of the probands has been diagnosed with
autism, and these data are expected to be enriched in variants that are autism-causing.
Therefore, these data are particularly well suited for use in the work described here,
as it has been previously reported that numbers of cases of autism in children show
a linear increase with paternal age, hypothesising that this is a reflection of the large
numbers of divisions that spermatogonial cells undergo before forming mature sperm
(Goriely et al., 2013). We, in turn, speculate that at least some of those mutations
could be occurring at protein-binding sites.
Currently MSSNG cohort holds whole-genome sequences of 1,740 probands.
In total, there were 121,181 de novo mutations, averaging at ≈ 70 de novo muta-
tions per proband. The latest release (acquired December 2017) of data used here has
been obtained from the MSSNG portal API and de novo mutation coordinates have
been taken from the file Annotated_de_novo_variants.xlsx. Any variants marked
as having failed filters have not been included in the analysis.
Another large source of the de novo mutations is the deCODE study (Jónsson
et al., 2017) described in the Subsection 3.2.2. The deCODE cohort holds 108,778
de novo mutations from whole-genome sequencing of families with 1,548 probands.
Some of the variants are phased, which means that it is inferred whether the mutation
occurred in the maternal or paternal germline.
Data from a few other smaller-scale studies were included in the analysis
described here – 36,441 de novo mutations from the Goldmann et al. (2016) study,
which is of a particular interest, as it is enriched for older fathers; 11,020 mutations
from the Francioli et al. (2015); and 251 mutations from the Wang et al. (2009). All
coordinates were converted to correspond to the hg38 genome assembly using liftOver
utility from USCS (v326 ) and chain files from USCS database. The final aggregated
dataset contained 268,759 mutations.
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3.2.5 Mouse de novo mutations
While there have been multiple studies generating whole-genome sequencing data for
human family trios, there have not been many studies looking to identify de novo
mutations in mice. Here, I used the data from whole-genome sequencing of more
than 20 generations of wild-type C57BL/6 and mutator mice, which have high DNA
replication error rates (Uchimura et al., 2015). A total of 7 mice were whole-genome
sequenced (2 wild-type and 5 mutator mice) to >40X average coverage, and the final
dataset contains 7,007 mutations.
3.2.6 Measuring variation at protein-binding sites
Peaks in each category (from Chapter 2) have been aggregated together and centred
either on the peak mid-point (in case of SF peaks, Subsection 2.3.5, Table 2.8) or
the identified edge of the bound protein (Subsection 2.3.7 , Table 2.10). In the latter
case, corresponding aggregated scores centred on the edges identifies as right have been
reversed and added to the left-edge scores.
When looking at human population variation, the proportions of rare and
common variants from deCODE relative to the average over the region excluding 400bp
around the centre point were plotted using R (3.3.2), as shown in Figure 3.3. Odds ratios
and p-values were calculated using the Fisher exact test for count data (fisher.test
function in R), as shown in Figure 3.4.
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Figure 3.3: Expected numbers of derived alleles over the region were estimated by (1.) first cal-
culating the frequency of common and rare allele occurrence in the context of each trinucleotide
within proximal regions on either side of the peak mid-point. Then, (2.) for each position
within the region, this calculated frequency of each trinucleotide rare and common derived allele
occurrence was multiplied by the number of instances in which the corresponding trinucleotide
occurred. Observed (3.) and expected derived alleles (4.) were plotted relative to the average
across flanks.
When looking at between-species divergence, the same set of sites as described
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Figure 3.4: Binding sites
were defined as either
0bp:+50bp window rela-
tive to the identified left
edge (by FLOP method;
Section 2.2.8, Box 2.2), or
as 100bp window centred
on the peak mid-point.
2x2 contingency matrix
containing the counts of
the rare and common de-
rived alleles in the binding
site and flank was used to
perform Fisher’s exact test
to obtain odds ratio value
and associated p-value.
and plotted with lower values signifying higher divergence going up the y-axis, and
higher values, signifying higher constraint, going lower down the y-axis. While counter-
intuitive, this upside-down plotting strategy enforces correspondence of the within- and
between-species variation plots. Expected GERP scores over the region were estimated
by first calculating the mean GERP score for each trinucleotide within the 1kB:4kB
flank regions on either side of the mid-point. Similar to within-species variation plots,
for each position of the region, this calculated mean was multiplied by the number of
instances in which the corresponding nucleotide occurred.
Beanplots with de novo mutations were plotted using the beanplot R (3.4.1)
package. Flanks were defined as regions -1000:-800 and 800:1000bp away from the
peak boundary or edge. In cases where the binding site was defined as a peak, its area
was taken as a binding site. In the case of edges, binding sites were defined as region
0:100bp relative to the left edge, and -100:0bp relative to the right edge.
Due to spareness of the data, distributions with the numbers of de novo muta-
tion per flank/site were bootstrapped, sampling 10,000 times with replacement. Each
point in the plotted distribution represents the mean number of mutations in flank/site
set from each individual bootstrapped sample. Empirical p-values were calculated as a
proportion of the instances where the mean de novo rate in the flank matched or was
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3.3.1 Germline protein-binding sites are hotspots for functionally
consequential mutations
To see if protein-binding sites show an increase of variation in germline cells, I looked at
the sites that I defined as ‘active’ in spermatogonial cells based on the ATAC-seq signal.
Figure 3.5 shows the patterns of observed and expected GERP scores and amounts of
rare and common derived alleles over aggregate of those sites in humans. GERP scores
(top plot) show a high level of constraint around the midpoint of the binding site, as
would be expected for the region containing a functionally important binding motif.
The middle plot of the Figure 3.5 shows the enrichment of rare and common derived
alleles over the region relative to the flanks. Both rare and common derived alleles
show accumulation over the binding sites, indicating that there is increased variation
all over the region. While the proportion of rare and common derived allele numbers
stays relatively the same in the flanks, there is a higher proportion of rare derived
alleles compared to common when moving into the binding site (a leftward shift of
the DAF, Section 3.1), indicating that there is purifying selection acting all across the
region covered by the peak (DAF OR : 1.188; p-val : 2 x 10−46). This is described by
the green line in the bottom plot of the Figure 3.5, where the proportion of common
derived alleles is used to represent the pattern of selection unaffected by mutation rate.
The region showing the enrichment of derived alleles extends ≈50bp either
direction from the defined peak mid-point. While a single bound protein would probably
be expected to cover a region that is smaller than this, identified peaks frequently
represent clusters of bound proteins, for example, promoter and enhancer regions. The
extent of binding site clustering indicated by the span of peak coverage which closely
mirrors the distribution of increased polymorphism rate (Figure 3.6).
Figure 3.9 shows similar plots with variation measures over the mouse sper-
matogonial binding sites. Similarly to the human data, there is a striking increase in
rare variants across the binding site.
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Figure 3.5: Germline variation at ag-
gregate of all identified human sper-
matogonial binding sites (n=66,379).
All plots are centered at aggregate
peaks midpoint. Individual points rep-
resent measures at single nucleotide
resolution (y-axis), while lines are
plotted through rolling average in 10bp
(top plot), or 50bp (middle and bot-
tom plots) sliding window. Grey
points and lines represent an expecta-
tion from trinucleotide sequence con-
text. Top plot shows sequence between-
species divergence as measured by
GERP scores. Higher GERP scores
(lower down the y-axis) represent se-
quence constraint. Middle plot shows
enrichment of rare and common de-
CODE derived alleles relative to flanks
(see Figure 3.3 for details of how this
was plotted). ’OR’ denotes odds ratio
of the enrichment of the rare derived
alleles at the site relative to the flanks,
with associated p-value. Bottom plot
shows proportion of common derived
alleles, representing pattern of selec-
tion unaffected by mutation rate, with
lower values indicating stronger puri-
fying selection pressure. Protein bind-
ing sites explored here show increased
numbers of rare derived alleles rela-
tive to the putatively neutrally evolving















































































Figure 3.6: Spacial distributions of the peaks
(purple), nucleosomes (grey), TF ChIP-seq (or-
ange), enrichment of deCODE alleles (blue),
and GERP scores (red). Plot is centered on the
aggregate peak midpoint with a putative binding
sites in the middle.
3.3.2 Increase in expected pattern of derived alleles over the binding
sites is driven by methylated state of CpGs in the flanks
Along with the pattern of observed increased variation over the binding sites, there
is also a very distinct pattern of increased expected variation over the same region.
While this intuitively suggests that the variation that we see is purely a reflection of
the sequence composition, I investigated this further.
The regions that we are looking at (ATAC-seq peaks) appear to have a dis-
tinctly different sequence composition (with a high frequency of CpG dinucleotides)
from what one can observe in the flanks (more AT-rich) (Figure 3.7). In addition to
that, most of the sites in question would also be expected to be unmethylated, as has
been reported before for the TF binding sites and accessible regulatory regions of the
genome (Groudine and Conkin, 1985; Thurman et al., 2012). That is indeed the case,
as demonstrated in Figure 3.7. This shows the pattern of methylation measured by
whole-genome shotgun bisulfite sequencing in the pancreatic tissue (ENCODE acces-
sion ENCSR344YUA) around the aggregate of pancreas-defined peaks, along with the
108
CHAPTER 3. MUTATION RATES AT BINDING SITES 109

























Figure 3.7: CpG counts (cyan) and methylation
(blue) around the aggregate set of binding sites. Re-
gions around protein binding sites have higher num-
ber of CpGs which are not methylated relative to
more distant surrounding sequences.
numbers of CpG dinucleotides. The expected measures of polymorphism frequencies
(for Figure 3.5, middle) in each trinucleotide context are taken from the flanks that
are 1-4kB away from the binding sites (as described in Subsection 3.2.6). Those flank
regions are more likely to have CpGs methylated and therefore would increase the ex-
pected frequency of polymorphisms at any CpG-containing trinucleotides over what
actually would be expected at the unmethylated binding sites.
To disentangle the contributions of CpG and non-CpG effects, I have produced
similar plots, but either excluding all of the alleles in the CpG context, or conversely
only leaving the allelles that were found to have occurred in the context of CpG (NCG
or CGN). As the numbers of sites at each position would then vary (due to each of
the positions having different numbers of CpG and non-CpG context trinucleotides), I
plotted the relative proportions of rates, rather than observed counts (Figures 3.8). In
both of those cases the expected rate stays uniform across the region, as it is estimated
once again from the flank regions. The pattern of non-CpG polymorphism rate still
shows an enrichment in the binding site region (Figure 3.8a). Rates of CpG-context
polymorphisms shows a decrease towards the middle (Figure 3.8b), closely reflecting
109
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the methylation pattern (Figure 3.7). In the area of the putative binding sites, however,
there is an increase in the rare derived allele frequency, despite the lower methylation
status of that region, suggesting that a different mutational process is responsible from
this increase, in agreement with our hypothesis.
Through separation of individual contributions of mutation rate and selection,
data presented here demonstrate that former, rather than the latter is the predomi-
nant force increasing nucleotide diversity at the protein binding sites. Protein binding
sites are shown to be under purifying selection pressure, and there is no evidence of
diversifying selection driving increase in sequence variation at or near those regions.
Germline mutation rate is elevated both adjacent to and within the sequence specific
binding site. Thus, germline protein binding sites would be expected to act as hotspots
for potentially functionally consequential mutations.
110












































































−2000 −1000 0 1000 2000












































−2000 −1000 0 1000 2000
Distance from the peak mid−point
(b) Only CpGs
Figure 3.8: GERP scores
(top), rates of common
(blue) and rare (red)
derived alleles (middle),
and pattern of selection
(bottom) in the context
of trinucleotides that
don’t contain (a), or




represent measures at sin-
gle nucleotide resolution
(y-axis), while the lines
are plotted through rolling
average in 10bp (GERP),
or 50bp (deCODE) slid-
ing window. Grey points
and lines represent an
expectation from trinu-
cleotide context. ’OR’
denotes odds ratio of the
enrichment of the rare
derived alleles at the site
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Figure 3.9: Germline variation at ag-
gregate of all identified mouse sper-
matogonial binding sites (n=12,460).
All plots are centered at aggregate
peaks midpoint. Individual points rep-
resent measures at single nucleotide
resolution (y-axis), while lines are
plotted through rolling average in 10bp
(top plot), or 50bp (middle and bot-
tom plots) sliding window. Top plot
shows sequence between-species diver-
gence as measured by GERP scores.
Higher GERP scores (lower down the
y-axis) represent sequence constraint.
Middle plot shows enrichment of rare
and common wild mice alleles relative
to flanks (see Figure 3.3 for details of
how this was plotted). ’OR’ denotes
odds ratio of the enrichment of the
rare alleles at the site relative to the
flanks, with associated p-value. Bot-
tom plot shows proportion of common
alleles, representing pattern of selec-
tion unaffected by mutation rate, with
lower values indicating stronger puri-
fying selection pressure. Protein bind-
ing sites explored here show increased
numbers of rare alleles relative to the
putatively neutrally evolving flanking
regions which is not driven by diver-
sifying selection..
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3.3.3 Protein binding sites active in germline, but not
somatic-specific ones show enrichment of germline mutations
My analysis of mutation and selection around spermatogonial binding sites has so far
considered all binding sites collectively. However, if protein binding is causally related
to the elevated mutation rates as the results thus far suggest, then one would expect
to see the elevated mutation rate at ubiquitously bound sites and sites bound in germ
lineage cells but not somatic cells. We would not expect to see evidence of elevated
mutation at binding sites occupied exclusively in somatic cells. In this section I set
out to test these expectations, accepting that I only have partial measurements of
binding across all cells of the germ and somatic lineages, so cannot exclude binding site
occupancy in some unmeasured cell type.
Chapter 2 describes the separation of the different categories of sites for several
tissue types based on the ATAC-seq data. Here, I looked at the germline variation
measures over those separated categories of regions. Figure 3.10 shows patterns of
between- and within- species variation over the protein-binding sites that have been
defined to be active in both human spermatogonial and somatic cells (‘housekeeping’
or ’common’ sites), those specific to somatic cells, and those specific to spermatogonial
cells. Corresponding plots with mouse protein-binding sites are in Figure 3.11. Two
categories of ’common’ sites presented here include a set of ’ultimate common’ sites, and
a set of sites occupied across all cell types in regions that were defined as consistently
open between tissues (see Figure 2.4 for classification of those two categories).
In humans, there appears to be an increase in variation over the both ’com-
mon’ categories of binding sites (Figures 3.10a and 3.10b), but not over either germline
or somatic-specific ones (Figures 3.10d and 3.10c). Highest increase is observed across
the set of ’ultimate common’ sites (Figure 3.10a). While this category contains small-
est number of sites (n=14,574), those are regions that are most consistently occupied
between all of the cell types analysed, and therefore likely to represent the strongest
binders with highest occupancy time. ’Common’ sites found in regions that are con-
sistently open across cell types (n=52,017) also show enrichment of rare derived alle-
les (Figure 3.10b), while the somatic-specific ones (n=68,273) do not (Figure 3.10c).
Spermatogonia-specific set has relatively small number of sites (n=24,330), and does
not show a convincing enrichment of rare derived alleles (Figure 3.10d). It does, how-
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ever, show a decrease in GERP scores (increase in sequence divergence) proximal to
the putative binding sites.
In mice, there is a clear enrichment of rare variants across the ’ultimate com-
mon’ set of binding sites (Figure 3.11a), but not a very evident enrichment over the
more general category of ’common’ sites (Figure 3.11b). However, there is a clear de-
pletion of variation over the ’somatic-specific’ category (Figure 3.11c), similar to the
human binding sites. There appears to be a more striking enrichment of rare variants
over the ’spermatogonia-specific’ set of binding sites (Figure 3.11d), albeit a much lower
levels of evolutionary constraint and purifying selection across them.
For human set of binding sites, to perform a more fair type of comparison,
I attempted to account for the differential numbers of regions and variable protein-
binding strength and occupancy between ’tissue-specific’ and ’common’ sites that are
being compared. For each of the individual datasets I compared the sets of ’common’
and ’tissue-specific’ regions that contained the same numbers of sites with the matched
distributions of peak scores (see Chapter 2, Subsection 2.2.7 for details of how this was
done). As seen in Figure 3.12, with the matched categories of regions, sites in ’common’
category show the enrichment of variants, while ones in ’somatic-specific’ category do
not. For one set of the germline binding sites (H5.25; Figure 3.13), there appears to
be an increase in the ’spermatogonia-specific’ category. While with a modest increase
compared to a ’common’ category, this set of ’spermatogonia-specific’ sites shows an
enrichment of the rare derived alleles in contrast to the absence of variation across
’somatic-specific’ set. This increase is not present in other sets of ’spermatogonia-
specific’ sites, potentially indicating that H5.25 cells represent the subset of cells where
majority of mutations at binding sites are occurring.
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(d)
Figure 3.10: Variation over (a) ’ultimate’ set of common, (b) common ,(c) spermatogonia-
specific, and (d) somatic-specific human protein-binding sites. Individual points represent
measures at single nucleotide resolution (y-axis), while the lines are plotted through rolling
average in 10bp (GERP), or 50bp (deCODE) sliding window. Grey points and lines represent
an expectation from trinucleotide context. ’OR’ denotes odds ratio of the enrichment of the rare
derived alleles over common at the site relative to the flanks, with associated p-value. There
is an enrichment of the rare derived alleles across binding sites that are bound by proteins in
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Figure 3.11: Variation over (a) ’ultimate’ set of common, (b) common ,(c) spermatogonia-
specific, and (d) somatic-specific mouse protein-binding sites. Individual points represent mea-
sures at single nucleotide resolution (y-axis), while the lines are plotted through rolling average
in 10bp (GERP), or 50bp (wild mice alleles) sliding window.’OR’ denotes odds ratio of the
enrichment of the rare alleles over common at the site relative to the flanks, with associated p-
value. There is an enrichment of the rare alleles across binding sites that are bound by proteins
in spermatogonial cells (a,b and c), but at those that are not bound in spermatogonial cells (d).
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Figure 3.12: Varia-
tion over human colon
(a) common and (b)
somatic-specific binding
sites sites. Both sets of
sites have been matched
in number and peak score
distribution. Individual
points represent mea-
sures at single nucleotide
resolution (y-axis), while
the lines are plotted
through rolling average
in 10bp (GERP), or
50bp (deCODE) sliding
window. Grey points
and lines represent an
expectation from trinu-
cleotide context. ’OR’
denotes odds ratio of the
enrichment of the rare
derived alleles at the site
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nia (H525) (a) common
and (b) germline-specific
sites. Both sets of sites
have been matched in
number and peak score
distribution. Individual
points represent mea-
sures at single nucleotide
resolution (y-axis), while
the lines are plotted
through rolling average
in 10bp (GERP), or
50bp (deCODE) sliding
window. Grey points
and lines represent an
expectation from trinu-
cleotide context. ’OR’
denotes odds ratio of the
enrichment of the rare
derived alleles at the site
relative to the flanks,
with associated p-value.
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3.3.4 Edges of protein binding sites active in germline, but not
somatic-specific ones show enrichment of germline mutations
I have also looked at the same variation measures around the protein-binding edges
identified by the FLOP method (see Chapter 2, Subsection 2.3.7 for details of the
method). It is more advantageous to aggregate the protein binding sites by centring
them on the edge of the bound TF, rather than the mid-point, as we are particularly
interested in the patterns of variation at the edges of the bound proteins. When looking
at the aggregate set of multiple different proteins, their binding sites are going to be of
varied widths. When aggregating different-widths sites centred on the mid-point, the
pattern over the edges will be consequently diffuse. When aggregating multiple sites
and centring on one of the edges, the signal over the boundary is going to be more
defined.
Figures 3.14 and 3.15 show patterns of between- and within-species variation
over the protein-binding edges (CpGs excluded). A similar pattern as seen before can
be observed with an increase in the between-species divergence near the edge of the
defined ’common’ binding sites, followed by region of constraint when looking at GERP
scores, and increased number of derived alleles from deCODE. There is an observable
and highly localized spike of increased expected enrichment of both derived alleles and
between-species substitutions right at the edge, which is mirrored by the observed
pattern in the case of GERP scores, but not alleles within the human population. This
peak is most likely caused by the sequence context of the Tn5 preferential insertion
bias.
An increase in the proportional abundance of the rare derived alleles versus
common relative to the flanking regions is observed at both binding site and over the
binding site edge. This indicates that there is purifying selection acting all across the
region. Consistent with the results from the previous subsection, this enrichment is
absent from the somatic-specific edges category. There is a subtle increase of variation
surrounding the spermatogonia-specific edges and a pronounced difference in GERP
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Figure 3.14: Germline variation at
aggregate of the ’common’ set of hu-
man binding edges (CpGs excluded).
All binding edges have been oriented
so that the putative binding sites pro-
ceed to the right of plot midpoint. In-
dividual points represent measures at
single nucleotide resolution (y-axis),
while lines are plotted through rolling
average in 10bp (top plot), or 50bp
(middle and bottom plots) sliding win-
dow. Grey points and lines represent
an expectation from trinucleotide se-
quence context. Top plot shows se-
quence between-species divergence as
measured by GERP scores. Higher
GERP scores (lower down the y-axis)
represent sequence constraint. Mid-
dle plot shows enrichment of rare and
common deCODE derived alleles rel-
ative to flanks (see Figure 3.3 for de-
tails of how this was plotted). ’OR’ de-
notes odds ratio of the enrichment of
the rare derived alleles at the -5:+5bp
region around the binding edge relative
to the flanks, with associated p-value.
Bottom plot shows proportion of com-
mon derived alleles, representing pat-
tern of selection unaffected by muta-
tion rate, with lower values indicating
stronger purifying selection pressure.
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(b) Somatic-specific
Figure 3.15: Varia-
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3.3.5 There is an enrichment of de novo mutations at
’housekeeping’ protein-binding sites
As mentioned in Subsection 3.1, de novo mutations are the most direct way of measuring
germline mutation rate, but currently available datasets have less power compared
to derived alleles from population variation measures. There are two ways in which
statistical power could be increased – by increasing the number de novo mutations
within the dataset, or by looking at larger number of sites. We are rather limited as far
as the latter point, as there is a finite number of spermatogonia-specific sites that one
can look at. However, there have been increasing numbers of studies looking at de novo
mutations, and those are likely to be growing in the future, at least as far as human
data is concerned. Prior to starting these analyses, I estimated the size of the human
de novo variant dataset that would be required to be able to detect the enrichment
of mutations within the binding site (in this case the FLOP method-derived binding
sites defined from ATAC-seq from GM12878 cell line from Buenrostro et al. (2013)
were used). That was done by using rare derived alleles from deCODE as proxy for
de novo mutations. From down-sampling of this dataset, I estimated that a cohort
with ≈ 200, 000 de novo mutations would have a 97% power to detect a significant
increase in mutational burden of the complete set of human binding sites (based on
1000 bootstraps, Figure 3.16).
There is currently information on 268,759 human de novo mutations available
from multiple different studies (see Subsection 3.2.4 for details). While the size of
the datasets is not sufficiently large to be able to detect the enrichment of variants
across individual categories of the binding sites, for example, spermatogonia-restricted
or somatic tissue-restricted, I have compared bootstrapped average de novo mutation
rates in the peak region versus flanks in all defined human binding sites across all
tissues (Figure 3.17), as well as ’tissue-specific’ (Figure 3.18) and ’common’ (Figure
3.19) binding sites in all tissues types separately. While there is a clear and significant
increase in the de novo mutation rate at the binding site versus flank in the combined
set of sites and in the ’common’ category, there is no definitive difference in the ’tissue-
specific’ one.
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Figure 3.16: Estimation the required
size of human de novo mutation
dataset. Rare derived alleles from
deCODE were used as proxy for de
novo mutations. Increasing number
of variants were randomly sampled
until the significant increase in num-
bers of mutations in binding sites
(GM12878 cell line binding sites de-
fined by FLOP method) versus flanks
could be detected. From this, a de
novo mutation dataset with 200 000
variants is sufficient to detect ele-























Figure 3.17: Differences in the num-
bers of human de novo mutations
(with bootstrapping) between binding
sites (-100:100bp relative to the mid-
dle of the peak) and flanks (-1000:-
800,800:1000bp away from the peak
boundaries). Inverse-coloured line
represents an observed mean (with-
out bootstrapping) and bars indicate
95% confidence intervals (estimated















































































Figure 3.18: Differences in the numbers of human de novo mutations (with
bootstrapping) between tissue-specific peaks (purple) and flanks (blue; -1000:-
800,800:1000bp relative to the peak midpoint. Inverse-coloured line repre-
sents an observed mean (without bootstrapping) and bars indicate 95% con-
fidence intervals (estimated from bootstrapping). P-val (**) < 0.005 < p-val
(*) < 0.05
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Figure 3.19: Differences in the numbers of human de novo mutations (with
bootstrapping) between common peaks (purple) and flanks (blue; -1000:-
800,800:1000bp relative to the middle of the peak). Inverse-coloured line
represents an observed mean (without bootstrapping) and bars indicate 95%
confidence intervals (estimated from bootstrapping). P-val (**) < 0.005 <
p-val (*) < 0.05
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The number of potentially deleterious human de novo mutations per birth
(generation) can be calculated using set of formulas below, where:
ω - number of deleterious mutations per birth
µ - de novo mutations per bp
ϑ - common derived alleles per bp
B - binding site
F - flank














−→ 5.3% variants lost to purifying selection under












ω = proportion of deleterious mutations× δB =
= 0.165× 1.51 = 0.249 (deleterious mutations/birth) (f:3.3.5)
Mouse de novo mutation dataset only contains 7,007 substitutions, and bootstrapped
data for mouse binding sites is presented in Figure 3.20. As this dataset contained
few mutations, unsurprisingly, there is no significant difference between numbers of
de novo substitutions between the binding site and the flanks. However, there is a
slight trend in somatic-specific binding sites being depleted of de novo mutations, while
spermatogonia-specific ones showing a small increase.
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(d) Somatic-specific binding sites
Figure 3.20: Differences in the numbers of mouse de novo mutations
(with bootstrapping) between peaks (purple) and flanks (blue; -1000:-
800,800:1000bp relative to the middle of the peak). Inverse-coloured line
represents an observed mean (without bootstrapping) and bars indicate 95%
confidence intervals (estimated from bootstrapping). P-val (***) < 0.0005
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3.4 Discussion
The aim of the work described in this Chapter was to test that protein binding sites in
the germline carry an increased mutational burden and if this results in an accumulation
of deleterious mutations at those potentially functionally important regions. In addition
to that, I wanted to examine whether the protein binding is causal of this increase in
mutation rate. I explored variation over sets of binding sites that are active in multiple
cell types, and tried to disentangle patterns of mutation and selection that contribute
to the observed variation.
Here, the particular interest was to investigate the increased numbers of
germline mutations that could be potential causes of heritable disease. Evidence of
the possible elevated mutation rates in germline has been presented previously by Rei-
jns et al. (2015), from between-species divergence measures (Figure 1.8). They have at
the same time proposed a potential causal replication-associated mutational mechanism
(Figure 1.9). Following on from that study, I was especially interested in looking at cells
where most of the germline replications is thought to be occurring - spermatogonial
cells (Figure 2.1; Box 2.1).
The aggregate set of putative binding sites identified in spermatogonial cells
showed an increased in polymorphic sites compared to the flanking regions (Figure 3.5
and 3.9). Those variants have arisen as mutations at some point in germline lineage
cells. This enrichment either demonstrates a differential mutation rate between sites
and flanks, or can be evidence of diversifying selection. Those binding sites at the
same time show high level of between-species conservation, consistent with the action
of purifying selection. Through separation of those variants based on the frequency of
the derived allele, I was able to perform a derived allele frequency test and infer the
predominant selectional pressure acting on the region. The proportion of the rare alleles
within the binding site is higher than it is in the presumably more neutrally evolving
flanking regions. This suggests that the binding sites are under purifying selection,
and therefore an elevated mutation rate is likely responsible for increased variability.
The observation of the increase in the between-species divergence at the edges of the
protein-binding sites is similarly driven by the increased mutation rate, rather than
diversifying selection (Figure 3.15a).
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This means that many of those mutations are potentially harmful, as they
are being purged from the population, making protein binding sites in human and
mouse germlines hotspots for deleterious mutations that could lead to heritable disease.
Based on the distributions of rare and common derived alleles over the spermatogonia-
active binding sites, about 20% of mutations occurring within them are likely to be
deleterious. From analysis of de novo mutation and common derived allele frequencies
across all of the identified human binding sites, I calculate that ≈15% of all de novo
mutations at those sites are likely to be deleterious, corresponding to ≈0.245 mutations
per generation (Formula f:3.3.5). This means that nearly 1 in 4 births is likely to
harbour one of those deleterious mutations within a binding site.
I hypothesise that the physical presence of the protein at the binding site is
necessary for this mutational pressure to be exerted. In order to test this, I looked at
the germline variation at two different categories of regions – those that are commonly
bound between all different tissue types (so called ”housekeepers”) and sites that are
preferentially occupied in only one tissue type. I was particularly interested in looking
at sites that are preferentially bound only in the cells of the germline and those bound
only in the somatic cells. To demonstrate the dependence of the elevated mutation rate
on protein binding, one would expect to see the increase in germline variation at the
sites occupied in germ cells (this category includes both housekeeping and germline-
specific binding sites), but not at somatic-specific binding sites. It is worth emphasizing
that we do not necessarily expect all of the binding sites for all the TFs to exhibit an
increase in mutation rate, but possibly only a subset.
There is an evident enrichment of human population polymorphisms over the
’common’ category of binding sites (≈ 25% increase). Those measures are made using
the variants in non-CpG context, to circumvent our inability to get a correct estima-
tion of the expected numbers of rare and common derived alleles from the trinucleotide
context, due to a differential methylation state of the regulatory sites and their flanks.
Measure of derived alleles found in a CpG context indicates that addition of those vari-
ants would make the mutational burden even bigger. Somatic-specific binding sites do
not appear to exhibit increased germline variation. This is supported by the variation
patterns observed across mouse protein-binding sites. The fact that the somatic-specific
sites do not exhibit increase in germline variation means that the elevated mutation rate
is not just an inherent feature of the binding sites as such. Taken together, this sup-
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ports the hypothesis of protein binding being associated with the increased mutational
burden.
There is an enrichment of rare alleles across the ’spermatogonia-specific’ cat-
egory of binding sites in mouse, further supporting this hypothesis. However, complete
sets of human spermatogonia-specific binding sites does not show an increase in germline
variation to the same extent as germline sites in mouse, or human housekeeping binders
do. There does appear to be a modest enrichment over what is observed for the somatic-
specific binders, mainly at the edges of the putative binding sites. The more prominent
increase in mutation rate over the spermatogonia-specific protein-binding site category
in mice rather than humans is surprising. Mouse variants were obtained from only 10
sequenced individual, and therefore this dataset was expected to have less power than
human one to detect an increase in mutation rate. However, with the advantage of the
genetic lineage-tracing method for cell isolation, cell populations obtained from mice
might be a better representative of the highly dividing spermatogonial cells. Therefore,
possibly, more specific and relevant protein binding sites were identified in mice.
Furthermore, the ’common’ category does have more regions than the ’spermatogonia-
specific’ ones, so insufficient power cannot be ruled out as a potential reason. To test
this, I looked at the paired sets of common and tissue-type specific human protein-
binding sites that have been matched in number and score peak distribution (a joint
proxy for binding strength and occupancy). When comparing those two matched
sets, ’common’ binding sites still exhibit more variation than the ’tissue-specific’ cat-
egory ones. However, there is some evidence for elevated mutation rate in a subset of
spermatogonia-specific binding sites (H5.25), even though it is a modest effect compared
to ’common’ binders and is not compellingly seen across all replicates.
Those results are recapitulated by the comparisons of the numbers of hu-
man de novo mutations at binding sites versus flanks. Although these comparisons
were performed with bootstrapped data, I observe the mutation rate to be signifi-
cantly increased in human protein-binding sites in the ’common’ subset, while neither
of the ’tissue-specific’ subsets are significantly enriched for mutations. ’Spermatogonia-
specific’ H5.25 subset of protein-binding sites shows the largest enrichment of mutations
within the site, consistent with previous results.
There are number of potential reasons why we are not seeing such clear evi-
dence of elevated mutation at human germline-specific binding sites:
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- The types of sites we are comparing might be different. As described in Sub-
section 2.3.5, the ’common’ and ’tissue-specific’ sites are found in different
genomic contexts and might even represent binding sites of variable level of
interaction strength and occupancy. It is worth noting that this point would
equally be applicable to the somatic-specific category of sites as well.
- In addition to that, we do not necessarily expect all of the binding sites for all
the TFs to induce an increase in mutation rate. It might be that it is primar-
ily the ’housekeeping’ TFs that are effecting increased mutational pressures,
and therefore a higher proportion of ’mutable’ binding sites happen to be in
the ’common’ set.
- It could be that we are actually looking at the binding sites in the wrong
cell type. The main advantage of a mouse model is the ability to more
precisely target a specific cell population for isolation through use of genetic
lineage tracing methods. Therefore, cells isolated from mice are more likely
to represent the most highly dividing subset of spermatogonial cells, while
human ones might represent a more diverse population.
- Potentially, ATAC-seq might not have captured the most representative
protein-binding landscape of the cells that we have isolated, or possibly the
binding site identification and separation method used here does not give
the best differentiation between the different categories of binders.
Taken together, this analysis shows that protein-binding sites that are active
within the human and mouse germlines are hotspots for likely deleterious mutations
that could potentially lead to heritable disease, with ’housekeeping’ category of sites
being most highly affected. Physical presence of the protein on DNA appears to be
associated with induction of those mutations, as demonstrated by the lack of germline
polymorphism enrichment over the somatic-specific binding sites. The affected sites
are active in the population of potentially most highly dividing cells of male germline,
with the numbers of division increasing linearly with age of the male. This implies as-
sociation of this mutational property and the increasing numbers of de novo mutations
in offspring of older fathers, if the mechanism is indeed replication-dependent.
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4.1 Introduction
4.1.1 Somatic mutations can lead to cancer and drive further
mutagenesis
Mutations occurring within the cells of the germline are going to be propagated to
the next generation and could become a cause of hereditary disease, while those that
occur within the somatic cells are not heritable and would only affect the individual in
question, and would perish with the death of the organism. The consequences of these
mutations, however, are much more important from the perspective of an individual,
as they would potentially lead to diseases that would affect an organism’s fitness or
survival.
Tumour growth and cancer are some of the most pronounced and medically
important consequences of somatic cell mutations. Tumour growth is characterised by
dysregulated control of cell division and survival, and if coupled to invasiveness of other
tissues, another aspect of dysregulated genetic control, is considered a cancer. These
dysregulations are often a consequence of specific genetic mutations that drive prolif-
eration or inhibit apoptosis (Hanahan and Weinberg, 2011). As multiple mutations
are generally required to transform a normal somatic cell into a dis-regulated tumour
cell (Zarnack et al., 2013), cancers are often associated with mutator phenotypes -
genetic dis-regulations that lead to the increased rate of somatic mutagenesis or arise
as a consequence of exposure to mutagenic agents that increase the mutational load.
Consequently making the other mutational hits necessary for oncogenesis more likely.
As noted previously (Subsection 3.1), the statistical power of local mutation pattern
analysis is dependent in part on the number of mutations available. The high mu-
tation load and large number of cancers sequenced along with non-cancerous somatic
cells from the same individuals, make this an attractive system in which to explore the
details of transcription factor binding associated mutagenesis. Comparisons between
the genome sequence of cancer and normal samples of the same individuals provide a
well controlled analysis system to identify somatic mutations with confidence. This is
also helped by the nature of cancers to grow by clonal expansion, making it easy to
call those mutations that occurred early in the progression of the cancer in contrast to
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calling somatic mutations from clonally diverse tissue samples.
4.1.2 Different cancers are driven by various processes and can
exhibit distinct mutations and lesions
Different cancer types are known to exhibit distinct mutational signatures - when com-
plete set of mutations acquired during cancer progression is dominated by particular
types of changes (Alexandrov, 2018), often evaluated in the context of immediately
neighbouring bases (trinucleotide context) (Blake et al., 1992). For example, malig-
nant melanoma is dominated by the C−→T mutations (Alexandrov et al., 2013). Mu-
tational signatures are often a reflection of particular processes that are responsible for
initiation and progression of the disease. Since across the genome most of the changes
are passenger mutations that do not confer an advantage to the cell, they are not
strongly affected by selection. The origins of some signatures are known, for example,
the aforementioned signature 5 dominated by C−→T changes is known to be caused by
ultraviolet radiation, and signature 4 (C−→A) by tobacco smoke, while others remain
elusive (Alexandrov et al., 2016). Endogenous sources of damage, frequently originating
from the failures of DNA maintenance processes, also leave distinct imprints, such as
signature 6 due to the defective mismatch repair, or signatures 2 and 13 as a hallmark
of the activity of the APOBEC enzymes (Alexandrov et al., 2013).
Large cohorts of cancer mutation data, such as TCGA (https://cancergenome.
nih.gov) and ICGC (https://dcc.icgc.org/), have made it possible to study the
mutational landscapes of different tumours and infer the processes that contribute to
them. Because of the different mutational processes attributed to different cancers, and
the different mutational loads in cancer cohorts, one might expect variation between
cancer types. Typically, cohorts contain large numbers of mutations that allow for
exploration of the differences in the types of mutations and the rates at which they
occur at various sites across the genome, such as protein binding sites. Because there
are variable defects and sources of mutagenic lesions that can be inferred from these
cancer genomes, it provides an avenue with which to explore the mechanistic basis of
particular mutation patterns, an approach exemplified by Supek and Lehner (2015,
2017).
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4.1.3 Paradoxical observations of mutation retention by
transcription factors at protein binding sites in cancer
In Chapter 3, I showed that mutations are elevated at the protein binding sites. The
mechanistic basis of this mutational heterogeneity is not clear, but binding of the
proteins appears to be necessary, and potentially causal for increase in mutation rate.
As mentioned in Section 1.2.2, most DNA-interacting proteins, and in partic-
ular TFs, tend to have a sequence-specific preference in where they bind. Signalling
networks that control proper cell function are reliant on this specificity to turn on and
off expression of certain genes at particular times. This sequence preference can be de-
fined by the methods of ChIP-seq and its variations, followed by search for recurrence
of specific sequences, or motifs (de novo motif discovery methods reviewed in Lihu and
Holban (2015)). From those, the position weight matrices (PWMs) can be constructed,
which describe how often a particular type of nucleotide occurs within each position
of the motif. Alternatively, systematic evolution of ligands by exponential enrichment
(SELEX) method can be used, where protein affinity to a pool of oligonucleotides with
random sequences is tested to select the best binders (Klug and Famulok, 1994).
Protein binding sites have been previously observed to be mutated in cancers
(Kaiser et al., 2016; Sabarinathan et al., 2016). One of the striking examples is an
increase cancer mutations within the binding motifs of CTCF. This TF is a ubiquitously
expressed DNA-binding protein with a variety of different roles as a transcription factor,
insulator or repressor, modulator of chromatin organisation and so on, which is largely
conserved in eukaryotes (Kim et al., 2015). A particular position harbours excess of
single nucleotide substitutions within CTCF binding sites (Katainen et al., 2015; Kaiser
et al., 2016). This specific mutation is expected to lead to abolition of the protein
binding ability (Umer et al., 2016).
Models that aim to explain the increase of mutations at TF binding sites
mostly propose retention of lesions by DNA-interacting proteins, be that either though
impeding procession of high fidelity polymerase (Reijns et al., 2015) or through pre-
vention of access by repair machinery (Sabarinathan et al., 2015). With CTCF being
a sequence-specific binding TF, this seems paradoxical. It implies that while mutation
within CTCF motif impacts the binding, a lesion at the same position does not, as to
occlude it from repair processes, the protein has to still be able to bind to its target
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sequence. Potential differences in effects on protein binding ability of a lesion versus
a mutation are to date largely unexplored. This, however, provides an avenue for in-
vestigation of causes for elevated rates of harmful mutations at the TF binding sites
observed in Chapter 3.
Differences in tolerance of a TF to various types of changes within its binding
motif would naturally depend on the structural properties of the protein-DNA contacts
and its plasticity. CTCF is classified as a member of C2H2 zinc finger (ZnF) proteins,
as it interacts with DNA with different combinations of its central domain tandem array
of Cys2 −His2 zinc fingers (Filippova et al., 1996). Crystal structure of CTCF-DNA
complex has recently been described (Hashimoto et al., 2017), allowing for investigation
of the differences in binding in context of physical interactions between protein residues
and DNA strands. Investigation of mutational patterns within motifs of other TFs
could provide an insight into whether the CTCF motif-observed pattern is generalisable
across a particular type of binding factor (C2H2 ZnF) and beyond. Separation of the
substitutions observed in different types of cancers could allow for speculations about
types of lesions and changes that are likely to be causal.
4.1.4 Questions addressed in the current Chapter
In this Chapter I (1.) propose a model that could explain the mutational pattern
at the CTCF binding site, (2.) explore other examples of TFs showing an increase
in mutations within their motifs, and (3.) consider how those proteins interact with
DNA to glean any insights into the mechanistic basis of the protein binding-induced
mutagenesis. I extend the analysis done by Kaiser et al. (2016) by looking at the
mutational patterns at the sequence-specific binding sites in distinct cancer cohorts
that exhibit different predominant mutation signatures and types of lesions, focusing
on TFs for which motifs and ChIP-seq data is available. I also (4.) touch on the
possibility of discovering the highly mutable binding sites without relying on the pre-
defined information about the specific motifs.
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4.2.1 Cancer mutation data
Most of the cancer mutation data used here was obtained through the ICGC (International
Cancer Genome Consortium). Files containing simple somatic mutations were down-
loaded for each cancer and study type separately from the ICGC portal (https:
//dcc.icgc.org/releases/release_26/Projects; release 26; hg19 assembly). Vari-
ants were then filtered to only include single nucleotide substitutions from whole genome
sequencing. Some studies (LINC-JP; LIRI-JP; PRAD-CA) had entries for mutations
without base identity change (e.g. C−→C), and those have been excluded from the
analysis (total of 6,179 that kind of mutations were excluded). The filtered set of single
nucleotide substitutions contained a total of 65,103,967 mutations from 5,249 donors.
Table 4.1 shows the numbers of variants from donors obtained from each of the study
and cancer type.
4.2.2 Mismatch repair-deficient cancer data
Mutations from the mismatch repair-deficient (MMRd) tumours were obtained from
both ICGC and Wang et al. (2014). From ICGC, mismatch repair-deficient breast
cancer (BRCA) tumours were identifies same as in Supek and Lehner (2017), where
any tumours with > 3000 indels were classed as MMRd (9 donors; 352,554 single
nucleotide substitutions). Mutations from the MMRd stomach cancers were obtained
from Wang et al. (2014) study (10 donors; 678,464 single nucleotide substitutions).
4.2.3 ChIP-seq data and motif scanning
ChIP-seq data for multiple TFs was downloaded from the ENCODE database (https:
//www.encodeproject.org; data obtained on 22.01.2018). All the ChIP-seq files which
did not pass at least one of the audit filters set by ENCODE (such as insufficient
read depth/length, severe bottlenecking, missing control alignments, or poor library
complexity) were excluded from the analysis. All of the coordinates were converted
to correspond with hg19 assembly. Multiple ChIP-seq files for the same TF were
intersected with each other (bedtools multiinter command) and for each TF, any of
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Table 4.1: Numbers of
donors and counts of muta-
tions for each cancer study
from ICGC used in this




Table 4.1: Numbers of
donors and counts of muta-
tions for each cancer study
from ICGC used in this
analysis (continued)
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the regions that were found to be present in at least half of the files were kept. Genomic
sequences in regions of interest were extracted using bedtools getfasta command.
FIMO software (part of MEME suite version 4.11.1) (Grant et al., 2011) was
then used to look for the occurrence of motifs for the sequence-specific TFs in regions
identified by ChIP-seq with the default options and default p-value threshold of 10−4.
PWMs for all the motifs were downloaded from the Jaspar database (http://jaspar.
genereg.net/downloads/), keeping the redundant motifs for each of the TFs (multiple
PWMs for the same TF from different studies). Only matrices obtained from human
studies were retained. Table 4.2 details TFs that had both ChIP-seq and PWMs
available, numbers of ChIP-seq replicates, and counts of motifs identified.
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Table 4.2: List of transcription factors with available ChIP-seq and motif data.
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4.2.4 Mutation rate calculation and plots
Genome-wide mutation rates were calculated for each of 64 possible trinucleotide con-
texts (where the mutated base was in the middle of the triplet) recording the change to
each of the 3 alternate bases. Rates were calculated by dividing the number of observed
mutations in each trinucleotide context by the total number of the trinucleotide occur-
ring in the genome (excluding the low mappability regions). For plotting purposes, 64
trinucleotide categories were folded into 32 categories, where each of the trinucleotides
was matched with the corresponding reverse-complement trinucleotide (e.g. AGC −→
ATC change was matched with GCT −→ GAT change).
For the aggregate set of motifs (binding sites) for individual TFs, the observed
mutation rate at each of the individual positions of the motif was calculated by divid-
ing the number of observed mutations (change to specific type of base) in particular
trinucleotide context by the number of occurrences of that trinucleotide at the posi-
tion. The expected mutation rate (change to a specific type of base) at each position
was calculated by multiplying the genome-wide calculated rate for each trinucleotide
by the instances of that trinucleotide observed at particular position. The ratio of
the observed to expected mutation rate was then plotted to look for the enrichment of
particular mutations at certain positions of the motif. Trinucleotides that did not con-
stitute a reasonable enough proportion (10%) of all the trinucleotides at an individual
position were excluded from plotting, for clarity of visualization. All the graphs were
plotted using R (3.3.2).
4.2.5 Pentanucleotide mutational frequencies
Mutation rates for each pentamer (5-nucleotide sequence with the mutated base at
the middle position 3) were calculated for each of the donors in the same way as trinu-
cleotide mutation rates. Rates were either compared within a trinucleotide category (all
pentanucleotides with the same trinucleotide in the middle) genome-wide, or between
genomic contexts (different regions in the genome). The rates observed in different
genomic contexts were compared by dividing mutation rate observed in one region by
the observed mutation rate in another region. Those were then plotted as either the
ratios in the context of each trinucleotide (32 possible categories when folded), or as
145
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individual points in Region 1 versus Region 2 mutation rate plots.
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4.3 Results
4.3.1 Biased mask model
Mutations mostly initiate as lesions that occur on one of the Watson or Crick strands of
double-stranded DNA. If the lesion is not repaired, after the next round of replication
one of the daughter cells will receive a copy with original base, while the other will
receive a copy with a lesion that will have been either fixed or converted into a mutation
(Figure 4.1).
Figure 4.1: Consequences of replicating an
unrepaired lesion on a single strand of DNA.
A lesion (red circle) has formed on a single
strand of DNA (blue), and has not been re-
paired prior to replication commencing. After
synthesis of new strands (grey) with affected
(blue)) and unaffected (green) strands as tem-
plates, one of the daughter cells receives a
non-mutated copy (bottom right), while the
other daughter cell receives a copy where le-
sion has turned into mutation with change in
nucleotide identity on both of the strands (bot-
tom left).
While TFs can be thought of as sequence-specific binders, the range of contacts
that they make with either of DNA strands can differ. The importance of position
within a motif is typically measured in a strand-agnostic nature - e.g. we do not
necessarily know if one strand, both strands or neither are making contact with protein
residues, unless we have some structural evidence, such as a crystal structure of the
protein-DNA complex. Even if there is a structure available, we can’t readily predict
how change at any position of a motif sequence on a strand that is contacted or not
contacted by the TF can influence the conformation of the DNA. While molecular
dynamic simulations may offer some insights in this case (Liu and Heermann, 2015;
Blanco et al., 2018) there is almost no grounding experimental data on the interactions
of sequence specific binding TFs interacting with mismatched or modified bases beyond
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base methylations that don’t alter base-pairing (Hashimoto et al., 2017). While binding
motifs are defined primarily by the nature of the nucleotides that proteins bind over, the
shape of the DNA, rather than sequence as such, has a major contribution to binding
site recognition by TFs (Mathelier et al., 2016; Yang and Ramsey, 2015). A lesion or a
mismatch can potentially distort DNA conformation in a way that could affect binding.
Similarly, we do not possess knowledge of the strand (Watson or Crick) that mutations
have occurred on.
The unusual pattern of mutations observed at CTCF binding sites could be
explained by a model that we propose, and term here the biased mask model. This model
explores the possibility of some of the sequence-specific binding proteins exhibiting a
higher tolerance to occurrence of a single-stranded lesion, in contrast to a mutation, at
a particular position of the motif. Tolerance of those lesions by proteins, and thus their
retention through them being masked from normal cellular maintenance processes by
binders, could lead to consequent occurrence of mutations post-replication. This model
explains the observed mutational patterns (such as observed at CTCF binding sites)
as the consequence of several possible scenarios, as illustrated in Figure 4.2.
In the first scenario (Figure 4.2, left), change of the nucleotide identity on
either of the strands has no effect on protein binding. Thus, the TF is likely to frequently
bind across and occlude a lesion and one would predict an excess of mutations at
that position. However, those changes would not be expected to have any phenotypic
consequence, unless the mutation at that position affects binding more than individual
mismatches on either of the strands separately. In the another scenario (Figure 4.2,
middle), change of the nucleotide identity at either of the strands results in impairment
of the protein binding. In that case, upon formation of a lesion, a protein is unable
to act as a barrier to the procession of high-fidelity polymerase, or obscure it from
detection by repair machinery. Hence, that lesion has a higher probability of being
fixed and not be observed to be mutated very frequently. In the third scenario, a lesion
on one of the strands affects protein binding ability, while a lesion on the other strand
does not. As a result, occurrence of a lesion on the permissive strand would allow for
protein binding and lead to its occlusion. After the next round of replication, one of
the daughter cells would end up with a binding site that is disrupted on both of the
strands, including the non-permissive one and binding would be lost. Similarly, protein
tolerance to lesions on both strands, and not to the mutation would lead to a similar
148
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outcome. The mutational excess one would expect to see in scenario 3 is exactly what
is observed at position 9 of the CTCF motif with a nucleotide that is important for








































































Figure 4.2: Biased mask model. This model aims to explain the preferential occurrence of
specific types of mutations at particular sites of protein-binding motifs as a consequence of
protein binding dynamics. Mutations originate as lesions on either Watson or Crick strands,
and there are different consequences for protein binding depending on whether lesion is tolerated
by the protein. Higher mutation rates at sites bound by a protein in the presence of a lesion
assumes protection of lesions from repair machinery (Repair−). Described fully in Section 4.1
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4.3.2 Other zinc finger protein motifs have positions with increased
mutation load similar to CTCF
In light of the observation that position within the motif of one of the C2H2 ZnFs
DNA-binding TFs, CTCF, exhibits an unusually high number of mutations in cancers
despite its importance in binding, I wanted to investigate whether there are other TFs
in that family that exhibit similar mutational patterns. Two proteins were of particular
interest - KLF4 and EGR1, as crystal structures in complex with DNA are available for
those (Schuetz et al., 2011; Hashimoto et al., 2014, 2016). KLF4 and EGR1 are C2H2
ZnF proteins each containing 3 zinc fingers that they use to interact with target DNA
sequences. KLF4 belongs to the category of ’pioneer’ TFs that are able to bind closed
chromatin and initiate its opening (Zaret and Carroll, 2011), and is one of the four
Yamanaka factors (Takahashi and Yamanaka, 2006), that have an ability to reprogram
a cell to induce a pluripotent state. It is expressed in a wide range of tissues, with one
of the main roles being promoting cell survival (Ghaleb and Yang, 2017). EGR1 (also
known as ZIF268) is an early growth response protein involved in signal transduction,
which is rapidly induced by various signals such as growth factors, stress, injury and
oxygen deprivation (reviewed in Pagel and Deindl (2011)).
Figure 4.3 shows the excess of particular types of mutations at each position
of the motifs over what would be expected from the genome-wide mutation spectrum in
that trinucleotide context. All CTCF, KLF4 and EGR1 appear to have positions within
their binding motifs that exhibit a site-specific excess of mutations in the pan-cancer
dataset.
In agreement with previous observations (Kaiser et al., 2016; Umer et al., 2016;
Katainen et al., 2015), position number 9 within the CTCF motif shows largest excess
of the T−→C (A−→G) changes, followed by T−→A/G (A−→T/C) single nucleotide
substitutions at position number 9, where adenine (thymine on opposite strand) is a
preferred base (Figure 4.3a). Umer et al. (2016) has previously shown that T−→C and
T−→A mutations at that position disrupt CTCF binding.
There are several PWMs available for KLF4 protein in the Jaspar database
(http://jaspar.genereg.net; accessed July 2018), two of which are annotated as
mouse-derived (MA0039.1 and MA0039.2), and one as human-derived (MA0039.3).
MA0039.1 is a SELEX-derived matrix and does not appear to resemble most of the
150
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(a) CTCF mutational spectrum


























































(b) KLF4 mutational spectrum
















































































(c) EGR1 mutational spectrum
Figure 4.3: Mutational spectra for KLF4,
CTCF and EGR1. Top set of bars in each sub-
plot represent the ratio of the observed muta-
tion rate at each position versus the expected
mutation rate, based on the genome-wide rate
of substitutions to each alternate nucleotide in
each trinucleotide context, essentially showing
the excess of mutations when accounted for
the tumour-specific mutational pattern. Bot-
tom set of bars represents the PWM for TF in
question. Positions number 9 in CTCF mo-
tif, number 5 in KLF4 motif, and number 6 in
EGR1 motif show peaks of unusually elevated
mutation rates.
published KLF4 binding motifs. MA0039.2 is marked as mouse-derived, but was vali-
dated in the Chen et al. (2008) study. There de novo hESC ChIP-seq derived matrix
appears similar, but with a slightly higher weight of thymine at the position number 5.
This is in accordance with the human MA0039.3 matrix, derived from the reanalysis of
multiple human cell line/tissue KLF4 ChIP-seq datasets (Chèneby et al., 2018), where
position number 5 adenine (reverse complement of position 5 thymine in MA0039.2)
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is an overrepresented base. Therefore, here MA0039.3 was used as a representative of
the KLF4 binding sites. KLF4 TF normally exhibits a preference for adenine or gua-
nine at the position number 5 (Watson strand) of its binding motif (MA0039.3), while
the most frequently encountered mutation is potentially disrupting T−→G (A−→C),
rather than T−→C (A−→G) or C−→T (G−→A) that would preserve the binding mo-
tif (Figure 4.3b). C−→T is generally most abundant type of change at binding sites
and genome-wide, but as here we are observing an excess of changes when adjusted
for the genome-wide trinucleotide mutational rare, this particular mutation class does
not dominate. EGR1 exhibits and abundance of the T−→G mutations at the position
that does not carry as much importance as positions numbers 9 and 5 according to the
PWMs in CTCF and KLF4, respectively, but the level raises above what we can see in
the flanks.
When exploring the particular types of change in a trinucleotide context, we
can see that GTG−→GGG mutation is observed most frequently at position number
5 in KLF4 (Figure 4.4b), which is the most abundant trinucleotide at that position,
while for EGR1, TCC−→TGC is the most elevated change, while not the most frequent
trinucleotide at the position (Figure 4.4c).
The extent of the contacts that those proteins make with DNA are largely
known and represented in Figures 4.5 and 4.6. Position number 5 within the KLF4
motif makes direct hydrogen bond and van der Waals contact with the second zinc finger
of KLF4 protein (Figure 4.5). Thymine (or cytosine) at the position number 5, rather
than adenine (or guanine) on opposing strand, appears to be important for making
the hydrogen bond, while van der Waals contact is made by the adenine/guanine.
If there were to be a strand asymmetry in protein tolerance for a lesion at position
number 5, one might expect modified adenine/guanine to be tolerated better than
altered thymine/cytosine. The excess of T−→G mutations would therefore be expected
to arise from occlusion of, for example, mismatch involving A−→C change. In case of
EGR1, level of preference towards thymine or adenine at position number 6 of the
motif is similar, but lesion on the C-rich strand would be expected to be tolerated
better (Figure 4.6).
Figure 4.7 shows the pan-cancer mutation pattern of several other TFs anal-
ysed. All of those, with the exception of FOXA1 and GABPA, are C2H2 ZnF-containing
proteins and have a certain position within their binding motifs that appear to exhibit
152












































































































































































ACC ACCACGC A CCACCA ACCCCC CCC CCC CCC
CCC






















































C C C C
C














A A A A A
B
its















































CCG CCGC G C G
CCG
CCT


































































































A A A A A
B
its
(c) EGR1 trinucleotide mutational spectrum
Figure 4.4: Trinucleotide mutational patterns TF over motifs. Each triplet on the plot repre-
sents the middle nucleotide change in a particular trinucleotide context. The size of the triplet
is proportional to the relative abundance of that trinucleotide at the position in question. Only
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Figure 4.5: KLF4 protein Ref-seq transcripts from UCSC (top) and zoom in at the amino acid
sequence that forms zinc fingers. Positions within amino acid sequence important for DNA
contacts are indicated in red, and semi-transparent lines represent contacts made with motif
sequence (red lines – direct hydrogen bonds, blue lines – van der Waals contacts). Connection
of the semi-transparent line with the top of base letter means that contact occurs with nucleotide
on represented strand, while connection on the bottom means contact with the complement
base. Below motif are mutational profiles KLF4 binding sites as measured by single nucleotide
substitutions from ICGC cohort (same as Figure 4.3b). Principal source Hashimoto et al. (2016)
an excess of mutations similar to CTCF, KLF4, and EGR1, suggesting that the ob-
served phenomenon of highly mutated positions within a motif is likely be a general
feature of DNA-binding TFs, and might extend beyond the ZnF family.
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Figure 4.6: EGR1 protein Ref-seq transcripts from UCSC (top) and zoom in at the amino acid
sequence that forms zinc fingers. Positions within amino acid sequence important for DNA
contacts are indicated in red, and semi-transparent lines represent contacts made with motif
sequence (red lines – direct hydrogen bonds, blue lines – van der Waals contacts). Connection
of the semi-transparent line with the top of base letter means that contact occurs with nucleotide
on represented strand, while connection on the bottom means contact with the complement
base. Below motif are mutational profiles EGR1 binding sites as measured by single nucleotide
substitutions from ICGC cohort (same as Figure 4.3c). Principal source Hashimoto et al. (2014)
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Figure 4.7: Excess of mutations over expectation (based on the trinucleotide context
mutability genome-wide) from the ICGC (pan-cancer) for several TFs binding sites
where both motifs and ChIP-seq were available. These TF motifs also ascribe to similar
property as TF motifs for CTCF, KLF4 and EGR1, with an important positions within
binding motifs exhibiting excess of substitutions.
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4.3.3 Mutational patterns at binding motifs vary across cancer types
While pan-cancer analysis is beneficial in a sense that it provides us with great statistical
power, at the same time it contains data from multiple different cancers, each with their
individual spectra contributing to the observed variation. Each type of cancer would
be expected to be driven, or to exhibit, a different combination of predominant muta-
tional processes (Helleday et al., 2014). While the patterns of the observed/expected
rate plotted here are meant to account for the mutational spectra dominating each par-
ticular cancer type/tumour, the excess of mutations that we observe could be shaped
by processes that do not leave genome-wide signature, but might still be limited to
one type or subset of cancers. Hence, I have conducted similar analysis of TF motif
mutation rates, but for each of the available cancer types (Table 4.1) separately for all
binding TFs listed in Table 4.2 and show results for the KLF4 and CTCF binding sites
in Figures 4.8 and 4.9.
Figures 4.8 and 4.9 show patterns over KLF4 and CTCF binding sites, re-
spectively, which can be observed in the subset of cancers from ICGC with the highest
numbers of mutations. While most of the cancer types seem to exhibit an increase
in the mutation rate at positions numbers 5 (KLF4) and 9 (CTCF), they do so to a
varying degree and differ between the two TFs. Skin adenocarcinoma (SKCA), lung
cancer (LUSC), ovarian cancer (OV), paediatric brain cancer (PBCA), early onset
prostate cancer (EOPC), chronic lymphocytic leukaemia (CLLE) and pancreatic cancer
endocrine neoplasm (PAEN) appear to exhibit the highest excess of KLF4 mutations,
while esophageal adenocarcinoma (ESAD), breast cancer (BRCA), and liver cancer
(LIRI and LICA) show highest peaks within CTCF motif.
The T−→G change does not seem to be a particularly abundant type of change
in any of the cancers genome-wide (Figure 4.10 shows the relative abundances of sub-
stitution types across all the cancer datasets within ICGC). Therefore this particular
change is unlikely to arise purely due to the specific cancer-driving process.
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Figure 4.8: Excess of muta-
tions over expectation (based
on the trinucleotide context
mutability genome-wide) from
the ICGC (pan-cancer) for
KLF4 motif in separate cancer
types. Y-axis are uniform be-
tween plots for different cancer
types. Cancer type accession
code and number of donors are
indicated in the left upper cor-
ner.
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Figure 4.8: Excess of muta-
tions over expectation (based
on the trinucleotide context
mutability genome-wide) from
the ICGC (pan-cancer) for
KLF4 motif in separate cancer
types. Y-axis are uniform be-
tween plots for different cancer
types. Cancer type accession
code and number of donors are




























































































































































































































































































































































































































































































































































































































































































Figure 4.9: Excess of muta-
tions over expectation (based
on the trinucleotide context
mutability genome-wide) from
the ICGC (pan-cancer) for
CTCF motif in separate can-
cer types. Y-axis are uni-
form between plots for differ-
ent cancer types. Cancer type
accession code and number of
donors are indicated in the left
upper corner..
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Figure 4.9: Excess of muta-
tions over expectation (based
on the trinucleotide context
mutability genome-wide) from
the ICGC (pan-cancer) for
CTCF motif in separate can-
cer types. Y-axis are uni-
form between plots for differ-
ent cancer types. Cancer type
accession code and number of




Figure 4.10: Relative proportions of different types of sub-
stitutions for various cancer types from ICGC
4.3.4 Increased mutation rates within transcription factor motifs are
consistent with protection from mismatch repair
Here I propose that the increase in the mutation rates at certain positions within the
protein-binding motifs can be attributed to the protein binding interfering with normal
DNA surveillance and repair processes, primarily by protecting the underlying sequence
from processes such as mismatch repair (MMR). As described in the Section 4.1, MMR
plays crucial part during replication to perform a significant role in to preserving fi-
delity of newly synthesised DNA. Loss or reduction of the MMR activity leads to the
miscrosatellite instability phenotype (MSI), as many microsatellite regions are primar-
ily repaired by MMR and in its absence exhibit high rates of short indels. In addition
to high numbers of indels at the microsatellite regions, MMR-deficient (MMRd) cells
also exhibit high levels of single nucleotide substitutions.
Higher mutation rates at the positions numbers 9 and 5 within binding motifs
for CTCF and KLF4, respectively, would then be a result of lower levels of MMR
activity at those positions in comparison to the flanking sequences that are not occupied
by proteins. In this case, one would expect to see equally high numbers of mutations
in the flanks, as in the site, when looking at the mutations from the tumours that are
MMRd.
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Sizes of the datasets containing single nucleotide substitution data from the
MMRd tumours are not large enough to be able to see if that is actually the case across
a relatively small subset of protein-binding sites for a specific TF. One can, however,
model the expected pattern of substitutions at the aggregate of protein-binding motifs
just from the observed genome-wide trinucleotide mutational frequencies of the MMRd
tumours. That allows one to see if the observed levels and patterns of mutations at the
candidate regions that we propose are deprived of MMR match what we expect to see
in cells that we know are deprived of MMR.
Breast cancer (BRCA) is one of the tumour types where I can see increase
in mutations at position number 9 of the CTCF motif, and also have single nucleotide
substitution data for MMRd tumours. Figure 4.11a shows the patterns that we observe
at the aggregate of CTCF binding sites (with MMR intact) next to the pattern that
we expect to see at the same set of sites in the MMR-deficient tumours given the
sufficiently powered dataset (Figure 4.11b). First, one can see that, as expected, the
overall mutation rate is increased in the MMRd tumours. The level of increase with
MMRd appears to match the level observed at the highly mutated positions in cells
with intact MMR, and while types of changes appear to be somewhat different, this
is consistent with the observed pattern being shaped by protection from MMR. The
levels of mutations in flanks are of the same magnitude to what one would expect from
tumours with MMR intact (Figure 4.11c). It is worth to note that breast cancers are
rarely subject to MMR deficiency. The MMRd status of the tumours here was inferred
from the large numbers of the indels (as in Supek and Lehner (2017)), however breast
cancers can be subject to other repair defects that might produce large numbers of
indels. Therefore some fo these samples might not in fact be MMRd.
Figures 4.12 and 4.13 shows similar plots for CTCF and KLF4, using pan-
cancer ICGC MMR intact tumours and MMRd stomach cancer tumours from Wang
et al. (2014). I used pan-cancer ICGC data here, as the numbers of mutations in the
cancer types that are similar to stomach cancer are too few to be able to observe the
excess of mutations within the binding site. Even though the MMRd and non-MMRd
cancer types are not matched here, it appears that the level of mutations within the
binding sites is again of the same magnitude to what might be expected from the
MMRd tumour, albeit the mutational processes will likely differ and only specific types
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(c) BRCA expected mutation pattern given genome-wide rates of non-MMRd tumours
Figure 4.11: Observed (a) and expected (c) BRCA (breast cancer) mutations over the CTCF
binding motif (MA0139.1) in comparison with the expected mutational pattern over the same
sites based on genome-wide trinucleotide mutational frequencies in BRCA MMRd tumours (b).
Level of mutations observed at the position 9 of the motif (a) is similar to expected level of
mutations when MMR is suppressed (b).
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Position relative to the motif start site (bp)
(c) CTCF; expected from ICGC pan-cancer
Figure 4.12: Observed (a) and expected (c) pan-cancer (from ICGC) mutations over the CTCF
binding motif (MA0139.1) in comparison with the expected mutational pattern over the same
sites based on genome-wide trinucleotide mutational frequencies in stomach cancer MMRd tu-
mours (b). Level of mutations observed at the position 9 of the motif (a) is similar to expected
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Position relative to the motif start site (bp)
(c) KLF4; expected from ICGC pan-cancer
Figure 4.13: Observed (a) and expected (c) pan-cancer (from ICGC) mutations over the KLF4
binding motif (MA0139.1) in comparison with the expected mutational pattern over the same
sites based on genome-wide trinucleotide mutational frequencies in stomach cancer MMRd tu-
mours (b). Level of mutations observed at the position 9 of the motif (a) is similar to expected
level of mutations when MMR is suppressed (b).
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4.3.5 Analysis of mutational frequencies beyond trinucleotide
sequence can reveal highly mutated motifs
Investigation of unusually highly mutated positions within the protein binding motifs
requires several types of input information - such as motif PWM for a specific TFs, and
preferably ChIP-seq or an equivalent type of data to know which instances of the motif
are bound by the TF genome-wide. That limits the possibility of such analysis only
to the subset of reasonably well-studied TFs for which such information is available,
and also can make an integration of such inputs from various sources labour-intensive.
Limited availability of ChIP-seq data from cell matched with mutation origin leads to
the lack of knowledge of whether the binding site is actually active in that particular
cell type. Therefore, I prototyped novel approaches to extend this analysis to a more
general, genome-wide level and escape the need for the additional inputs.
Mutation rate of a particular position is determined in big part by its trin-
ucleotide context (i.e. by the identity of the surrounding base on either side) (Blake
et al., 1992), but has also been extended to longer tracks of sequences (penta- and septa-
nucleotides) serving as predictors for mutation rate (Aggarwala and Voight, 2016). In
the motif based analyses already presented (Subsections 4.3.3 and 4.3.4) I considered
the mutation rate of trinucleotides within a specific motif compared to the genome
wide rate for those motifs calculated from the same cancer samples. Here I generalise
that approach by considering the mutation rate of each penta-nucleotide relative to the
expectation for the central tri-nucleotide. The rationalisation being that generally the
petanucleotide rate will be well estimated by the central trinucleotide rate. Where it
is not, it indicates the wider sequence context contributes to defining outlier mutation
rate properties, for example by being part of a wider sequence specific binding motif.
Figure 4.14 shows the natural log ratio of the observed mutation rate of each pentanu-
cleotide to rate of middle trinucleotide. Any pentanucleotides that are above 1 on the
y-axis are mutated more frequently genome-wide than expected, while the ones below
- less frequently, indicating that this difference is driven by the identity of first and last
positions. There are some outliers which exhibit mutation rate which is strikingly dif-
ferent (increased) from expectation based on the context of middle trinucleotide, such
as TTTAA−→TTAAA, TCCTT−→TCTTT, and TTTCC−→TTCCC, which resem-
ble mutations occurring in repetitive sequences, but also elevated rate of such changes
167
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as TCCAT−→TCTAT and GGTTG−→GGCTG. Interestingly, GGTGN−→GGGGN
changes, which correspond to the increased mutation rate at position 5 of KLF4 motif,
all show mutation rate above trinucleotide-based expectation across the genome. This
genome-wide approach is unlikely to reveal the mutational pattern shaped by the inter-
actions of the TFs with specific sequences, unless the TF can be assumed to be bound
universally across the genome.
A more informative approach is to compare the mutational frequencies of the
pentanucleotides between two types of genomic states - such as accessible/active and
non-accessible regions of the genome. Variation in the mutation rate of a particular
pentanucleotide between what is observed genome-wide versus what is observed in the
region of interest can then be attributed to the nature of the region. Figure 4.15 shows
the natural log ratios of substitution rates in the subset of binding sites that were
found to be commonly occupied in multiple tissues by analysis of ATAC-seq data, as
described in Chapter 2, to the rates that are observed in the rest of the genome. Any
pentanucleotides that are above 0 on the y-axis are found to be more mutated in the
regions defined as binding sites commonly occupied in multiple tissues, while the ones
below are more mutated in the rest of the genome. Figure 4.16 shows similar data, but
as mutation rates correlation plot.
C−→T change in the CpG context is unsurprisingly the most pronounced
mutational pattern exhibiting the highest mutation rate in the genome-wide context.
All of the CpG-containing pentanucleotides, however, cluster around 1 on y-axis and
closer to left side of the plot, with not much spread (except for CCG trinucleotide
context), indicating that deamination of the methylated CpG is likely to be such an
influential driver of C−→T change that any of the surrounding sequence does not add
much effect. It also shows a large change in the mutation rate in the sites that I
have identified as common binding sites versus rest of the genome, clustering into a
separate group (Figures 4.14 and 4.16 −→T change). This is an expected observations,
as regulatory sites tend to exhibit lower levels of methylation, as discussed in Chapter
3.
Interestingly, the sequence that resembles the KLF4 motif (GGTGG/T) is
exhibiting the largest fold change to G between the common binding sites and the rest
of the genome, which follows my previous observation for KLF4 binding sites (Figure
4.3b).
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Figure 4.14: Natural log of ratios of pentanucleotide pan-cancer mutation rates to trinucleotide


















































































































































































































































































































































































































































































































































































Figure 4.14: Natural log of ratios of pentanucleotide pan-cancer mutation rates to trinucleotide
mutation rates genome-wide, where the central base is mutated to an C (left) or a T (right)
(continued). Note logarithmic y-axis.
170


























































































































































































































































































































































































































































































































































































Figure 4.15: Ratios of pentanucleotide pan-cancer mutation rates in the common binding sites
to the rest of the genome, where the central base is mutated to an A (top) or a G (bottom). Size
of each pentanucleotide corresponds to the − log10 p-value of the Fishers exact test, and each
pentanucleotide group is ordered according to the level of the mutation rate spread within the








































































































































































































































































































































































Figure 4.15: Ratios of pentanucleotide pan-cancer mutation rates in the common binding sites
to the rest of the genome, where the central base is mutated to an C (left) or a T (right)
(continued). Size of each pentanucleotide corresponds to the − log10 p-value of the Fishers exact
test, and each pentanucleotide group is ordered according to the level of the mutation rate spread
within the group. Note logarithmic y-axis.
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Figure 4.16: Petanucleotide pan-cancer mutation rates at common binding sites compared to
those occurring across the rest of the genome. The size of each pentanucleotide corresponds to
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4.4 Discussion
In this Chapter, I investigated the patterns of the mutations at the motifs of the
specific binding factors and introduced a biased mask model that could explain those
observations. I show that the striking pattern of cancer mutation abundance at the
positions in the CTCF motif that is important for binding is shared by wider range of
TFs, such as KLF4, EGR1 and others.
The unusual spike in mutations observed at position 9 of the CTCF motif
here corresponds with what has been previously observed by Kaiser et al. (2016) in
pan-cancer analysis and by Katainen et al. (2015) in colorectal cancer. Katainen et al.
(2015) has also shown that the binding of CTCF is necessary for induction of this mu-
tational increase, consistent with our hypothesis of protein binding causing retention of
mutations. There is a peak of mutation excess at the position number 5 of the KLF4
and position number 6 of the EGR1 motif, which are both C2H2 ZnF binding TFs,
like CTCF. KLF4 shows increase in mutation rate of GTG triplet, which is the most
abundant trinucleotide at that position, to potentially motif-disrupting GGG. The pre-
dominant mutation peak within the EGR1 binding motif occurs at the position that
does not carry substantial amount of importance. Change occurs in the similar GTG
−→ GGG context as with KLF4 , but is not the most frequent trinucleotide at this
position for EGR1. The mutation spikes in the pan-cancer analysis are not dominated
by a particular cancer type, but some types of tumours do tend to show a more dis-
tinct pattern than others, and those differ between CTCF and KLF4. Variability in
the mutational pattern that can be seen across the cancers is not all that surprising,
different types of tumours are known to be driven or to exhibit distinct mutational
processes and signatures. This just highlights the level of complexity that we are faced
with when trying to disentangle contributions of different mutational mechanisms in
various contexts. The characteristic T−→G change dominating at KLF4 and EGR1
motifs does not appear to be a type of change that could be attributed to a particular
cancer type or mutational process. It might, therefore, represent a type of change that
is preferentially retained specifically at those sites, in accordance with the biased mask
model.
Analysis of the bulk of binding sites of other TFs, for which PWMs and ChIP-
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seq were available showed that there are more instances of similar mutational patterns
for both C2H2 ZnF and other types of TFs (Figure 4.7).
As I expect this to be more of a global feature of many of the binding sites,
I have implemented a more general, genome-wide approach for finding sequences that
exhibit mutational rate distinct from what would be expected. I trialed the analysis
of sequences limited to 5-nucleotide length and compared their mutation rates between
sites bound by the protein and the rest of the genome. However, this type of approach
could be taken further to investigate longer sequence lengths (presuming sufficiently
powered datasets with mutations are available), and to test differences between differ-
ent types of genomic regions. Typical length of the protein binding motif is ≈ 6− 12.
Conceivably, by taking a set of sequences of approximate protein-binding motif length,
say 11 bases, with every possible combination of nucleotides (4,194,304 possible combi-
nations), and counting the frequencies of substitutions of every position to each alter-
nate nucleotide (138,412,032 possible types of changes), and comparing rates of those
between accessible and non-accessible regions, one could find outliers that could re-
veal the highly mutated positions within potential motifs. This is currently now being
developed as a follow-on project in the group.
One of the things to note is that the calculations of the genome-wide mutation
rates (both trinucleotides and pentanucleotides) are based on the whole of the genome.
At the same time there might be certain regions of the genome where one is unlikely
to find any cancer somatic mutations, not due to the biological reason, but rather
because of the technical bias in the way that ICGC data (or somatic mutation data
from other cohorts) has been processed. Therefore, I suspect that the genome-wide
mutation rates that I calculate here might be underestimated. That would mean that
the fold-enrichment in the mutation rates for some, or all, of the positions and changes
would be lower.
It would be of a great advantage if we could associate the magnitude of the
mutational effect within the motifs with the levels of the protein expression in the same
cells. That would be possible to do providing that there is WGS mutation data and
RNA-seq data available from the same donors. Within the ICGC cohort, there are not
enough samples for different types of tumours where both WGS mutation and RNA-seq
data is available. In addition, in relation to the KLF4 motif, there are multiple members
of the KLF family that bind similar motifs and those could be expressed at variable
176
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levels on different types of cells. That would then make it difficult to disentangle the
mutational effect contributed by each of the KLF family members.
I hypothesise that the abundance of mutations within protein binding motifs
in excess of what can be observed genome-wide is due to the TFs interfering with the
normal processes of replication and repair, in particular MMR. One of the ways to test
this is to compare the mutational pattern of tumours that have intact mismatch repair
with those that are MMRd. While mismatch deficiency does mean that any individ-
ual tumour is going to harbour a larger number of mutations, MMRd tumours occur
relatively rarely. In the absence of a dataset with enough mutations from the MMRd
tumours to be able to observe the mutational patterns at the relatively small number
of binding sites, I instead looked at the mutational patterns that we would expect to see
at the motifs based on the mutational spectrum of tumours lacking mismatch repair.
I find that the level of mutation excess at the highly mutated positions within KLF4
and CTCF motifs match the expectation from MMRd tumours. Relative proportions of
types of mutations that we expect to observe over the motif with MMRd differ from the
proportions we observe at the highly mutated positions. This can be explained by only
certain types of lesions being tolerated by the TFs, and therefore over-representation
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5.1 Introduction
5.1.1 Viability of the ’biased mask’ model in the context of
mismatch lesions
In the previous Chapter, I introduced the ’biased mask’ model that predicts that some
positions within the motifs of some of the sequence-specific binding TFs might become
highly mutated due to strand-specific tolerance to mismatches and other lesions. In
the current Chapter, I will describe the experimental in vitro validation of this model,
using KLF4 protein as an example, which I have shown before to exhibit an unusually
high mutation rate at position number 5 within its binding motif (Figure 4.3b).
There are multiple types of lesions, whose occurrence and failure to repair
could result in a mutated sequence following a single round of replication. Those in-
clude abasic sites, modified bases (such as thymine dimers), interstrand crosslinks, and
mismatches (Chatterjee and Walker, 2017). Mismatch repair, together with the exonu-
clease activity of replication polymerases, is responsible for fixing wrongly incorporated
bases during replication. Failure of the mismatch repair machinery to do that would re-
sult in the formation of mismatches - duplex DNA sequences, where non-complementary
bases are paired opposite each other. Unfixed, such mis-pairing will lead to mutation
in one of the daughter cells after the next round of replication.
In the previous Chapter, I showed that an unusually high level of mutations at
some positions within the KLF4 and CTCF motifs is consistent with a lack of protection
from mismatch repair. Therefore, the analysis presented here involves testing the ability
of the KLF4 protein to bind over sequences containing mismatches, although I expect
that this model is not restricted to this particular type of lesion and is likely to extend
to a wider variety of DNA base changes. To my knowledge, there have not been any
studies asking whether sequence-specific binding TFs are able to bind over a mismatch
lesion. Closest studies have investigated the role of naturally occurring DNA base,
such as methylation influencing TF binding affinity in site and strand-specific manner
(Hashimoto et al., 2016, 2017).
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5.1.2 Methods for measuring affinity of a protein to target DNA
sequence
It is possible to test how well protein is able to bind a specific DNA sequence with
a range of different assays using synthetic oligonucleotide duplexes. These oligonu-
cleotides can be artificially synthesised with fluorophores attached to the 5’ end of the
desired sequence. Binding affinity estimation methods involve mixing protein and tar-
get oligonucleotide duplexes in solution in the presence of other necessary components,
such as zinc in case of ZnF proteins.
Detection and estimation of the bound and unbound fractions of oligonu-
cleotide duplexes differ between assays. One of the methods is electrophoretic mobility
shift assay (EMSA) (Hellman and Fried, 2007), which involves loading the binding
reaction onto a polyacrylamide gel and passing a voltage to separate species by size.
By using fluorescently-labelled oligonucleotides, it is possible to detect where on the
gel they have migrated to. That allows one to detect an ’unbound’ fraction that has
migrated faster, and a ’bound’ fraction, that has migrated slower due to an increased
size of DNA-protein complex. By measuring the amount of fluorescence in each of the
fractions, it is then possible to estimate the proportion of the total DNA that has been
bound by the protein.
Another method used here is fluorescence anisotropy. This assay estimates the
proportion of bound fluorescently-labelled oligonucleotide by measuring the rotational
mobility of the labelled DNA. This is achieved by measurement of the fluorophore
emitted light parallel and perpendicular with respect to the plane of polarized light
excitation. In the time between excitation and emission, small molecules that rotate fast
due to Brownian motion and achieve a randomised orientational distribution, resulting
in a low ratio of parallel:perpendicular emitted light compared to larger species that
rotate relatively slowly, so a greater fraction of emitted light is parallel to the plane of
excitation (reviewed in Hall et al. (2017)).
5.1.3 Questions addressed in the current Chapter
In the current Chapter, I aim to experimentally test the viability of the ’biased mask’
model. I do this by measuring the affinity of the KLF4 protein to its target motif con-
taining DNA sequences in the presence or absence of a mismatch or mutation primarily
182
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Here I test the affinity of the KLF4 protein to double-stranded oligonucleotides contain-
ing the KLF4 preferential binding sequence with or without a mismatch or mutation
at one position within the motif. As a ’perfect’ sequence (CORE; positive control) that
would be expected to bind KLF4, I have chosen an actual 37 base-pair genomic site
(chr14:23,340,913-23,340,949; hg19 ) that was found to be present under a KLF4
ChIP-seq peak within the core promoter of the LRP10 gene, and showed an occurrence
of 4 T−→G mutations at position number 5 of the motif in the ICGC skin adenocar-
cinoma (SKCA) dataset (≈ ×3000 increase relative to the genome wide expectation in
SKCA for GTG trinucleotide context). A complete set of oligo sequences can be found
in Table 5.1. Oligonucleotides containing changes at position number 5 on the KLF4
motif (T−→G change in the forward oligo and A−→C change in the reverse oligo)
were used to create duplexes with mismatched base on the forward strand (FMM -
forward mismatch) or reverse strand (RMM - reverse mismatch) when annealed to the
’perfect’ sequence reverse or forward oligo, respectively (Figure 5.1). Annealing of the
two altered oligos together produced a sequence without a mismatch, but containing a
mutation at position number 5 (MUT).
Additional oligos containing changes T−→A on forward strand and A−→T
on the reverse strand were obtained. To test changes at other positions of the motif, we
obtained oligos with T−→A change on forward and A−→T change on reverse at position
number 7 (Jaspar motifs MA0039.2). This position is similar to position number 5 in
PWM, but is not found to be highly mutated in cancers. Also we obtained oligos
with G−→A and C−→T changes at position number 4 (Jaspar motifs MA0039.2), that
would be strongly expected to abolish binding due to the high information content of
this position in all KLF4 PWMs.
We have also obtained an alternative set of 35 base-pair sequences that contain
the KLF4 binding site in the promoter region of the LEFTY2 gene (chr1:226,128,999
- 226,129,033; hg19 ), same as in Soufi et al. (2015), including a set of oligonucleotides
with incorporated uracil at the position number 5 of the KLF4 motif, which should allow
184
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Table 5.1: KLF4 motif-containing Cy5-labelled synthetic oligonucleotide sequences. Positions
that have been changed relative to ’perfect’ CORE sequence (first two rows) are in brackets.
’Orientation’ denotes the direction of the KLF4 motif (Jaspar matrix MA0039.2; Figure 5.1),
and ’position’ denotes changed position according to the same motif PWM. ’Type of change’
indicates change relative to the CORE sequence. ’Mismatch’ indicated a type of mismatch that
will form upon annealing that oligo with CORE oligo of opposite orientation.
G GGG GGG A CT
C CCC C C C T GA
1 432 6 7 8 9 105
G GGG GGG A CG
C CCC C C C T GA
1 432 6 7 8 9 105
G GGG GGG A CG
C CCC C C C T GC
1 432 6 7 8 9 105
G GGG GGG A CT
C CCC C C C T GC









Figure 5.1: Formation of oligonucleotide duplexes with mismatches and mutation at position
number 5 of the KLF4 motif (Jaspar PWM MA.0039.2; top). Forward and reverse oligos that
form a ’perfect’ CORE double-stranded motif can be combined with oligos that form a mutations
(MUT) to get forward (FMM) and reverse (RMM) mismatched duplex oligos. Icons further used
to represent those duplexes are drawn under each of the sequences.
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for production of abasic sites by uracil-DNA glycosylase (no results from use of those
oligos are presented in this work).
As a non-specific negative control I used oligonucleotides containing binding
motif for the NANOG protein (where no sequence resembling the KLF4 binding site is
present) from Soufi et al. (2015).
All oligonucleotides were ordered from IDT with 5’ Cy5 label and HPLC
purification. Oligo annealing was performed in annealing buffer that contained 20µM
TrisHCl (pH7.6), 50µM NaCl, 0.1µM DTT (added shortly before use), 1µM EDTA.
Annealing reaction was carried out for 15 minutes at ≈80◦C in a water-bath, and then
left to cool gradually overnight.
5.2.2 KLF4 protein
Full-length refolded histidine-tagged KLF4 protein (in 2M urea) was supplied by Dr
Abdenour Soufi, and previously published (Soufi et al., 2015). Concentration of the
protein stock was determined by running a range of KLF4 stock dilutions alongside
known concentrations of bovine serum albumin (BSA) on a pre-cast SDS-PAGE gel
(Figure 5.2). Stock concentration was calculated to be ≈ 0.7mg/ml.
Figure 5.2: KLF4 protein stock quantification.
Different volumes of KLF4 protein dilution were
compared to a range of volumes of BSA di-
lutions with of known concentration. Protein
amount per unit of fluorescence was calculated
from BSA range (except at 2µl, as signal was
over-saturated at in that lane), and protein
amount per ml of KLF4 protein loaded was cal-
culated accordingly.
5.2.3 EMSA experimental set-up
5% acrylamide gel was prepared by mixing 2.5ml of 10X TBE (0.9M Tris, 0.9M Borate,
0.02M EDTA; pH 8.3), 8.3ml acrylamide (30% Acrylamide Gel Solution Bis-Acrylamide
Ratio 29:1; Severn Biotech 20-2600-05), 38.8ml H2O, 350µl ammonium persulfate (10%
W/V ; Thermo Fisher Acrōs Organics, 98%+, 7727-54-0 ) and 50µl TEMED (Sigma-
Aldrich, T9281 ). After pouring, the gels were left to polymerise either overnight at
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+4◦C or for 1 hour at room temperature, then pre-run for 1 hour at 90V in 0.5X TBE
prior to loading.
5X binding buffer was pre-made with 50mM Tris-HCl (pH 7.5), 5mM MgCl2,
50µM DTT, 25% glycerol and 2.5 mg/ml BSA, and stored at -20◦C. The binding
reaction was performed in 1X binding buffer (made up from 5X binding buffer with
H2O). Mixtures with ranges of protein concentrations were prepared by serial dilutions
of protein stock in 1X binding buffer (on ice).
Non-specific inhibitor poly(deoxyinosinic-deoxycytidylic) acid sodium salt
(poly(dIdC); Sigma-Aldrich, P4929 ) was added to the oligo diluted to the desired con-
centration prior to the binding reaction. An optimal concentration of poly(dI-dC) was
estimated by performing a titration (5-30ng/µl) in reaction with 1nM of either the per-
fect binding sequence (CORE) or non-specific (Nanog) oligo, and 5nM of KLF4 protein
(Figure 5.3). As low as 5ng/µl of poly(dI-dC) did not completely prevent binding of all
CORE oligo by the KLF4 protein, while fully abolishing non-specific binding of Nanog
oligo. In results presented here either 2.5ng/µl or 1.25ng/µl of poly(dI-dC) was used,
as indicated.
poly(dI-dC) (ng/ul) 5 10 20 30 5 10 20 30





Figure 5.3: Titration of poly(dIdC)
amounts. Range of poly(dIdC) con-
centrations were added to the bind-
ing reactions containing 5nM KLF4
protein and 1nM oligo duplex, in
order to find concentration that
would abolish non-specific binding
(Nanog), while still retaining spe-
cific binding (KLF LRP CORE).
40µl reactions containing Cy5-labelled annealed DNA probes and a range of
protein concentrations were made up by mixing equal volumes of protein mix and DNA
mix, and the binding reaction was allowed to proceed for 1 hour at room temperature
in the dark. 30µl of sample was then loaded into each well, alongside 2µl of loading
dye (6X, Thermo Fisher, cat.num: R0611) (to monitor the progression of the gel, as
the binding reactions did not contain any dye, so could not be tracked), while the gel
was run at 150V. At least 2 free wells were left between dye and the sample, as blue
dye gives out strong fluorescence at Cy5 wavelength). Gels were run at 90V at room
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temperature for ≈3.5 hours. Gels were imaged on Fujifilm FLA-5100 fluorescent image
analyser (Cy5 filter; 635 wavelength; 400V).
5.2.4 Quantification of binding affinity from EMSA gel images
Fluorescence intensity was quantified using MultiGauge (Ver 3.0 ) software. Back-
ground correction was applied to each individual gel image by subtracting the fluores-
cence value from an image area outside the lanes. Equal-sized windows were used to
measure region intensity (measured in LAU - Linear Arbitrary Units) of each band.
LAU values that became negative after background correction were set to 0. Following






The LAU value that corresponded to the Oligototal was measured in one of two ways:
Oligototal = Oligounbound at 0nM protein (f:5.2.2)
or
Oligototal = Oligobound +Oligounbound (f:5.2.3)
The resulting value from Formula f:5.2.2 was used for a set of lanes with a range of
protein concentrations and same oligo, while Formula f:5.2.3 value was calculated for
each of the lanes individually. While the resulting estimation of total in case of Formula
f:5.2.2 is more affected by the variability in sample loading between lanes, the result
from Formula f:5.2.3 would be more affected by the presence of ’smeared’ signal between
measured bound and unbound fraction that can result from dynamic association and
dissociation of the protein-oligo complex during electrophoresis (Dr A.Soufi, personal
communication). Therefore, in the latter case, the proportion of total amount of oligo
could be underestimated, which would lead to overestimation of the bound proportion.
Another option is to measure total amount of oligo as the florescence value obtained
from the whole lane, however that would lead to the introduction of a larger error
due to high levels of background noise. While all of the described methods could
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potentially introduce an error in estimation of the bound proportion, this error is likely
to be uniform between all experiments, so would not be expected to affect comparison
between these.
Apparent dissociation constant (Kd) was used to measure the affinity of the
protein to each oligo. Kd was measured by fitting a non-linear model to the data using
R (3.4.1). Binding curves describing the fraction of bound DNA as a function of the
protein concentration (Prot) from multiple separate experiments for each oligo type
were fitted to the data using either nonlinear least squares nlsLM function from the
minpack.lm (v1.2-1) package, or nls function in R. The Kd and Hill coefficient (HC )






Where Prot denotes protein concentration; Bmax (maximal fraction of oligo
bound) was kept constant and equal to 1; and the supplied starting values were 1 and
0.1 for Kd and HC, respectively.
5.2.5 Anisotropy experimental setup
The anisotropy assay was performed in black non-transparent 384-well plates (Corning,
product number: 10109202 ). The binding reaction was carried out in PBS with addition
of 50µM ZnSO4 (Sigma Aldrich, 83265 ). 5’ 6-FAM labelled oligos were used for this
assay. 20µl of oligo mix was added to a range of protein dilutions (20µ of each dilution).
There were 3 replicate binding reactions for each protein concentration. Incubation
reactions were carried out for 1 hour at room temperature in the dark. Fluorescence
polarization was then measured on a PerkinElmer Wallac 1420 Victor2 microplate
reader, with 3 replicate readings for each well (F485 CW-lamp excitation filter; F535
emission filter; measurement time 0.2sec; CW-lamp energy 65,535 (instrument arbitrary
units); constant voltage; G-factor 1).
Fluorescence polarization values (mP) were background-corrected by subtract-
ing the polarization value obtained at 0nM protein for each replicate and each reading
separately. Resulting values were then used to fit non-linear least squares model us-
ing nls function in R (3.4.1), similar to what was done for EMSAs, where Formula
f:5.2.4 was used, but with HC value fixed to 1, and a non-fixed Bmax value. Confidence




5.3.1 KLF4 shows strand-specific affinity to sequences with
mismatches by electrophoretic mobility shift assay
To test the tolerance of KLF4 protein to the T−→G mutation at position number 5 of
the motif (Figure 4.3b), along with a G:A (FMM - forward mismatch) and T:C (RMM
- reverse mismatch) mismatches, I performed EMSAs for a range of protein concentra-
tions with fixed amounts of oligo, constructed binding curves for each oligo type, and
estimated a dissociation constant value (Kd) using Formula f:5.2.3 for estimation of
total amount of oligo in a lane. Here the value of Kd essentially represents a protein
concentration at which half of the ligand (fluorescently-labelled oligonucleotide duplex)
present in solution is free, and half is bound. Lower Kd values represent higher affinity.
Kd values reported here are apparent dissociation constant value and do not reflect the
physiological concentrations of protein required to achieve half-maximal binding.
I initially tested affinity of a range of KLF4 protein concentrations (0-10nM)
to 2nM oligonucleotide duplexes in the absence of any non-specific inhibitor. Fitted
binding curves with estimated Kd values and images of the gels can be seen on Figure
5.4. In the absence of non-specific inhibition KLF4 protein shows highest affinity (Kd =
2.42nM) for the ’perfect’ binding sequence (CORE). Sequences containing mismatches
at position number 5 of the motif (FMM and RMM), while reach almost full binding
at 10nM protein, show a lower affinity in the intermediate protein concentrations,
increasing Kd to ≈4.9nM ,with no significant difference between the two. The oligo
duplex containing a mutation at position number 5 of the motif shows the lowest affinity
amongst all, failing to reach half maximal binding at the highest protein concentration
tested, with a calculated Kd of 63.6nM. This oligo, however, was only tested with one
replicate and therefore this result lacks a measure of significance. As can be seen from
the gel images on Figure 5.4, there is a high degree of ’smeared’ signal over the lanes
in between the bound and un-bound fractions, particularly with increasing protein
concentrations, indicative of non-specific binding, as those initial experiments were
done in absence of any non-specific inhibitor. Therefore in the subsequent experiments
I used the non-specific inhibitor poly(dI-dC).
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Figure 5.4: KLF4 binding affinity in the 0-10nM protein concentration range for CORE (n=3),
MUT (n=1), FMM (n=2), and RMM (n=2) oligonucleotide duplexes (2nM) in absence of non-
specific inhibitor. Dissociation constant (Kd) and Hill coefficient (HC) obtained from fitted
model. Error bars represent 90% confidence interval. Note log-scale x-axis. Gel images from
each separate replicate are shown below, and bands corresponding to both free DNA and protein-
DNA complex indicated.
Figure 5.5 shows fitted binding curves with estimated Kd and gel images of
binding assays where a range of KLF4 protein concentrations (0-10nM) were tested
for the affinity to different types of duplex oligonucleotides (1nM) in the presence of
2.5ng/µl poly(dI-dC). Kd values became higher with addition of poly(dIdC), as ex-
pected. The protein still shows highest affinity to the oligo duplex containing ’perfect’
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binding motif (CORE), with Kd = 10.72nM. Similar to what has been seen without
non-specific inhibition, oligo duplex containing a guanine instead of thymine at posi-
tion number 5 of the motif on the forward strand (FMM) is bound by protein worse
than CORE, but better than oligo duplex with mutation at the same position (MUT).
Interestingly, the oligo duplex with a mismatch on the reverse strand (adenine replaced
by cytosine on the reverse strand) is now bound by the protein with similar affinity
to MUT with Kd of 25.29nM. None of the oligonucleotide duplexes, including CORE,
reach full or near full binding at the highest protein concentration, with CORE only
just about reaching the half-maximal binding.
I have therefore increased protein concentration to get a fuller picture of bind-
ing dynamics. Figure 5.6 shows KLF4 binding to oligonucleotide duplexes (1nM) in
0-50nM protein concentration range in presence of 1.25ng/µl poly(dI-dC). Higher affin-
ity of KLF4 to FMM over RMM hold true at 20nM protein concentration, after which
point there is no significant difference between two mismatch types. Difference between
FMM and MUT, however holds true up to 35nM protein (Figure 5.7, RMM values have
been removed for better discrimination between FMM and MUT), after which point
there is also an increase in non-specific binding, as measured by affinity of the protein
to the non-specific NANOG oligonucleotide duplex.
Importantly, these results show that KLF4 protein is able to bind over the
mismatched lesion.
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Figure 5.5: KLF4 binding affinity in the 0-10nM protein concentration range for CORE (n=2),
MUT (n=5), FMM (n=4), RMM (n=4), and NANOG (n=1) oligonucleotide duplexes (1nM)
in presence of 2.5ng/µl non-specific inhibitor poly(dIdC). Dissociation constants (Kd) and Hill
coefficients (HC) were obtained from fitted model. Error bars represent the 90% confidence
interval. Note log-scale x-axis. Gel images from each separate replicate are shown below, and
bands corresponding to both free DNA and protein-DNA complex indicated. Dates are indicated
































Figure 5.6: KLF4 binding affinity in the 0-50nM protein concentration range for CORE (n=3),
MUT (n=4), FMM (n=4), RMM (n=4), and NANOG (n=2) oligonucleotide duplexes (1nM) in
presence of 1.25ng/µl non-specific inhibitor poly(dIdC). Dissociation constants (Kd) and Hill
coefficients (HC) were obtained from fitted model. Error bars represent the 90% confidence
interval. Note log-scale x-axis. Gel images from each separate replicate are shown below, and
bands corresponding to both free DNA and protein-DNA complex indicated.
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Figure 5.7: KLF4 binding affinity in the 0-50nM protein concentration range for CORE (n=3),
MUT (n=4), FMM (n=4), and NANOG (n=2) oligonucleotide duplexes (1nM) in presence of
1.25ng/µl non-specific inhibitor poly(dIdC). Dissociation constants (Kd) and Hill coefficients




5.3.2 KLF4 binding affinity to a winder range of mismatches
I have also tested the affinity of the KLF4 protein to a wider range of changes at three
different positions (n=1; Figure 5.8). Similar to what has been observed in the binding
assays described above, at lower protein concentration (3nM) there is considerable
variability that is not necessarily consistent with values at higher protein concentration
(10nM). This is not surprising in light of the fact that the largest amount of poly(dIdC)
(3ng/µl) was added here. At 10nM protein concentration, in accordance with the
previous assays, the G:C mutation at position number 5 is bound worse than the
reverse strand mismatch (T:C), which in turn shows lower affinity for the protein than
the forward mismatch (G:A). Other types of change at position number 5 (forward
mismatch A:A ; reverse mismatch T:T ; or mutation A:T) appear to be better tolerated
by the KLF4 protein, and unlike the previous type of change, mutation is tolerated
better than either of the mismatches. Interestingly, at position number 4 of the motif,
which is strongly biased towards G:C within the PWM, mutated A:T is tolerated almost
just as well as ’perfect’ sequence, while either of the mismatches (G:T or A:C) show
much lower affinity. Position 7, at which KLF4 protein exhibits a nucleotide preference
most similar to position number 5 (except for G being expected to be more tolerated),
is least tolerated with the mismatch on the reverse strand (T:G) and mutation (C:G),
while mismatch on the forward strand (C:A) binds KLF4 better. This binding assay
has only been performed in one replicate, therefore any conclusions made here are not
statistically robust.
5.3.3 KLF4 binding affinity measured by fluorescence anisotropy
I also performed a binding assay that allows detection of the protein affinity by fluores-
cence polarization/anisotropy. In principle, this method allows for the faster, higher-
throughput measurement of the affinity of the protein to its ligand, and can be done
with a number of different fluorescently-labelled oligonucleotide duplexes in one 396-
well plate. I tested 0-200nM range of KLF4 protein concentrations with 1nM of CORE,
MUT (position number 5 G:C), FMM (position number 5 G:A), and RMM (position
number 5 T:C) oligos in the presence of 0.625ng/µl poly(dIdC) (Figure 5.9). There is
a lot of variability in the range of polarization values between replicates, which might
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4 5 7Position in PWM
Figure 5.8: KLF4 binding affinity to mismatches and mutations at positions numbers 4,5 and
7 of the KLF4 motif (MA0039.2). The proportion of oligo (1nM) duplex bound at 10nM and
3nM (green and red, respectively) in presence of 3ng/µl poly(dIdC) are plotted in ascending
order of 10nM protein binding affinity. Simplified illustrations of lesions are represented below
the graph with the forward (G-rich) strand to the left of the image. Colours represent different
position within the motif (blue - 4; pink - 5; green - 7), as indicated at PWM at the bottom.
The non-altered motif is in black, and non-specific sequence (Nanog) in yellow.
be due to failure to define the most optimal binding conditions or measure-instrument
settings. Perfect motif-containing CORE sequence has shown the lowest binding affin-
ity, contrary to what would be expected. The rest of the oligonucleotide duplexes show
patterns similar to what was observed before with EMSAs, with FMM binding better
than RMM or MUT. However, none of these show differences between each other that
197
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could be deemed significant. More assay optimization would be needed to apply this











































































































































Figure 5.9: KLF4 (0-200nM) binding affinity to CORE, MUT, FMM and RMM oligo duplexes
(1nM) measured by fluorescence anisotropy (3 replicates for each oligo type were read 3 times)
in presence of 0.625ng/µl poly(dIdC). Polarization values (mP) were adjusted by subtracting
the mP value at 0nM protein. Kd values for each oligo type are indicated on the plots. Error
bars represent 90% confidence intervals. All four plots represent the same data, individual
comparisons included for better visual discrimination between pairs of oligonucleotide duplexes.
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In the current Chapter, I explored the experimental plausibility of the biased mask
model in relation to the binding site of the KLF4 transcription factor. As described in
the previous chapter, KLF4 binding sites show an enrichment of potentially binding-
abolishing mutations in cancers (in particular T:A−→G:C) at position number 5 of the
motif (Figure 4.3b). By assessing the affinity of KLF4 protein to duplex oligonucleotides
containing a KLF4 binding motif in vitro, I show that the T:A−→G:C mutation at
position number 5 of the motif is indeed likely to lead to a significant reduction in
binding affinity (Figure 5.6).
The biased mask model proposed here predicts that the high level of mutations
at position number 5 of KLF4 motif arises due to the protein being able to bind over
a mismatch, or other types of lesions, and thereby protect those from being fixed by
repair machinery. This then assumes that protein is able to bind over a lesion at a
position within a motif which might be important for protein-DNA interaction. Here I
show that KLF4 can indeed bind over the G:A mismatch at the position number 5 of
the motif (Figure 5.6). While the binding affinity is reduced to below what can be seen
for the ’perfect’ motif sequence, it is higher than the protein’s affinity to the mutated
position. There is also a general trend for KLF4 being able to tolerate a T:G mismatch
somewhat better than A:C mismatch, which is consistent with the proposed idea of
the strand-specific lesion tolerance by sequence-specific binding factors. The binding
dynamics of the RMM (A:C at position number 5 of the motif) appears to differ with
various protein concentrations, lagging behind FMM (T:G at position number 5 of
the motif) at lower concentrations, but reaching a similar level of binding at higher
concentrations.
It is important to note that those conclusions come from binding assays per-
formed in vitro with the concentrations of protein and oligonucleotides that do not
necessarily represent the true physiological conditions. The Kd values estimated here
are also not absolute, but apparent Kd values, specific only to the conditions of assay
and differ with the amounts of added non-specific inhibitor. In addition to that, the
proportion of the total protein in the solution that is catalytically active is not known.
While seen consistently, the differences in binding affinity of KLF4 protein to mutated
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position number 5 versus T:G mismatch as the same position is not very big. The effect
of this difference in vivo physiological conditions on the binding affinity is impossible
to quantify.
A brief analysis of the wider range of changes including different positions
within the motif shows that at the highly important position number 4 of the MA0039.1
KLF4 motif, a mismatch on either of the strands substantially reduces binding affinity,
while the G:C−→A:T mutation has a smaller effect. This is consistent with our model
and the low mutation rate at that position, as an inability of protein to bind over a
lesion of this type means it would get fixed more efficiently. T:A−→A:T mutation at
position number 5 of the motif appears to be affecting KLF4 binding the least amongst
all the changes tested here. Corresponding mismatches (A:A and T:T) appear to reduce
binding by ≈40% (at 10nM protein ; by ≈80% at 3nM), which is somewhat consistent
with a lack of increase in T:A−→A:T mutations at that position. Position 7 of the
motif, however, shows a ≈35% decrease in KLF4 binding affinity with C:A mismatch,
while either T:G mismatch or T:A−→C:G mutation show ≈60% decrease. This leads
to an anticipation of a higher rate of T:A−→C:G mutation at this position, which we
do not observe in cancer data. Due to the fact that this assay was not performed in
replicate, further experiments would be necessary to confirm any of the findings and
conclusions made here.
When trying to replicate the results obtained by EMSAs using the fluorescence
anisotropy assay, KLF4 binding affinity to mutated position number 5 and both types
of mismatches showed similar trends. However, the binding affinity to oligonucleotide
duplex containing a ’perfect’ binding motif, which should represent a positive control
and would be expected to show highest binding affinity, did not do so. This, in conjunc-
tion with high variability in anisotropy values for replicate binding reactions, suggests
that a better optimization of the assay conditions and measurement setting is needed
in the future. Fluorescence anisotropy provides a potential effective high-throughput
way to test the binding affinity of a protein to a variety of different oligonucleotide
duplexes in a more time-efficient manner. It also provides an opportunity to perform
competition assays, where affinity of the protein to different oligonucleotide duplexes
labelled with fluorophores with non-overlapping emission spectra could be tested in the
same reaction.
The results presented here are supportive of the biased mask model, and act
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as a preliminary indication of the plausibility of this model as a mechanism that drives
retention of certain types of lesions. However, further implementation of, ideally, more
high-throughput methods, such as anisotropy, would be necessary to confirm the current
results, and to show generalizability of this model to a wider range of TFs.
A further idea is to implement a larger-scale assay that can detect the binding
affinity of a protein to a complete range of mismatches and mutations at all of the
positions within the motif. That would involve use of ’doped’ oligonucleotides, where
during oligonucleotide production, whenever each position gets synthesised, instead of
providing the polymerase with 100% nucleotides of correct identity, a certain percentage
of alternate nucleotides are introduced. That means that in the final pool of oligonu-
cleotides every position is going to have a specific percentage of alternate nucleotide.
Combining the pool of ’doped’ forward or reverse strand oligos with reverse or forward
strand oligos containing an unaltered binding motif, respectively, would result in pools
of oligonucleotide duplexes where every position would be expected to have every type
of mismatch at each position that has been ’doped’ on both strands. A GST-tagged
protein can then be used to perform binding assays with both of these pools. The
protein-DNA complexes can then be attached to a magnetic bead with glutathione,
and pulled down with a magnet. Both input and pulled-down fractions can then be
sequenced to determine the relative proportion of every type of mismatch that has
formed a complex.
I have already attempted to implement the pull-down approach using two
types of oligonucleotide duplexes (either two from perfect motif-containing, mismatch-
containing at highly mutated position on either strand, or mutation-containing at the
same position) that have been labelled with different fluorophores with non-overlapping
excitation spectra and commercially obtained GST-tagged CTCF protein. The aim was
to estimate the proportions of each type of oligonucleotide duplex that has formed a
protein-DNA complex by comparing the amounts of each type of fluorescence in both
input and bound fractions. Unfortunately, the GST-tagged CTCF protein did not
appear to be functional for DNA binding in this assay, and neither did it show binding
to its consensus binding motif in EMSA. The ongoing work by Susan Campbell is aimed
at expression and purification of the CTCF, BORIS, KLF4 and EGR1 proteins for use
in this assay.
Overall, the results presented here are consistent with the biased mask model
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proposed in the previous chapter, but more experiments would be necessary to confirm
findings presented here, as well as to generalise to a broader range of proteins, and
positions to show that this model applies to more than just one TF and a single type
of change. In particular, it would be interesting to implement a these assays with the
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6.1 Protein binding sites are mutational hotspots
Work presented here was specifically motivated by the observation of increased sequence
variation proximal to some sequence-specific binding sites by Reijns et al. (2015). Sev-
eral possible models could have explained the observed pattern, with either selection
pressures or differential mutation rate as a cause. Elevated mutation model was previ-
ously the favoured hypothesis, but it had not been explicitly tested prior to this work.
By utilizing measures of human and mouse population variation and performing derived
allele frequency tests, I have separated patterns of selection and mutation in order to
differentiate between those possibilities across protein binding sites that are active in
spermatogonial cells. Those sites were defined through analysis of in-house generated
ATAC-seq data.
This analysis has revealed that there is an increase in germline variation across
and at the edges of the binding sites (Figure 3.5). I have shown for the first time
that this variability is not driven by diversifying selection, but rather by differential
mutation rate, which is elevated at regions occupied by proteins. This means that
protein binding sites in the human and mouse populations are mutational hotspots for
deleterious mutations. While with less power, differences in rates of de novo mutations
between binding sites and proximal regions further support this observation (Figure
3.17). I estimate that almost 1 in 4 births is likely to harbour one of those deleterious
de novo mutations across the protein binding sites.
This finding has implications for human health - many protein binding sites
harbour sequences that are important for recruiting TFs which are part of gene regu-
latory networks, and dysregulation of those could lead to disease. Here I observe an
increase in germline mutations at these sites, which means that they are also likely to
be inherited. This is not to say that this mutational mechanism is active exclusively in
the germline cells, as we anticipate that protein binding sites in somatic cells show the
same mutational property.
The importance of increased rate of mutations at protein binding sites is also
reflected in an expansion of our knowledge about the neutral expectation of single
nucleotide substitutions across the genome. Estimations of neutrality are important,
as they are utilized as a baseline to understand whether a sequence is mutated above or
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below expectation and used to define functionality. While the work described here has
been limited to investigation of properties of single nucleotide substitutions, exploration
of other types of DNA sequence changes, such as indels, would be a useful complement
to this analysis.
Investigation of transcriptional profiles of our isolated cells would also be of
great interest. For one, this could allow us to better characterise the isolated cell
populations, but also to associate the mutagenic effects at the protein binding sites
with transcriptional activity. In addition, it is possible to perform single-cell ATAC-seq
on the isolated spermatogonial cells, which would allow for more detailed exploration
of the individual cell populations.
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6.2 Identified binding sites in the human germline can
allow for the prioritization of disease-causing variants
While the link between an increased mutational burden of protein binding sites and
replication has not been conclusively demonstrated in the current work, general asso-
ciation between mutagenesis and replication has previously been shown through the
observation of increased numbers of de novo mutations in the children of older fathers.
The incidence of conditions such as autism and schizophrenia in offspring have also
been linked to the age of father at time of conception (Kong et al., 2012). Additionally,
a large proportion of cases of such disorders currently can’t be explained by mutations
found within the protein-coding regions, implying that non-coding mutations, partic-
ularly those located within the regulatory sites are likely to be contributing to the
incidence of the disease (Zhou et al., 2018).
The main focus of the current work was to explore the germline mutational
burden of the non-coding part of the genome that contains functionally active regulatory
regions in highly dividing cells of the male germline (spermatogonial cells). Therefore,
a map of the protein binding sites in spermatogonial cells can be a place to look for the
disease-causing variants, such as hits from genome-wide association studies (GWAS).
Being able to narrow search space to regions that are germline-active regulatory sites
might aid with the identification of candidate variants for prioritisation in assessment
of their functional roles both in eliciting molecular and organismal phenotypes.
Future work could also involve the further development of the FLOP method
to be used for the protein binding site identification. As mentioned in Subsection
2.4.2 , use of the machine learning methods and utilization of the Segway software for
this purpose can lead to a new way of ATAC-seq data utilization for protein-binding
landscape mapping.
While the current work was focused on identification of mutational land-
scape at the protein binding sites in spermatogonial cell, it could be extended to other
germline cell populations. For example, arrested meiosis in oocytes, oxidative stress in
sperm cells, as well as rapid divisions during initial stages of embryogenesis, all could
probably lead to distinct heritable mutational patterns.
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6.3 Germline-active, but not somatic-specific binding
sites show increased germline variation supporting a
link between physical DNA-protein interaction and
mutagenesis
The causal relationship between an increased rate of mutation and physical interaction
of DNA by TFs has been suggested before and attributed to the occlusion and retention
of DNA lesions by bound proteins (Reijns et al., 2015; Sabarinathan et al., 2016; Perera
et al., 2016). Here I tested this association through comparison of different categories
of binding sites - those bound in both germline and somatic cells, or exclusively in
either. Identification of these categories of sites was achieved through generation and
analysis of primary ATAC-seq data from spermatogonial cells that we have isolated
from testicular tissues, complemented by analysis of ATAC-seq data from a range of
somatic cell types from publicly available sources.
I have shown that there is an association between protein binding and an
increase in mutation rate, as only the sites that are active in germline cells, and not
somatic-specific ones, show increased rates of germline mutations (Figure 3.10). The
strongest mutational effect was observed in the ’housekeeping’ category of sites, those
that are bound most consistently across all the tissues analysed (Figure 3.10a). The
fact that those sites were detected to be occupied in all of the tissues might also reflect
a stronger interaction of these proteins with DNA, with longer residency time, which
makes them more likely to be detected by ATAC-seq. Most ’housekeeping’ sites appear
to be located close to the transcription start sites and are proximal or located within
the promoters (Figures 2.17c and 2.17b).
Rapid binding of those regions by TFs post-replication (Smith and White-
house, 2012) might be necessary for establishment of the proper gene expression pat-
terns in the cell and priming of pluripotency-associated gene promoters in germline
cells (Guo et al., 2017). To explore whether the increase in mutation rate is replication-
associated, I looked at the protein binding sites that are specific to the highly dividing
spermatogonial cells. Spermatogonia-specific binding sites showed a modest increase
in mutation rates, although not consistently across all replicates tested (Figure 3.13b).
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While in the current work I have considered the protein-binding landscape
map as a whole, only making a distinction between tissue-specific and housekeeping
protein binding sites, in future it would be useful to more specifically interrogate the
nature of these binders.
The mutation measures used here were germline mutations derived or inferred
from large cohort studies. Exploring where those mutations are most likely to occur
and have functional consequences is a question directly relevant to human health. How-
ever, other avenues could be explored to test the dependency of this mutational effect
on replication. Comparisons of numbers, types and locations of mutations acquired
at protein binding sites through multiple generations of slow and fast replicating cells
in culture, for example. Sequencing of individual sperm cell and acquisition of infor-
mation about where mutations have occurred is also one of the potential avenues that
could provide enough power to explore the mutation rate heterogeneity in germline
cells. But with current technology it is not economically feasible to attain a sufficient
discrimination of real mutations from sequencing errors. Future work could involve
investigation of distribution of the de novo mutations that have been phased (ideally
from the a range of the paternal ages), to explore whether most of mutations at the
protein binding sites indeed come from the male germline. This is currently impeded
by the insufficient available data about these mutations.
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6.4 Biased mask model - mechanistic basis for retention
of mutations by proteins at transcription factor
binding sites
An association of the increased mutation rate and DNA-protein interactions leads to a
question about the mechanistic basis of this relationship. The sequence-specific nature
of the interaction of transcriptions factors with DNA makes it counter-intuitive to
assume that a lesion can be occluded or protected from repair at a position that is
crucial for binding. However, as exemplified by the binding motif of CTCF and cancer-
derived mutations (Katainen et al., 2015; Kaiser et al., 2016), there is an increase in
mutation load at positions within the motif that are likely to lead to an abolition of
binding ability (Umer et al., 2016).
There is an open question whether the occurrence of a lesion on a single strand,
such as a mismatch, would similarly lead to loss of binding, and to knowledge, has
not been tested previously beyond base modifications such as methylation (Hashimoto
et al., 2016, 2017). Assuming there is a different outcome for mutation or a single
lesion, the mutational pattern over the CTCF binding motif could be explained by
the ’biased mask model’ that is proposed here. This model explains specific types of
changes at particular positions within binding motifs as a consequence of differential
tolerance of various types of lesions by a TF, possibly in a strand-specific manner. This
is complemented by the level of mutagenesis at positions of interest being consistent
with protection from mismatch repair (Figures 4.11, 4.12, and 4.13), supporting the idea
that a particular type of change can escape surveillance and repair through occlusion
by bound TF. Future work aimed at exploration of larger datasets of mutations from
tumours with impaired mismatch repair would be advantageous, especially if there
was enough power to look at the observed, rather than expected, level of non-repaired
mutations over and next to the binding sites. Also, as only certain subsets of cancer
cohorts appear to exhibit elevated mutations within the motifs, matched cancer type
MMRd data would allow one to explore whether it is certain types of lesions that are
normally protected from repair. Such datasets have been generated by studies such as
Katainen et al. (2015), and procedures toward obtaining these data for further analyses
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have already been initiated.
The presence of unusually highly mutated positions within the motifs of other
TFs, such as KLF4 and EGR1, shows that this is likely to be a generalisable mutational
mechanism which is not specific to just CTCF. The incidence of those mutations are
cancer-type dependent and might be driven by particular processes or occurrences of
distinct types of lesions. In future, it would also be interesting to explore data, such
as recently published study (Corces et al., 2018), where chromatin accessibility and
mutation data is available from the same cancer samples.
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6.5 The biased mask model is supported by the DNA
binding properties of the KLF4 protein
I have experimentally validated the viability of the ’biased mask’ model through testing
binding affinity of KLF4 protein to synthetic DNA sequences with mismatch lesions.
I show that presence of a mismatch, while weakening, does not abolish KLF4 binding
to its target motif (Figure 5.6). There is also evidence of the hypothesised strand
asymmetry in this tolerance. The presence of double-stranded mutation at the tested
position significantly lowers protein binding affinity even further. An important finding
here is that the KLF4 is able to bind over a mismatch, which means a protein could
protect a lesion from being fixed and thereby induce formation of mutation after a
single round of replication, something that has not been demonstrated before for any
DNA-interacting TF.
In future, more high-throughput method for testing other positions and other
TFs could be achieved by optimizing the condition for the anisotropy assay. Testing
of a wider variety of the binders will be necessary for generalization of the biased mask
model to DNA-interacting protein families beyond C2H2 family. In addition to that,
further testing of more diverse types of lesions should be carried out in the future.
Work aimed at this, and purification of CTCF and EGR1 proteins is currently under-
way within the group, carried out by Susan Campbell. Further complementation of this
with the pull-down method described in Section 5.4, will provide another orthogonal
approach towards measuring of the tolerance of the proteins to strand-specific lesions.
In addition, future work on structural and molecular dynamic modelling of
KLF4, CTCF and other zinc finger TFs in the context of mismatches and other lesions





This work explores protein-binding sites as a feature that influences germline regional
mutation rates, showing that those sites are mutational hotspots that could potentially
lead to occurrence of variant that would result in hereditary disease. It also provides
a map of protein-binding sites within germline cells that are potentially most prone to
accumulate those mutations, which could narrow the search space for disease-causing
variants. This elevation in mutation rate at protein-binding sites is expected to be
equally applicable to mutations in somatic cells, that could lead to cancer and other
non-heritable diseases. In addition, this work proposes and experimentally tests a mech-
anistic model through which those mutation escape the normal processes of surveillance
and repair, and are therefore retained in the genome. The results presented in this thesis
will improve our ability to detect genetic mutations and the mechanisms driving these
events which lead to both heritable disease and cancer, which is crucial for widening
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M. S. (2015). Lagging-strand replication shapes the mutational landscape of the
genome. Nature, 518(7540):502–506.
Rhee, H. S. and Pugh, B. F. (2011). Comprehensive genome-wide protein-DNA inter-
actions detected at single-nucleotide resolution. Cell, 147(6):1408–1419.
Richardson, G. M., Lannigan, J., and Macara, I. G. (2015). Does FACS perturb gene
expression? Cytometry Part A, 87(2):166–175.
Roach, J. C., Glusman, G., Smit, A. F. A., Huff, C. D., Shannon, P. T., Rowen, L.,
Pant, K. P., Goodman, N., Shendure, J., Drmanac, R., Jorde, L. B., Hood, L., and
Galas, J. (2011). Analysis of Genetic Inheritance in a Family Quartet by Whole
Genome Sequencing. Science, 328(5978):636–639.
240
BIBLIOGRAPHY 241
Roadmap Epigenomics Consortium, Kundaje, A., Meuleman, W., Ernst, J., Bilenky,
M., Yen, A., Heravi-Moussavi, A., Kheradpour, P., Zhang, Z., Wang, J., Ziller, M. J.,
Amin, V., Whitaker, J. W., Schultz, M. D., Ward, L. D., Sarkar, A., Quon, G.,
Sandstrom, R. S., Eaton, M. L., Wu, Y.-C., Pfenning, A. R., Wang, X., Claussnitzer,
M., Liu, Y., Coarfa, C., Harris, R. A., Shoresh, N., Epstein, C. B., Gjoneska, E.,
Leung, D., Xie, W., Hawkins, R. D., Lister, R., Hong, C., Gascard, P., Mungall,
A. J., Moore, R., Chuah, E., Tam, A., Canfield, T. K., Hansen, R. S., Kaul, R.,
Sabo, P. J., Bansal, M. S., Carles, A., Dixon, J. R., Farh, K.-H., Feizi, S., Karlic, R.,
Kim, A.-R., Kulkarni, A., Li, D., Lowdon, R., Elliott, G., Mercer, T. R., Neph, S. J.,
Onuchic, V., Polak, P., Rajagopal, N., Ray, P., Sallari, R. C., Siebenthall, K. T.,
Sinnott-Armstrong, N. A., Stevens, M., Thurman, R. E., Wu, J., Zhang, B., Zhou,
X., Beaudet, A. E., Boyer, L. A., De Jager, P. L., Farnham, P. J., Fisher, S. J.,
Haussler, D., Jones, S. J. M., Li, W., Marra, M. A., McManus, M. T., Sunyaev,
S., Thomson, J. A., Tlsty, T. D., Tsai, L.-H., Wang, W., Waterland, R. A., Zhang,
M. Q., Chadwick, L. H., Bernstein, B. E., Costello, J. F., Ecker, J. R., Hirst, M.,
Meissner, A., Milosavljevic, A., Ren, B., Stamatoyannopoulos, J. A., Wang, T., and
Kellis, M. (2015). Integrative analysis of 111 reference human epigenomes. Nature,
518(7539):317–30.
Roberts, E. G., Mendez, M., Viner, C., Karimzadeh, M., Chan, R. C. W., Ancar, R.,
Chicco, D., Hesselberth, J. R., Kundaje, A., and Hoffman, M. M. (2016). Semi-
automated genome annotation using epigenomic data and Segway. bioRxiv, page
080382.
Sabarinathan, R., Mularoni, L., Deu-Pons, J., Gonzalez-Perez, A., and Lopez-Bigas,
N. (2015). Nucleotide excision repair is impaired by binding of transcription factors
to DNA. bioRxiv, 532(7598):028886.
Sabarinathan, R., Mularoni, L., Deu-Pons, J., Gonzalez-Perez, A., and López-Bigas,
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